aidx;assay_category;assay_cell_type;assay_chembl_id;assay_classifications;assay_organism;assay_parameters;assay_strain;assay_subcellular_fraction;assay_tax_id;assay_test_type;assay_tissue;assay_type;assay_type_description;bao_format;bao_label;cell_chembl_id;confidence_description;confidence_score;description;document_chembl_id;relationship_description;relationship_type;src_assay_id;src_id;target_chembl_id;tissue_chembl_id;variant_sequence
CLD0;;A-375;CHEMBL618622;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308077;Target assigned is non-molecular;1;Tested in vitro against A-375 cell line human melanoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL613859;;
CLD0;;;CHEMBL635477;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logD7.4);CHEMBL1124835;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL633721;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP);CHEMBL1122587;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;AMML;CHEMBL641185;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307901;Target assigned is non-molecular;1;Compound was tested for the inhibition of AMML (acute myelomonocytic leukemia);CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL614270;;
CLD0;;B16;CHEMBL648676;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;In vitro inhibitory activity against Mouse melanoma (B16) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL381;;
CLD0;;B16;CHEMBL650753;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;Tested in vitro inhibitory activity against murine B16 melanoma cells line;CHEMBL1126561;Non-molecular target assigned;N;;1;CHEMBL381;;
CLD0;;;CHEMBL650218;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Multiple homologous protein targets may be assigned;4;"Beta-blocking activity measured by applying the stepwise linear discriminate analysis; Inactive";CHEMBL1129855;Homologous protein target assigned;H;;1;CHEMBL2094118;;
CLD0;;BSC-1;CHEMBL652997;[];Cercopithecidae;[];;;9527.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307388;Target assigned is non-molecular;1;Inhibition of cellular DNA synthesis in BSCL cells at the dose of 1.4 ug/mL.;CHEMBL1122461;Non-molecular target assigned;N;;1;CHEMBL614528;;
CLD0;;Osteoclast-like;CHEMBL650359;[];Mus musculus;[];;;10090.0;;Bone element;F;Functional;BAO_0000219;cell-based format;CHEMBL3307605;Target assigned is non-molecular;1;Percent inhibition of [123I]UdR incorporation in the DNA synthesis assay in bone marrow cells at a concentration of 10 e-3 M;CHEMBL1122387;Non-molecular target assigned;N;;1;CHEMBL614359;CHEMBL3638214;
CLD0;;CAKI-1;CHEMBL654989;[];Mus sp.;[];;;10095.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;In vitro cytotoxicity was evaluated against renal CAKI-1 cells;CHEMBL1133006;Non-molecular target assigned;N;;1;CHEMBL614067;;
CLD0;;CCRF-CEM;CHEMBL649978;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Concentration required for 50% inhibition of cell growth of CCRF CEM leukemic cell lines in human.;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL657627;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Inhibit the replication of CCRF-CEM cell line in vitro.;CHEMBL1125248;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;MCF7;CHEMBL651490;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Anticancer activity carried out in vitro against breast carcinoma MCF-7;CHEMBL1134486;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;CCRF-CEM;CHEMBL656070;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against CCRF-CEM human leukemic lymphoblastoid cell lines;CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL656080;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;In vitro cytotoxicity of compounds were determined on Inhibition of human leukemia cell line(CCRF-CEM). ;CHEMBL1129397;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL656083;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;In vitro inhibitory activity against Human T-cell acute lymphoblastoid leukemia (CCRF CEM) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL652485;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;In vitro concentration required for 50% inhibition of growth of human leukemia cell line CCRF-CEM with hPAP (0.2 unit/mL);CHEMBL1133824;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL652486;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;In vitro concentration required for 50% inhibition of growth of human leukemia cell line CCRF-CEM without hPAP (0.2 unit/mL);CHEMBL1133824;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL654283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Concentration required to inhibit replication of CCRF-CEM cell lines by 50% after 72 hr incubation;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL653253;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Concentration required to inhibit replication of CCRF-CEM deoxycytidine kinase deficient variant CCRF-CEM(dCK-);CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM/ara-C;CHEMBL653264;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307392;Target assigned is non-molecular;1;Cytotoxicity against CCRF-CEM/ara-C human leukemic lymphoblastoid cell lines;CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL614539;;
CLD0;;CCRF-HSB-2;CHEMBL653265;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307642;Target assigned is non-molecular;1;Antiproliferative effects on CCRF-HSB-2 (human leukemia) cells.;CHEMBL1130421;Non-molecular target assigned;N;;1;CHEMBL614541;;
CLD0;;CCRF-CEM;CHEMBL651477;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;In vitro inhibitory effect on growth of human T-cell acute lymphoblastoid leukemic CCRFCEM cell lines.;CHEMBL1124118;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CHO;CHEMBL876078;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Effect on cross resistance of CHO cells resistant to colchicine (CHRC5);CHEMBL1124835;Non-molecular target assigned;N;;1;CHEMBL613853;;
CLD0;;CML/BC;CHEMBL659398;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308655;Target assigned is non-molecular;1;Compound was tested for the inhibition of CML/BC(chronic myeloid leukemia, blast crisis);CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL614800;;
CLD0;;DLD-1;CHEMBL664537;[];Mus sp.;[];;;10095.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307580;Target assigned is non-molecular;1;In vitro cytotoxicity was evaluated against colon DLD-1 cells;CHEMBL1133006;Non-molecular target assigned;N;;1;CHEMBL614285;;
CLD0;;;CHEMBL665304;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of cytidine deaminase partially purified from mouse kidney.;CHEMBL1122440;Homologous protein target assigned;H;;1;CHEMBL2110;;
CLD0;;;CHEMBL665311;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibitory constant was measured on cytidine/deoxycytidine deaminase;CHEMBL1125190;Homologous protein target assigned;H;;1;CHEMBL4502;;
CLD0;;Epithelial cell;CHEMBL664749;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307627;Target assigned is molecular non-protein target;3;The compound was tested for its ability to inhibit the incorporation of tritiated thymidine into mammalian epithelial cells (DNA) at 30 uM dose;CHEMBL1125851;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL657234;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Rate of deamination was determined against deaminase purified from human acute myeloblastic leukemia cells;CHEMBL1123554;Homologous protein target assigned;H;;1;CHEMBL2448;;
CLD0;;;CHEMBL657235;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Relative velocity was determined against deaminase purified from human acute myeloblastic leukemia cells;CHEMBL1123554;Homologous protein target assigned;H;;1;CHEMBL2448;;
CLD0;;;CHEMBL663661;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibitory concentration against Drosophila melanogaster deoxyribonucleoside kinase (Dm-dNK);CHEMBL1134069;Homologous protein target assigned;H;;1;CHEMBL4760;;
CLD0;;L5178Y;CHEMBL669614;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307690;Homologous single protein target assigned;8;Inhibitory activity against dihydrofolate reductase (DHFR) isolated from murine L5178Y tumor cells resistant and sensitive to methotrexate;CHEMBL1122587;Homologous protein target assigned;H;;1;CHEMBL4564;;
CLD0;;G-401;CHEMBL679422;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308394;Target assigned is non-molecular;1;Tested in vitro against human ovarian cancer cells (G-401) for anticancer activity at dose 0 uM (Cell number 1*10 e-4);CHEMBL1127382;Non-molecular target assigned;N;;1;CHEMBL613509;;
CLD0;;G-401;CHEMBL679425;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308394;Target assigned is non-molecular;1;Tested in vitro against human ovarian cancer cells (G-401) for anticancer activity at dose 1 uM (Cell number 1*10 e-4);CHEMBL1127382;Non-molecular target assigned;N;;1;CHEMBL613509;;
CLD0;;G-401;CHEMBL679427;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308394;Target assigned is non-molecular;1;Tested in vitro against human ovarian cancer cells (G-401) for anticancer activity at dose 10 uM (Cell number 1*10 e-4);CHEMBL1127382;Non-molecular target assigned;N;;1;CHEMBL613509;;
CLD0;;G-401;CHEMBL679587;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308394;Target assigned is non-molecular;1;Tested in vitro against human ovarian cancer cells (G-401) for anticancer activity at dose 100 uM (Cell number 1*10 e-4);CHEMBL1127382;Non-molecular target assigned;N;;1;CHEMBL613509;;
CLD0;;Glioblastoma cell line;CHEMBL681014;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308593;Target assigned is non-molecular;1;Compound was tested for the inhibition of glioblastoma;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL614503;;
CLD0;;HL-60;CHEMBL871954;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Inhibitory activity against HL-60 (human, promyelocytic leukemia) cell line;CHEMBL1145096;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL686516;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Anticancer activity was evaluated for the compound against parent promyelocytic leukemia cell line (HL-60-GHPRT+/dCK+);CHEMBL1123319;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL686517;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Anticancer activity of the compound against ara-C resistant promyelocytic leukemia cell line that is Cyd-kinase deficient (HL-60-HGPRT-/dCK-) is determined;CHEMBL1123319;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL688698;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro inhibitory activity against Human promyelocytic leukemia (HL-60) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL687280;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;The cytotoxic activity in HL-60 cells;CHEMBL1130401;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL688795;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Differentiating activity of compound in HL60 cells at conc 0.016 ug/mL;CHEMBL1130401;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL684637;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Differentiating activity of compound in HL60 cells at conc 0.08 ug/mL;CHEMBL1130401;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL684640;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Differentiating activity of compound in HL60 cells at conc 0.4 ug/mL;CHEMBL1130401;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL695272;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Compound was tested for the inhibition of human HL60 Leukemia;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL689641;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro concentration required to induce apoptosis in HL60 cells;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL689647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro inhibitory concentration against proliferation of HL60 cells;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL689656;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Concentration required for 50% inhibition of cell growth of HL60 leukemic cell lines in human.;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL687002;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro concentration required to induce apoptosis in HL60R cells;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL690288;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro concentration required to induce apoptosis in HL60R cells;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;;CHEMBL691768;[];Human herpesvirus 1;[];;;10298.0;;Kidney;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro antiviral activity against Herpes simplex virus -1 strain KOS was evaluated in african green monkey kidney;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL377;CHEMBL3638241;
CLD0;;;CHEMBL691778;[];Human herpesvirus 1;[];;;10298.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against herpes simplex virus-1.;CHEMBL1159161;Non-molecular target assigned;N;;1;CHEMBL377;;
CLD0;;;CHEMBL694611;[];Human herpesvirus 2;[];;;10310.0;;Kidney;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus -2 strain MS was evaluated in african green monkey kidney;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL370;CHEMBL3638241;
CLD0;;;CHEMBL690817;[];Human herpesvirus 2;[];;;10310.0;;Kidney;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro antiviral activity against Herpes simplex virus -2 strain MS was evaluated in african green monkey kidney;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL370;CHEMBL3638241;
CLD0;;;CHEMBL690823;[];Human herpesvirus 2;[];;;10310.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against herpes simplex virus-2.;CHEMBL1159161;Non-molecular target assigned;N;;1;CHEMBL370;;
CLD0;;BSCL;CHEMBL880036;[];Human herpesvirus 1;[];;;10298.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Growth inhibition against HSV-1 virus in BSCL cells at the dose of 1.4 ug/mL and 22h time of treatment.;CHEMBL1122461;Non-molecular target assigned;N;;1;CHEMBL377;;
CLD0;;;CHEMBL691710;[];Human herpesvirus 1;[];;;10298.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of viral DNA synthesis in HSV-1 virus at the dose of 1.4 ug/mL.;CHEMBL1122461;Non-molecular target assigned;N;;1;CHEMBL377;;
CLD0;;HT-1080;CHEMBL699064;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308396;Target assigned is non-molecular;1;Tested in vitro against HT1080 cell line human fibrosarcoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614580;;
CLD0;;;CHEMBL689919;[];Human herpesvirus 1;[];;;10298.0;;Kidney;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus -1 strain KOS was evaluated in african green monkey kidney;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL377;CHEMBL3638241;
CLD0;;HeLa;CHEMBL696160;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against HeLa human cell lines after 144 hr;CHEMBL1123889;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HeLa;CHEMBL874178;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against HeLa human cell lines after 72 hr;CHEMBL1123889;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HOS;CHEMBL695997;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308811;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human osteosarcoma HOS tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614736;;
CLD0;;HT-1080;CHEMBL695998;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308396;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human fibrosarcoma HT1080 tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614580;;
CLD0;;KHOS-321H ;CHEMBL696003;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308382;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human osteosarcoma KHOS-321H tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614591;;
CLD0;;MFH-ST;CHEMBL698909;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308652;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human malignant fibrous histiocytoma MFH-ST tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614796;;
CLD0;;MG-63;CHEMBL698911;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308498;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human osteosarcoma MG-63 tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614347;;
CLD0;;MKN-28;CHEMBL698914;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307602;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human stomach adenocarcinoma MKN-28 tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614353;;
CLD0;;HOS-TE85;CHEMBL698915;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307282;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human osteosarcoma MNNG-HOS tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614038;;
CLD0;;NCC;CHEMBL696461;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308410;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human renal cell carcinoma NCC-nu tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614190;;
CLD0;;NUGC-4;CHEMBL696463;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307267;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human stomach adenocarcinoma NUGC-4 tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL613519;;
CLD0;;OST;CHEMBL696629;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307563;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human osteosarcoma OST tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614210;;
CLD0;;PC-13;CHEMBL697063;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307865;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human lung large-cell carcinoma PC-13 tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614100;;
CLD0;;PC-3;CHEMBL697962;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human lung adenocarcinoma PC-3 tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;PC-6;CHEMBL697963;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307571;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human lung small-cell carcinoma PC-6 tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614235;;
CLD0;;PC-8;CHEMBL697964;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307866;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human lung adenocarcinoma PC-8 tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614101;;
CLD0;;PC-9;CHEMBL697965;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307867;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human lung adenocarcinoma PC-9 tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614102;;
CLD0;;QG-56;CHEMBL695855;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307796;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human lung suamous-cell carcinoma QG-56 tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL612268;;
CLD0;;SAOS-2;CHEMBL694103;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307737;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human osteosarcoma SAOS-2 tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614894;;
CLD0;;SK-ES1;CHEMBL694686;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307826;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human osteosarcoma SK-ES-1 tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL613970;;
CLD0;;ST-KM-1;CHEMBL872041;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307828;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human stomach adenocarcinoma ST-KM tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL613972;;
CLD0;;T-24;CHEMBL694852;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human bladder transitional cell carcinoma T-24 tumor cells;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL614774;;
CLD0;;U2OS;CHEMBL697856;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;In vitro inhibitory effect measured against human osteosarcoma U20-S tumor cells at 100 ug/mL;CHEMBL1125651;Non-molecular target assigned;N;;1;CHEMBL615023;;
CLD0;;KB ;CHEMBL699944;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against KB human cell lines after 144 hr;CHEMBL1123889;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL699945;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against KB human cell lines after 72 hr;CHEMBL1123889;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;L1210 (1565);CHEMBL700050;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307841;Target assigned is non-molecular;1;Tested in vitro inhibitory activity against murine L 1210 leukemia cells line;CHEMBL1126561;Non-molecular target assigned;N;;1;CHEMBL614000;;
CLD0;;KKLS;CHEMBL702246;[];Homo sapiens;[];;;9606.0;;Stomach;F;Functional;BAO_0000219;cell-based format;CHEMBL3307839;Target assigned is non-molecular;1;Tested in vitro against KKLS human stomach adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL613996;CHEMBL3638185;
CLD0;;K562;CHEMBL700229;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;In vitro inhibitory effect on growth of human chronic myelogenous leukemic K562 cell lines.;CHEMBL1124118;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL704801;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Evaluated for erythroid induction of benzidine-positive K562 cells at concentration 3 mM;CHEMBL1131873;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL701088;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Effect of compound on erythroid differentiation of K562 cells was determined after a period of 3 days at concentration 500 nM;CHEMBL1131873;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL701092;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Effect of compound on erythroid differentiation of K562 cells was determined after a period of 5 days at concentration 500 nM;CHEMBL1131873;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL700090;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Effect of compound on erythroid differentiation of K562 cells was determined after a period of 7 days at concentration 500 nM;CHEMBL1131873;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL700257;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Effect of compound on erythroid differentiation of K562 cells was determined after a period of 9 days at concentration 500 nM;CHEMBL1131873;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL872512;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Concentration required for 50% inhibition of cell growth of K562 leukemic cell lines in human.;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL705727;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Inhibition of cell growth against human myeloid leukemia K562(S) cells;CHEMBL1131873;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;KATO III stomach cancer cell line;CHEMBL700750;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308432;Target assigned is non-molecular;1;In vitro inhibitory activity against Human gastric carcinoma (KATO III) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL612700;;
CLD0;;KATO III stomach cancer cell line;CHEMBL700751;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308432;Target assigned is non-molecular;1;Tested for in vitro cytotoxicity against KATO III human stomach adenocarcinoma cell line;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL612700;;
CLD0;;KATO III stomach cancer cell line;CHEMBL700753;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308432;Target assigned is non-molecular;1;Concentration required for 50% inhibition of human lung squamous cell carcinoma KATO III solid cell lines. ;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL612700;;
CLD0;;KATO III stomach cancer cell line;CHEMBL700926;[];Homo sapiens;[];;;9606.0;;Stomach;F;Functional;BAO_0000219;cell-based format;CHEMBL3308432;Target assigned is non-molecular;1;Tested in vitro against KATO-III human stomach adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL612700;CHEMBL3638185;
CLD0;;KB ;CHEMBL704862;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;In vitro inhibitory activity against Human oral epidermoid carcinoma (KB) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL705481;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Tested for in vitro cytotoxicity against KB human oral epidermoid carcinoma cell line;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL706147;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Default value - Target unknown or has yet to be assigned;0;Tested in vitro inhibitory activity against human oral epidermoid carcinoma KB cells;CHEMBL1126568;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;L1210;CHEMBL703526;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by change in tumor weight at 100 mg/kg (treatment of 1-9qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703529;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '300.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '300.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by change in tumor weight at 300 mg/kg (treatment of 1-5qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703941;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '400.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted L1210 leukemia in mice by change in tumor weight at 400 mg/kg (treatment of 1-5qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703942;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '400.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted L1210 leukemia in mice by change in tumor weight at 400 mg/kg (treatment of 1qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702726;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by range in survival days at 100 mg/kg (treatment of 1-9qd schedule) dosage; Range is 11-18";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL701734;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '300.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '300.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by range in survival days at 300 mg/kg (treatment of 1-5qd schedule) dosage; Range is 15-18";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL701744;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro inhibitory effect on growth of mouse leukemic L1210 cell lines.;CHEMBL1124118;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL701008;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Apparent inhibition of incorporation of labeled thymidine into DNA in murine leukemia L1210 cell;No inhibition";CHEMBL1123684;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL699582;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro antitumor activity against L1210 cell line in mice.;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702177;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by range in survival days at 200 mg/kg (treatment of 1-5qd schedule) dosage; Range is 15-17";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702186;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '400.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by range in survival days at 400 mg/kg (treatment of 1qd schedule) dosage; Range is 9-11";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708644;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent increase in life span at 100 mg/kg (treatment of 1-9qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL709276;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '300.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '300.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent increase in life span at 300 mg/kg (treatment of 1-5qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL709281;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent increase in life span at 200 mg/kg (treatment of 1-5qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708741;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '400.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent increase in life span at 400 mg/kg (treatment of 1qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705244;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity against ic implanted L1210 lymphoid leukemia in mice expressed as active dose range (1-5qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 50-300";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705245;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity against ic implanted L1210 lymphoid leukemia in mice expressed as active dose range (1-9qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 100-300";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705251;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity against ip implanted L1210 leukemia in mice expressed as active dose range (1-5qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 5-350";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707468;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted L1210 leukemia in mice by 45-day survivors in mice at 200 mg/kg (treatment of 1-5qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707473;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '400.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted L1210 leukemia in mice by 45-day survivors in mice at 400 mg/kg (treatment of 1qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702952;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent median survival rate (treated/control) at 100 mg/kg (treatment of 1-9qd schedule) dosage; 14/7.0";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704627;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '300.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '300.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent median survival rate (treated/control) at 300 mg/kg (treatment of 1-5qd schedule) dosage; 16.0/7.0";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704632;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent median survival rate (treated/control) at 200 mg/kg (treatment of 1-5qd schedule) dosage; 17.0/7.0";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL701479;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '400.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent median survival rate (treated/control) at 400 mg/kg (treatment of 1qd schedule) dosage; 9.5/8.0";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705942;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Concentration required to inhibit replication of L1210 cell lines by 50% after 72 hr incubation;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705948;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Effective dose to inhibit the replication of L1210 cell line in vitro.;CHEMBL1125248;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705950;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro cytotoxicity with cleavage by phosphodiesterase-I concentration for 50% loss of viability was determined at 72 hours.;CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704562;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested for its antiproliferative activity on murine leukemia L1210 cells;CHEMBL1129846;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704563;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested in vitro inhibitory activity against murine leukemia L1210;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707114;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '156.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '156.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 156 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707115;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '208.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '208.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 208 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707116;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '34.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '34.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 34 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707117;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '56.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '56.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 56 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707118;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '93.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '93.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 93 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703722;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '156.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '156.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 156 mg/kg dose (post inoculation life span, days);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703723;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '208.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '208.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 208 mg/kg dose (post inoculation life span, days);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703724;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '34.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '34.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 34 mg/kg dose (post inoculation life span, days);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL880807;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '56.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '56.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 56 mg/kg dose (post inoculation life span, days);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703725;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '93.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '93.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 93 mg/kg dose (post inoculation life span, days);CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703887;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Compound was tested for percent increase in life span against L1210 lymphoid leukemia;CHEMBL1123674;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702613;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against the ic implanted L1210 lymphoid leukemia in mice expressed as optimal dose (1-5qd treatment schedule) required to produce greatest increase in life span was determined;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702615;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against the ic implanted L1210 lymphoid leukemia in mice expressed as optimal dose (1-9qd treatment schedule) required to produce greatest increase in life span was determined;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702617;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against the ip implanted L1210 leukemia in mice expressed as optimal dose (1-5qd treatment schedule) required to produce greatest increase in life span was determined;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL702618;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against the ip implanted L1210 leukemia in mice expressed as optimal dose (1 qd treatment schedule) required to produce greatest increase in life span was determined;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703294;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested in vitro for cytotoxicity against L1210 leukemia cell line in mouse;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL857778;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cross resistance profile versus L1210/R71 cells.;CHEMBL1124835;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707922;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Concentration required for 50% inhibition of cell growth of L1210 leukemic cell lines in mouse.;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L5178Y;CHEMBL701931;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307690;Target assigned is non-molecular;1;The compound was tested for anticancer activity against L5178Y (arc-C resistant) cell lines of mouse leukemia;CHEMBL1121538;Non-molecular target assigned;N;;1;CHEMBL614720;;
CLD0;;L5178Y;CHEMBL701932;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307690;Target assigned is non-molecular;1;The compound was tested for anticancer activity against L5178Y (sensitive) cell lines of mouse leukemia;CHEMBL1121538;Non-molecular target assigned;N;;1;CHEMBL614720;;
CLD0;;L1210;CHEMBL711690;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 25 mg/kg/day x 5 was determined as percentage increase in the life span as compared with control tumor bearers;CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710344;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 5 mg/kg/day x 5 was determined as percentage increase in the life span as compared with control tumor bearers;CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710353;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 9.2 mg/kg/day x 5 was determined as percentage increase in the life span as compared with control tumor bearers;CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710355;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 18.2 mg/kg/day x 5 was determined as percentage increase in the life span as compared with control tumor bearers;CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710361;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 18.2 mg/kg/day x 5 was determined as Survival time in days; Range is 10-19 days";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710260;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 25 mg/kg/day x 5 was determined as Survival time in days; Range is 9-16 days";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710262;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 5 mg/kg/day x 5 was determined as Survival time in days; Range is 9-22 days";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL709478;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 9.2 mg/kg/day x 5 was determined as Survival time in days; Range is 14-42 days";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710140;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 18.2 mg/kg/day x 5 was determined and number of animals survived on 30 th day were reported; 0/8";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710144;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 25 mg/kg/day x 5 was determined and number of animals survived on 30 th day were reported; 0/8";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710289;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 5 mg/kg/day x 5 was determined and number of animals survived on 30 th day were reported; 0/7";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL711141;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 9.2 mg/kg/day x 5 was determined and number of animals survived on 30 th day were reported; 1/7";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704300;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose of 18.2 mg/kg/day x 5 was determined as mean survival of treated group compared to untreated; 14.5/10";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703789;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose of 25 mg/kg/day x 5 was determined as mean survival of treated group compared to untreated; 9.5/8";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703682;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose of 5 mg/kg/day x 5 was determined as mean survival of treated group compared to untreated; 13.5/9";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;Lewis lung carcinoma cell line;CHEMBL703695;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307859;Target assigned is non-molecular;1;Tested for in vitro cytotoxicity against LLC Lewis lung carcinoma cell line;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL614088;;
CLD0;;L1210;CHEMBL708559;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose of 9.2 mg/kg/day x 5 was determined as mean survival of treated group compared to untreated; 17/9";CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708572;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 25 mg/kg/day x 5 was determined as weight change (g/mouse) on 8th day;CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708574;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 5 mg/kg/day x 5 was determined as weight change (g/mouse) on 8th day;CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707124;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 9.2 mg/kg/day x 5 was determined as weight change (g/mouse) on 8th day;CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707126;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 18.2 mg/kg/day x 5 was determined as weight change (g/mouse) on 8th day;CHEMBL1121364;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707128;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of L1210 lymphoid leukemia cells 24 hr after administration (length of preincubation=0 hr);CHEMBL1126194;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL709115;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of L1210 lymphoid leukemia cells 48 hr after administration (length of preincubation=0 hr);CHEMBL1126194;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL873018;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of L1210 lymphoid leukemia cells 72 hr after administration (length of preincubation=0 hr);CHEMBL1126194;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707528;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against the L1210 murine cell lines after 72 hours;CHEMBL1123889;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL712032;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory concentration on multidrug-resistant L1210 leukemia cells.;CHEMBL1125271;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL712033;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory concentration on parentral (sensitive) L1210 leukemia cells.;CHEMBL1125271;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;MCF7;CHEMBL705897;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Tested in vitro against MCF-7 human breast adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;HOS-TE85;CHEMBL710604;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307282;Target assigned is non-molecular;1;Tested in vitro against MNNG/HOS cell line human osteosarcoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614038;;
CLD0;;MOLT-4;CHEMBL711767;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;In vitro inhibitory effect on growth of human T-cell acute lymphoblastic leukemic MOLT 4 cell lines.;CHEMBL1124118;Non-molecular target assigned;N;;1;CHEMBL614177;;
CLD0;;MOLT-4;CHEMBL709467;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;Cytotoxicity against MOLT-4 human leukemic lymphoblastoid cell lines;CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL614177;;
CLD0;;MOLT-4;CHEMBL854761;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;In vitro inhibitory activity against Human T-cell acute lymphoblastic leukemia (MOLT-4) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL614177;;
CLD0;;MOLT-4;CHEMBL714945;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;Concentration required for 50% inhibition of cell growth of MOLT-4 leukemic cell lines in human.;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL614177;;
CLD0;;L1210;CHEMBL714950;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro antiproliferative activity was measured in mouse myeloma L1210 cell line;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MPC-11;CHEMBL714951;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307317;Target assigned is non-molecular;1;In vitro antiproliferative activity was measured in mouse myeloma MPC-11 cell line;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL614179;;
CLD0;;MPC-11;CHEMBL714952;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307317;Target assigned is non-molecular;1;In vitro lethal dose was measured in mouse myeloma MPC-11 cell line;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL614179;;
CLD0;;MKN-45;CHEMBL707718;[];Homo sapiens;[];;;9606.0;;Stomach;F;Functional;BAO_0000219;cell-based format;CHEMBL3307603;Target assigned is non-molecular;1;Tested in vitro against MKN-45 human stomach adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614354;CHEMBL3638185;
CLD0;;;CHEMBL716139;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Number of animals survived after 30-days in mice bearing lymphoid leukemia, treatment schedule is 1-5 qd.;CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL718517;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Number of animals survived after 30-days in mice bearing lymphoid leukemia, treatment schedule is 1-9 qd.;CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL720569;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span at 100 mg/kg (411 umol) per day;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL720574;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span at 200 mg/kg (822 umol) per day;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL720584;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '71.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '71.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span at 71 mg/kg (292 umol) per day;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL720521;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span calculated as (T/C-1)X100 at a dose of 10 mg/kg/day *5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL720522;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span calculated as (T/C-1)X100 at a dose of 20 mg/kg/day X5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL720524;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span calculated as (T/C-1)X100 at a dose of 40 mg/kg/day X5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL720526;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span in mice bearing lymphoid leukemia, treatment schedule is 1-5 qd.;CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL720527;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span in mice bearing lymphoid leukemia, treatment schedule is 1-9 qd.;CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL724308;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of drug-treated mice relative to tumored, vehicle treated controls at a dose of 100 mg/kg oral treatment;CHEMBL1125796;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL721881;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of drug-treated mice relative to tumored, vehicle treated controls at a dose of 500 mg/kg oral treatment;CHEMBL1125796;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL721882;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of drug-treated mice relative to tumored, vehicle treated controls at a dose of 500 mg/kg orally in the presence of 500 mg/kg of zebularine.;CHEMBL1125796;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL724210;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of leukemic mice administered, with compound at 100 mg/kgx5, intraperitoneally;CHEMBL1124443;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL724213;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of leukemic mice administered, with compound at 50 mg/kgx5, intraperitoneally;CHEMBL1124443;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL721972;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"In vivo activity against transplanted Mam-16/C/ Taxol tumors of mice; Not active";CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL721973;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"In vivo activity against transplanted Mam-16/C/Adr tumors of mice; Not active";CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL726142;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for the ability to suppress humoral immune response in mice treated for days 0,+1,and +2 at dose of 25 mg/kg (control = 7.0);CHEMBL1121811;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL723571;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Median survival day of mice bearing lymphoid leukemia was determined, treatment schedule is 1-9 qd.; 25/10.5";CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729753;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Median survival time expressed as (T/C) was measured at dose of 10 mg/kg/day *5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729757;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Median survival time expressed as (T/C) was measured at dose of 20 mg/kg/day X5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729761;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Median survival time expressed as (T/C) was measured at dose of 40 mg/kg/day X5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL880123;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Number of mice survived after 30 days;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL731179;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Median survival day of mice bearing lymphoid leukemia was determined, treatment schedule is 1-5 qd.; 15.5/9.5";CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729669;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Change in weight of mouse on day 8 was measured in L1210 lymphoid leukemia inoculated mice after ip administration at dose of 10 mg/kg/day *5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729670;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Change in weight of mouse on day 8 was measured in L1210 lymphoid leukemia inoculated mice after ip administration at dose of 20 mg/kg/day X5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729672;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Change in weight of mouse on day 8 was measured in L1210 lymphoid leukemia inoculated mice after ip administration at dose of 40 mg/kg/day X5;CHEMBL1121968;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL731006;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Dose producing greatest increase in life span >/=25% in mice bearing lymphoid leukemia, treatment schedule is 1-5 qd; 5-80 [mg(umol)/kg] /day";CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL728568;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Dose producing greatest increase in life span >/=25% in mice bearing lymphoid leukemia, treatment schedule is 1-9 qd; 5-20 [mg(umol)/kg] /day";CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729824;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Dose producing greatest increase in life span of mice bearing lymphoid leukemia, treatment schedule is 1-5 qd.;CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729825;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antitumor activity against intraperitoneally inoculated L1210 Lymphoid leukemic mice (Dose producing greatest increase in life span, treatment schedule is 1- 9 qd);CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729383;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against iv transplanted AML Leukemia 1498 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734242;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against iv transplanted Leukemia L1210 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734243;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted Mam-16/C tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL879666;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted Mam-17 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734247;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted Mam-17/Adr tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL859316;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted Mel-B16 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734248;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted Panc-02 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734249;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted Panc-03 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734250;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted Squam lung-LC12 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734251;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted colon-26 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734252;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted colon-38 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734253;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activity against transplanted colon-51 tumors of mice;CHEMBL1134487;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL839847;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Number of survivors in mice bearing ip-implanted L1210 lymphoid leukemia after 45 day;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL731281;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Median T/C calculated based on survivors at 100 mg/kg (411 umol) per day against Ip-implanted L1210 lymphoid leukemia mice;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL733505;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Median T/C calculated based on survivors at 200 mg/kg (822 umol) per day against Ip-implanted L1210 lymphoid leukemia mice;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL733666;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '71.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '71.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Median T/C calculated based on survivors at 71 mg/kg (292 umol) per day against Ip-implanted L1210 lymphoid leukemia mice;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL732987;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antitumor activity against intraperitoneally inoculated L1210 lymphoid leukemic mice (Weight change observed on day 8.Treatment schedule is 1-9 qd);CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL732991;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight change observed on day 8 in mice bearing lymphoid leukemia, treatment schedule is 1-5 qd.;CHEMBL1122886;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730146;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 tumor in mice, at a dose of 500 mg/kg peroral administration in the presence of 100 mg/kg of zebularine.;CHEMBL1125796;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730147;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 tumor in mice, at a dose of 500 mg/kg peroral administration in the presence of 10 mg/kg of zebularine.;CHEMBL1125796;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL878125;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 tumor in mice, at a dose of 500 mg/kg peroral administration in the presence of 500 mg/kg of zebularine.;CHEMBL1125796;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730148;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 tumor in mice, at a dose of 500 mg/kg peroral administration.;CHEMBL1125796;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730605;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Change in weight in mice bearing ip-implanted L1210 lymphoid leukemia on day 8 at 100 mg/kg or 411 umol/kg per day;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730606;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Change in weight in mice bearing ip-implanted L1210 lymphoid leukemia on day 8 at 200 mg/kg or 822 umol/kg per day;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730609;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '71.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '71.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Change in weight in mice bearing ip-implanted L1210 lymphoid leukemia on day 8 at 71 mg/kg or 292 umol/kg per day;CHEMBL1127065;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL733941;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Average survival time includes only those mice that died prior to day 60 at 25 mg/kg;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL733942;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Average survival time includes only those mice that died prior to day 60 at 50 mg/kg;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL732365;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '75.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '75.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Average survival time includes only those mice that died prior to day 60 at 75 mg/kg;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL735645;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 1000 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL735646;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 100 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736258;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 200 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736675;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 250 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736683;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 500 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL878389;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 50 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736686;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 1000 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736687;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 100 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736825;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 250 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736826;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '468.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '468.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 468 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736827;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 500 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736828;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 50 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737220;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage increase in life span after 9-12 days;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737228;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against the P388/doxorubicin resistant murine cell lines after 72 hours;CHEMBL1123889;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737231;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 1000 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737232;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 100 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737240;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 200 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL734279;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 250 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738726;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 500 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738727;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 50 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739317;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 1000 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739318;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 100 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743174;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 200 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743176;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 250 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743179;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 500 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743180;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 50 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736522;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase of life span was determined against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 200 mg/kg per day after treatment 1-5;CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739857;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase of life span was determined against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 1;CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739859;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Increase of life span was determined against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 5;CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737995;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage increase in life span after 12-13days;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737996;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage increase in life span after 13-15 days;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737997;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage increase in life span after 15-18 days;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737999;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage increase in life span after 17-21 days;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738154;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage increase in life span after 7-8 days;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738156;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage increase in life span after 7 days;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742201;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Range of survival days for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 200 mg/kg per day after treatment 1-5; range is 15-17";CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL740852;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Range of survival days for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 1; range is 8-10";CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741452;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Range of survival days for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 5;CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;Lewis lung carcinoma cell line;CHEMBL740408;[{'assay_class_id': 82, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Carcinoma', 'source': 'phenotype'}, {'assay_class_id': 84, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Lewis Lung Carcinoma', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307859;Target assigned is non-molecular;1;In vivo percent inhibition of Lewis Lung Carcinoma cell line in mice at 100 mg/Kg per day (p<0.001) compared with NCDAC;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;Lewis lung carcinoma cell line;CHEMBL740411;[{'assay_class_id': 82, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Carcinoma', 'source': 'phenotype'}, {'assay_class_id': 84, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Lewis Lung Carcinoma', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307859;Target assigned is non-molecular;1;In vivo percent inhibition of Lewis Lung Carcinoma cell line in mice drug at 200 mg/Kg per day (p<0.001) compared with NCDAC;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741472;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741473;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1,5,9);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741474;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1-15);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741475;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1-5);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743184;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1-9);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743186;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C II) (qd 1-5);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742961;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;No of survivors after 45 days at a dose of 100 mg/kg/day;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742962;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;No of survivors after 45 days at a dose of 100 mg/kg/day;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742963;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;No of survivors after 45 days at a dose of 200 mg/kg/day;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742964;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;No of survivors after 45 days at a dose of 200 mg/kg/day;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742965;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;No of survivors after 45 days at a dose of 300 mg/kg/day;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742966;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;No of survivors after 45 days at a dose of 60 mg/kg/day;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742967;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;No of survivors after 45 days at a dose of 60 mg/kg/day;CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743095;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '75.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '75.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Long time survivors are the number mice that survived for >60 days relative to the number of treated mice at 75 mg/kg; 0 / 5";CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743097;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Long time survivors are the number mice that survived for >60 days relative to the number of treated mice 25 mg/kg; 0 / 5";CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743098;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Long time survivors are the number mice that survived for >60 days relative to the number of treated mice at 50 mg/kg; 0 / 5";CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742270;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Toxicity in mice after 12-13 days at a dose of 100 mg/kg/day; 12/8";CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741763;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Toxicity in mice after 15-18 days at a dose of 60 mg/kg/day; 15.5/8.5";CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741765;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Toxicity in mice after 17-21 days at a dose of 60 mg/kg/day; 21/8.5";CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL740838;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Toxicity in mice after 7-8 days at a dose of 100 mg/kg/day; 7/9";CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL740839;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Toxicity in mice after 7-8 days at a dose of 200 mg/kg/day; 8/9";CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743067;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Toxicity in mice after 9-12 days at a dose of 200 mg/kg/day; 10.5/9.5";CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743069;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Toxicity in mice after 13-15 days at a dose of 60 mg/kg/day; 14/8.5";CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743220;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Toxicity in mice after 7 days at a dose of 200 mg/kg/day; 7/9";CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742611;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 1000 mg/kg; Value represented as Test/Control = 15/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741974;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 100 mg/kg; Value represented as Test/Control = 16/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743573;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 200 mg/kg; Value represented as Test/Control = 17/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743044;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 250 mg/kg; Value represented as Test/Control = 13/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743665;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 500 mg/kg; Value represented as Test/Control = 13/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743666;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 50 mg/kg; Value represented as Test/Control = 14/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742018;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 1000 mg/kg; Value represented as Test/Control = 8/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742019;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 100 mg/kg; Value represented as Test/Control = 7/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742647;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 200 mg/kg; Value represented as Test/Control = 7/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742649;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 250 mg/kg; Value represented as Test/Control = 9/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742652;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 500 mg/kg; Value represented as Test/Control = 9/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742653;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 50 mg/kg; Value represented as Test/Control = 8/8";CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745456;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ratio of survival time of treated to control mice at 25 mg/kg;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745457;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ratio of survival time of treated to control mice at 50 mg/kg;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746038;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '75.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '75.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ratio of survival time of treated to control mice at 75 mg/kg;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746214;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Survival time treated / survival time (T/C) for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 200 mg/kg per day after treatment 1-5;16/7";CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL747523;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Survival time treated / survival time (T/C) for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 1;8/7";CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL747525;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Survival time treated / survival time (T/C) for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 5;10/7";CHEMBL1124763;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743884;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 1000 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746057;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 100 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742537;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 200 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL742542;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 250 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744515;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 500 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL880074;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 50 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744518;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 1000 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744519;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 100 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743770;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 200 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL743774;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 250 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745276;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 500 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745277;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 50 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745280;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 1000 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745281;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 100 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745284;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 200 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745286;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 250 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745289;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 500 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL880070;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 50 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745292;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 1000 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745293;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 100 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744541;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 200 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744543;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '250.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 250 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744546;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 500 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744547;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 50 mg/kg;CHEMBL1122008;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL748521;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mean body weight change on 17th day at a dose of 100 mg/kg/day;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL748522;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mean body weight change on 17th day at a dose of 200 mg/kg/day;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL748523;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mean body weight change on 5th day at a dose of 100 mg/kg/day;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL748524;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mean body weight change on 5th day at a dose of 200 mg/kg/day;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744528;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 100 mg/kg/day (qd=1,5,9);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744531;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 200 mg/kg/day (qd=1);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744533;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 60 mg/kg/day (qd=1-15);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744534;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 60 mg/kg/day (qd=1-5);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL744535;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 60 mg/kg/day (qd=1-9);CHEMBL1124302;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746651;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Death due to toxicity occurring at a maximum body weight decrease of 10 to 22% from the average post injection body weight at 25 mg/kg; 2 / 5";CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746652;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Death due to toxicity occurring at a maximum body weight decrease of 10 to 22% from the average post injection body weight at 50 mg/kg; 5 / 5";CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746653;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '75.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '75.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Death due to toxicity occurring at a maximum body weight decrease of 10 to 22% from the average post injection body weight at 75 mg/kg; 5 / 5";CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;Lewis lung carcinoma cell line;CHEMBL744149;[{'assay_class_id': 82, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Carcinoma', 'source': 'phenotype'}, {'assay_class_id': 84, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Lewis Lung Carcinoma', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307859;Target assigned is non-molecular;1;Tested for in vivo antitumor activity against Lewis Lung Carcinoma cell line in mice and tumor weight change at 100 mg/Kg per day;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;Lewis lung carcinoma cell line;CHEMBL744030;[{'assay_class_id': 82, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Carcinoma', 'source': 'phenotype'}, {'assay_class_id': 84, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Lewis Lung Carcinoma', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307859;Target assigned is non-molecular;1;Tested for in vivo antitumor activity against Lewis Lung Carcinoma cell line in mice and tumor weight change at 200 mg/Kg per day;CHEMBL1126569;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL741865;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Anticancer activity carried out in vitro against murine leukemia L1210;CHEMBL1134486;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL741866;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory activity against murine leukemia L1210 cells;CHEMBL1125745;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;P388;CHEMBL741868;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Anticancer activity carried out in vitro against murine leukemia P388;CHEMBL1134486;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;NCI-H23;CHEMBL882027;[];Mus sp.;[];;;10095.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;"In vitro cytotoxicity was evaluated against lung NCI-H23 cells; 1 x 10E1";CHEMBL1133006;Non-molecular target assigned;N;;1;CHEMBL614997;;
CLD0;;OST;CHEMBL753722;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307563;Target assigned is non-molecular;1;Tested in vitro against OST human osteosarcoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614210;;
CLD0;;P388;CHEMBL750172;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Concentration required to inhibit replication of P388 cell lines by 50% after 72 hr incubation;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL755832;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vitro antitumor activity against P388 cell line in mice.;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;SK-MEL-28;CHEMBL757832;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;In vitro inhibitory activity against Human melanoma (P-36) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL614919;;
CLD0;;P388;CHEMBL758686;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Effective dose to inhibit the replication of P388 cell line in vitro.;CHEMBL1125248;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL757452;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Antitumor activity against ip implanted P388 leukemia in mice expressed as active dose range (1-5qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 20-200";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL757456;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Antitumor activity against ip implanted P388 leukemia in mice expressed as active dose range (1 qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 100-600";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756732;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against the P388 murine cell lines after 72 hours;CHEMBL1123889;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL760569;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against the ip implanted P388 leukemia in mice expressed as optimal dose (1-5qd treatment schedule) required to produce greatest increase in life span was determined;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL760571;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against the ip implanted P388 leukemia in mice expressed as optimal dose (1 qd treatment schedule) required to produce greatest increase in life span was determined;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758638;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Antitumor activity was determined against the ip implanted P388 leukemia in mice by range in survival days at 200 mg/kg (treatment of 1-5qd schedule) dosage; Range is 22-24";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758326;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Antitumor activity was determined against the ip implanted P388 leukemia in mice by range in survival days at 500 mg/kg (treatment of 1qd schedule) dosage; Range is 14-15";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756469;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted P388 leukemia in mice by 45-day survivors in mice at 200 mg/kg (treatment of 1-5qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756472;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted P388 leukemia in mice by 45-day survivors in mice at 500 mg/kg (treatment of 1qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL759382;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted P388 leukemia in mice by percent increase in life span at 200 mg/kg (treatment of 1-5qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756296;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted P388 leukemia in mice by percent increase in life span at 500 mg/kg (treatment of 1qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756315;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Antitumor activity was determined against the ip implanted P388 leukemia in mice by percent median survival rate (treated/control) at 200 mg/kg (treatment of 1-5qd schedule) dosage; 23.0/11.0";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756914;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Antitumor activity was determined against the ip implanted P388 leukemia in mice by percent median survival rate (treated/control) at 500 mg/kg (treatment of 1qd schedule) dosage; 15.0/11.0";CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL754761;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent inhibition of [123I]UdR incorporation in the DNA synthesis assay in P388 cell lines at a concentration of 10 E-3 M;CHEMBL1122387;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P815;CHEMBL759531;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307568;Target assigned is non-molecular;1;The compound was tested for anticancer activity against P815(arc-C resistant) cell lines of mouse leukemia;CHEMBL1121538;Non-molecular target assigned;N;;1;CHEMBL614226;;
CLD0;;P815;CHEMBL759532;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307568;Target assigned is non-molecular;1;The compound was tested for anticancer activity against P815 (sensitive) cell lines of mouse leukemia;CHEMBL1121538;Non-molecular target assigned;N;;1;CHEMBL614226;;
CLD0;;P388;CHEMBL758404;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted P388 leukemia in mice by change in tumor weight at 200 mg/kg (treatment of 1-5qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758407;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity was determined against the ip implanted P388 leukemia in mice by change in tumor weight at 500 mg/kg (treatment of 1qd schedule) dosage;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL857658;[];para influenza virus type 3;[];;;11309.0;;Kidney;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Para influenza virus type 3 strain C243 was evaluated in african green monkey kidney;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL613126;CHEMBL3638241;
CLD0;;;CHEMBL761890;[];para influenza virus type 3;[];;;11309.0;;Kidney;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro antiviral activity against Para influenza virus type 3 strain C243 was evaluated in african green monkey kidney;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL613126;CHEMBL3638241;
CLD0;;PC10;CHEMBL761060;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307345;Target assigned is non-molecular;1;In vitro inhibitory activity against Human lung squamous cell carcinoma (PC-10) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL614234;;
CLD0;;PC-13;CHEMBL758465;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307865;Target assigned is non-molecular;1;In vitro inhibitory activity against Human lung large-cell carcinoma (PC-13) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL614100;;
CLD0;;PC-13;CHEMBL764657;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307865;Target assigned is non-molecular;1;Tested in vitro against PC-13 human lung large cell carcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614100;;
CLD0;;PC-14;CHEMBL764660;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307306;Target assigned is non-molecular;1;In vitro inhibitory activity against Human lung adenocarcinoma (PC-14) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL614140;;
CLD0;;PC-6;CHEMBL759722;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307571;Target assigned is non-molecular;1;In vitro inhibitory activity against Human lung small-cell carcinoma (PC-6) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL614235;;
CLD0;;PC-8;CHEMBL761193;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307866;Target assigned is non-molecular;1;Tested in vitro against PC-8 human lung adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614101;;
CLD0;;PC-9;CHEMBL761200;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307867;Target assigned is non-molecular;1;Tested in vitro against PC-9 human lung adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614102;;
CLD0;;PC10;CHEMBL761204;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307345;Target assigned is non-molecular;1;In vitro inhibitory effect on growth of human lung squamous cell carcinoma cell lines (PC10).;CHEMBL1124118;Non-molecular target assigned;N;;1;CHEMBL614234;;
CLD0;;PC10;CHEMBL761205;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307345;Target assigned is non-molecular;1;Concentration required for 50% inhibition of human lung squamous cell carcinoma PC10 solid cell lines. ;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL614234;;
CLD0;;PC-14;CHEMBL762698;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307306;Target assigned is non-molecular;1;Concentration required for 50% inhibition of human lung squamous cell carcinoma PC14 solid cell lines. ;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL614140;;
CLD0;;QG-95;CHEMBL765756;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307290;Target assigned is non-molecular;1;Tested in vitro against QG-95 human squamous cell carcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614052;;
CLD0;;RPMI 6410;CHEMBL770692;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307429;Target assigned is non-molecular;1;Cytotoxicity against RPMI-6410 human leukemic lymphoblastoid cell lines;CHEMBL1122440;Non-molecular target assigned;N;;1;CHEMBL614881;;
CLD0;;kidney;CHEMBL770522;[];Oryctolagus cuniculus;[];;;9986.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Concentration required to reduce DNA synthesis in primary rabbit kidney cells using [3H-Methyl]-dThd incorporation;CHEMBL1123394;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;kidney;CHEMBL770523;[];Oryctolagus cuniculus;[];;;9986.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Concentration required to reduce RNA synthesis in primary rabbit kidney cells using [3H-5]-Urd incorporation;CHEMBL1123394;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;kidney;CHEMBL770524;[];Oryctolagus cuniculus;[];;;9986.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Concentration required to reduce protein synthesis in primary rabbit kidney cells usingi [3H2-4,5]leucine incorporation;CHEMBL1123394;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;kidney;CHEMBL882655;[];Oryctolagus cuniculus;[];;;9986.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Dose required to reduce primary rabbit kidney cell growth;CHEMBL1123394;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;CCRF S-180;CHEMBL801460;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307278;Target assigned is non-molecular;1;Concentration required to inhibit replication of S-180 cell lines by 50% after 72 hr incubation;CHEMBL1125190;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;SNB-7;CHEMBL879238;[];Mus sp.;[];;;10095.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308418;Target assigned is non-molecular;1;"In vitro cytotoxicity was evaluated againstCNS SNB-7 cells; 1 x 10E1";CHEMBL1133006;Non-molecular target assigned;N;;1;CHEMBL614930;;
CLD0;;ST-KM-1;CHEMBL807503;[];Homo sapiens;[];;;9606.0;;Stomach;F;Functional;BAO_0000219;cell-based format;CHEMBL3307828;Target assigned is non-molecular;1;Tested in vitro against ST-KM human stomach adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL613972;CHEMBL3638185;
CLD0;;SW480;CHEMBL804021;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Target assigned is non-molecular;1;Concentration required for 50% inhibition of human lung squamous cell carcinoma SW 480 solid cell lines. ;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL612544;;
CLD0;;SW48;CHEMBL802155;[];Homo sapiens;[];;;9606.0;;Colon;F;Functional;BAO_0000219;cell-based format;CHEMBL3307292;Target assigned is non-molecular;1;Tested in vitro against SW-48 human colon adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614055;CHEMBL3638202;
CLD0;;SW480;CHEMBL803889;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Target assigned is non-molecular;1;In vitro inhibitory activity against Human colon adenocarcinoma (SW-480) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL612544;;
CLD0;;SK-MEL-28;CHEMBL809110;[];Mus sp.;[];;;10095.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;In vitro cytotoxicity was evaluated against melanoma SK-MEL-28 cells;CHEMBL1133006;Non-molecular target assigned;N;;1;CHEMBL614919;;
CLD0;;SW480;CHEMBL806558;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Target assigned is non-molecular;1;In vitro inhibitory effect on growth of human colon adenocarcinoma cell lines (SW480).;CHEMBL1124118;Non-molecular target assigned;N;;1;CHEMBL612544;;
CLD0;;CCRF S-180;CHEMBL803791;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307278;Target assigned is non-molecular;1;Effective dose to inhibit the replication of S180 cell line in vitro.;CHEMBL1125248;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;Small cell lung cancer cell line;CHEMBL805566;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307802;Target assigned is non-molecular;1;Compound was tested for the inhibition of small cell lung cancer;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL612561;;
CLD0;;MOLT-4;CHEMBL812941;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;Anticancer activity carried out in vitro against human T-lymphocyte Molt4/C8;CHEMBL1134486;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MOLT-4;CHEMBL812944;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Default value - Target unknown or has yet to be assigned;0;Compound was evaluated for its antiproliferative activity on human T-lymphocyte Molt4/C8 cells;CHEMBL1129846;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;T-24;CHEMBL810945;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;In vitro inhibitory effect on growth of human bladder transitional-carcinoma cell lines (T24).;CHEMBL1124118;Non-molecular target assigned;N;;1;CHEMBL614774;;
CLD0;;T-24;CHEMBL810952;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;Concentration required for 50% inhibition of human lung squamous cell carcinoma T24 solid cell lines. ;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL614774;;
CLD0;;TE-2;CHEMBL814170;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307467;Target assigned is non-molecular;1;In vitro inhibitory activity against Human esophagus adenocarcinoma (TE-2) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL615011;;
CLD0;;TE-2;CHEMBL814174;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307467;Target assigned is non-molecular;1;In vitro inhibitory effect on growth of human esophagus adenocarcinoma cell lines (TE2).;CHEMBL1124118;Non-molecular target assigned;N;;1;CHEMBL615011;;
CLD0;;TE-2;CHEMBL814175;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307467;Target assigned is non-molecular;1;Concentration required for 50% inhibition of human lung squamous cell carcinoma TE2 solid cell lines. ;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL615011;;
CLD0;;T-24;CHEMBL811354;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;In vitro inhibitory activity against Human bladder transitional-cell carcinoma (T-24) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL614774;;
CLD0;;CCRF-CEM;CHEMBL810388;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Default value - Target unknown or has yet to be assigned;0;Compound was evaluated for its antiproliferative activity on human T-lymphocyte CEM cells;CHEMBL1129846;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL809664;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Anticancer activity carried out in vitro against human T-lymphocyte CEM/0;CHEMBL1134486;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL810051;[];Herpes simplex virus (type 1 / strain SC16);[];;;10309.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibitory concentration against Herpes simplex virus type 1 thymidine kinase(HSV-1 TK);CHEMBL1134069;Direct protein target assigned;D;;1;CHEMBL1820;;
CLD0;;;CHEMBL810055;[];Human herpesvirus 1;[];;;10298.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Phosphorylating activity of viral HSV -1 (KOS) induced thymidine kinase relative to dThdK was determined;CHEMBL1123554;Direct protein target assigned;D;;1;CHEMBL1795127;;
CLD0;;;CHEMBL810058;[];Human herpesvirus 2;[];;;10310.0;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Phosphorylating activity of viral HSV -2 (333) induced thymidine kinase relative to dThdK was determined;CHEMBL1123554;Homologous protein target assigned;H;;1;CHEMBL1820;;
CLD0;;;CHEMBL819083;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Rate of phosphorylation relative to human CytodCydK was determined;CHEMBL1123554;Homologous protein target assigned;H;;1;CHEMBL2883;;
CLD0;;;CHEMBL819084;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Rate of phosphorylation relative to human CytodThdK was determined;CHEMBL1123554;Homologous protein target assigned;H;;1;CHEMBL2883;;
CLD0;;;CHEMBL819086;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Rate of phosphorylation relative to human MitoThdK was determined;CHEMBL1123554;Homologous protein target assigned;H;;1;CHEMBL2883;;
CLD0;;;CHEMBL819108;[];Human herpesvirus 3;[];;;10335.0;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibitory concentration against Varicella- zoster virus thymidine kinase(VZV TK);CHEMBL1134069;Homologous protein target assigned;H;;1;CHEMBL4784;;
CLD0;;;CHEMBL819111;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibitory concentration against cytosolic thymidine kinase (TK-1);CHEMBL1134069;Direct protein target assigned;D;;1;CHEMBL2883;;
CLD0;;;CHEMBL815477;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibitory concentration against mitochondrial thymidine kinase (TK-2);CHEMBL1134069;Direct protein target assigned;D;;1;CHEMBL4580;;
CLD0;;L1210;CHEMBL818067;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308391;Homologous single protein target assigned;8;Inhibition of thymidylate synthase in L1210 cells;CHEMBL1123319;Homologous protein target assigned;H;;1;CHEMBL3160;;
CLD0;;U-937;CHEMBL815115;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;In vitro inhibitory activity against Human histiocytic lymphoma (U-937) cell line.;CHEMBL1125609;Non-molecular target assigned;N;;1;CHEMBL612794;;
CLD0;;U-937;CHEMBL817606;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Concentration required for 50% inhibition of cell growth of U937 leukemic cell lines in human.;CHEMBL1125887;Non-molecular target assigned;N;;1;CHEMBL612794;;
CLD0;;;CHEMBL824280;[];Vaccinia virus;[];;;10245.0;;Kidney;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Vaccinia virus strain Elstree was evaluated in african green monkey kidney;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL613493;CHEMBL3638241;
CLD0;;;CHEMBL824451;[];Vaccinia virus;[];;;10245.0;;Kidney;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro antiviral activity against Vaccinia virus strain Elstree was evaluated in african green monkey kidney;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL613493;CHEMBL3638241;
CLD0;;Vero;CHEMBL820111;[];Chlorocebus sabaeus;[];;;60711.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;In vitro cytotoxicity against Vero cells.;CHEMBL1122970;Non-molecular target assigned;N;;1;CHEMBL391;;
CLD0;;COLO 320;CHEMBL872806;[];Homo sapiens;[];;;9606.0;;Colon;F;Functional;BAO_0000219;cell-based format;CHEMBL3307577;Target assigned is non-molecular;1;Tested in vitro against colo-320 human colon adenocarcinoma;CHEMBL1126568;Non-molecular target assigned;N;;1;CHEMBL614257;CHEMBL3638202;
CLD0;;Non-small cell lung cancer cell line;CHEMBL872828;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308576;Target assigned is non-molecular;1;Compound was tested for the inhibition of non- small cell lung cancer;CHEMBL1123247;Non-molecular target assigned;N;;1;CHEMBL615002;;
CLD0;;;CHEMBL844951;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 for Parental L1210 to that of multidrug resistant L1210.;CHEMBL1125271;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL881731;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Ratio of GI50 without hPAP/ GI50 with hPAP;CHEMBL1133824;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Panel NCI-60 (60 carcinoma cell lines);CHEMBL867669;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307560;Target assigned is non-molecular;1;Antiproliferative activity against NCI60 cell line;CHEMBL1138988;Non-molecular target assigned;N;;1;CHEMBL614194;;
CLD0;;NCI60;CHEMBL867670;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Activity against NCI60 cell line xenograft in nude mouse by HF assay;CHEMBL1138988;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;Hepatocyte;CHEMBL854848;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Target assigned is non-molecular;1;Production of araCTP in rat hepatocytes at 100 uM measured as AUC (0-4h);CHEMBL1138220;Non-molecular target assigned;N;;1;CHEMBL613362;;
CLD0;;;CHEMBL854867;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss Webster;;10090.0;In vivo;Liver;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Distribution of araCTP in Swiss Webster mouse liver at 100 mg/kg, ip measured as AUC (0-4h);CHEMBL1138220;Non-molecular target assigned;N;;1;CHEMBL613580;CHEMBL3559723;
CLD0;;;CHEMBL856525;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss Webster;;10090.0;In vivo;Plasma;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Drug level in Swiss Webster mouse plasma at 100 mg/kg, ip measured as AUC (0-4h);CHEMBL1138220;Non-molecular target assigned;N;;1;CHEMBL613589;CHEMBL3559721;
CLD0;;;CHEMBL855498;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss Webster;;10090.0;In vivo;Bone marrow;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Distribution of araCTP in Swiss Webster mouse bone marrow at 100 mg/kg, ip measured as AUC (0-4h);CHEMBL1138220;Non-molecular target assigned;N;;1;CHEMBL613563;CHEMBL3638253;
CLD0;;;CHEMBL855499;[];Mus musculus;[];Swiss Webster;;10090.0;;Liver;F;Functional;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Ratio of AUC for araCTP level in liver to plasma of Swiss Webster mouse;CHEMBL1138220;Non-molecular target assigned;N;;1;CHEMBL613580;CHEMBL3559723;
CLD0;;;CHEMBL855500;[];Mus musculus;[];Swiss Webster;;10090.0;;Liver;F;Functional;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Ratio of AUC for araCTP level in liver to bone marrow of Swiss Webster mouse;CHEMBL1138220;Non-molecular target assigned;N;;1;CHEMBL613580;CHEMBL3559723;
CLD0;;L1210/0;CHEMBL918058;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse L1210/0 cells after 48 hrs;CHEMBL1142978;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;NCI-H460;CHEMBL919713;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Growth inhibition of human NCI-H460 cells by MTT assay;CHEMBL1144504;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;HCT-116;CHEMBL919714;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Growth inhibition of human HCT116 cells by MTT assay;CHEMBL1144504;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;A-431;CHEMBL919715;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307523;Target assigned is non-molecular;1;Growth inhibition of human A431 cells by MTT assay;CHEMBL1144504;Non-molecular target assigned;N;;1;CHEMBL614069;;
CLD0;;CCRF-HSB-2;CHEMBL919716;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307642;Target assigned is non-molecular;1;Growth inhibition of human CCRF-HSB-2 cells by MTT assay;CHEMBL1144504;Non-molecular target assigned;N;;1;CHEMBL614541;;
CLD0;;KB ;CHEMBL919717;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Growth inhibition of human KB cells by MTT assay;CHEMBL1144504;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;A549;CHEMBL912074;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against A549 cells after 72 hrs by SRB assay;CHEMBL1147151;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;SW1573;CHEMBL912075;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307980;Target assigned is non-molecular;1;Cytotoxicity against SW1573 cells after 72 hrs by SRB assay;CHEMBL1147151;Non-molecular target assigned;N;;1;CHEMBL612570;;
CLD0;;CCRF-HSB-2;CHEMBL906781;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307642;Target assigned is non-molecular;1;Antitumor activity against human CCRF-HSB2 cells by modified MTT assay;CHEMBL1143758;Non-molecular target assigned;N;;1;CHEMBL614541;;
CLD0;;KB ;CHEMBL906782;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antitumor activity against human KB cells by modified MTT assay;CHEMBL1143758;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL886766;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human TK1 assessed as [methyl-3H]dThd phosphorylation;CHEMBL1139173;Direct protein target assigned;D;;1;CHEMBL2883;;
CLD0;;;CHEMBL886767;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human TK2 assessed as [methyl-3H]dThd phosphorylation;CHEMBL1139173;Direct protein target assigned;D;;1;CHEMBL4580;;
CLD0;;;CHEMBL886768;[];Human herpesvirus 1;[];;;10298.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of HSV1 TK assessed as [methyl-3H]dThd phosphorylation;CHEMBL1139173;Direct protein target assigned;D;;1;CHEMBL1795127;;
CLD0;;;CHEMBL886770;[];Drosophila melanogaster;[];;;7227.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of Drosophila melanogaster dNK assessed as [methyl-3H]dThd phosphorylation;CHEMBL1139173;Direct protein target assigned;D;;1;CHEMBL4760;;
CLD0;;;CHEMBL886771;[];Human herpesvirus 3;[];;;10335.0;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of VZV TK assessed as [methyl-3H]dThd phosphorylation;CHEMBL1139173;Homologous protein target assigned;H;;1;CHEMBL4784;;
CLD0;;CCRF-HSB-2;CHEMBL929830;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307642;Target assigned is non-molecular;1;Antitumor activity against human CCRF-HSB2 cells by MTT assay;CHEMBL1143144;Non-molecular target assigned;N;;1;CHEMBL614541;;
CLD0;;KB ;CHEMBL929831;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antitumor activity against human KB cells by MTT assay;CHEMBL1143144;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;L1210;CHEMBL1014839;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against mouse L1210 cells after 3 days by trypan blue exclusion technique;CHEMBL1158984;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;MOLT-3;CHEMBL1014840;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307556;Target assigned is non-molecular;1;Cytotoxicity against human TMOLT3 cells after 3 days by trypan blue exclusion technique;CHEMBL1158984;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL1014841;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 3 days by trypan blue exclusion technique;CHEMBL1158984;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;SW480;CHEMBL1014842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Target assigned is non-molecular;1;Cytotoxicity against human SW480 cells after 3 days by trypan blue exclusion technique;CHEMBL1158984;Non-molecular target assigned;N;;1;CHEMBL612544;;
CLD0;;HeLa S3;CHEMBL1014843;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3886002;Target assigned is non-molecular;1;Cytotoxicity against human HeLaS3 cells after 3 days by trypan blue exclusion technique;CHEMBL1158984;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MB9812;CHEMBL1014844;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human MB9812 cells after 3 days by trypan blue exclusion technique;CHEMBL1158984;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1017485;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human EH118MG cells after 3 days by trypan blue exclusion technique;CHEMBL1158984;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL987362;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Escherichia coli ATCC 25922 after 20 hrs;CHEMBL1155163;Non-molecular target assigned;N;;1;CHEMBL354;;
CLD0;;;CHEMBL987363;[];Streptococcus sp.;[];;;1306.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Streptococcus sp. 07941-1 after 20 hrs;CHEMBL1155163;Non-molecular target assigned;N;;1;CHEMBL614621;;
CLD0;;;CHEMBL987364;[];Streptococcus sp.;[];;;1306.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Streptococcus sp. 07706-1 after 20 hrs;CHEMBL1155163;Non-molecular target assigned;N;;1;CHEMBL614621;;
CLD0;;;CHEMBL987365;[];Streptococcus sp.;[];;;1306.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Streptococcus sp. 07686-2 after 20 hrs;CHEMBL1155163;Non-molecular target assigned;N;;1;CHEMBL614621;;
CLD0;;;CHEMBL987366;[];Staphylococcus aureus;[];;;1280.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 20 hrs;CHEMBL1155163;Non-molecular target assigned;N;;1;CHEMBL352;;
CLD0;;;CHEMBL987367;[];Staphylococcus aureus;[];;;1280.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Staphylococcus aureus CCM 885 after 20 hrs;CHEMBL1155163;Non-molecular target assigned;N;;1;CHEMBL352;;
CLD0;;;CHEMBL987368;[];Streptococcus pyogenes;[];AP1;;1314.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Streptococcus pyogenes AP1 after 20 hrs;CHEMBL1155163;Non-molecular target assigned;N;;1;CHEMBL356;;
CLD0;;SF-268;CHEMBL978893;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Cytotoxicity against human SF268 cells by MTT assay;CHEMBL1138617;Non-molecular target assigned;N;;1;CHEMBL613977;;
CLD0;;HT-29;CHEMBL981345;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981346;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 10 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981347;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981348;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981349;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;P388;CHEMBL981350;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981351;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981352;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981353;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;L1210;CHEMBL984102;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against mouse L1210 cells at 0.15 ug/disk by corbett disk diffusion assay;CHEMBL1147292;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;;CHEMBL984954;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against mouse Panc03 cells at 1.5 ug/disk by corbett disk diffusion assay;CHEMBL1147292;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;Vero;CHEMBL1004763;[];Chlorocebus sabaeus;[];;;60711.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay;CHEMBL1150133;Non-molecular target assigned;N;;1;CHEMBL391;;
CLD0;;Vero;CHEMBL1004764;[];Human herpesvirus 1;[];F;;10298.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiviral activity against HSV1 F infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay;CHEMBL1150133;Non-molecular target assigned;N;;1;CHEMBL377;;
CLD0;;Vero;CHEMBL1004765;[];Human herpesvirus 2;[];MS;;10310.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiviral activity against HSV2 MS infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay;CHEMBL1150133;Non-molecular target assigned;N;;1;CHEMBL370;;
CLD0;;;CHEMBL970837;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;Inhibition of rat brain protein kinase C;CHEMBL1156703;Direct protein target assigned;D;;1;CHEMBL2094266;;
CLD0;;KB ;CHEMBL970838;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Growth inhibition of human KB cells by MTT assay;CHEMBL1156703;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL970839;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of pp60c-src;CHEMBL1156703;Homologous protein target assigned;H;;1;CHEMBL267;;
CLD0;;KB ;CHEMBL973959;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells;CHEMBL1144073;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;HeLa;CHEMBL973960;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa S3 cells;CHEMBL1144073;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;CCRF-HSB-2;CHEMBL992583;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307642;Target assigned is non-molecular;1;Growth inhibition of human CCRF-HSB-2 cells by MTT method;CHEMBL1142473;Non-molecular target assigned;N;;1;CHEMBL614541;;
CLD0;;KB ;CHEMBL992584;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Growth inhibition of human KB cells by MTT method;CHEMBL1142473;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL1030633;[];Human herpesvirus 1;[];;;10298.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against HSV1 assessed as inhibition of virus-induced cytopathicity;CHEMBL1136856;Non-molecular target assigned;N;;1;CHEMBL377;;
CLD0;;;CHEMBL1030634;[];Human herpesvirus 2;[];;;10310.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against HSV2 assessed as inhibition of virus-induced cytopathicity;CHEMBL1136856;Non-molecular target assigned;N;;1;CHEMBL370;;
CLD0;;CCRF-HSB-2;CHEMBL953282;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307642;Target assigned is non-molecular;1;Antitumor activity against human CCRF-HSB2 cells by MTT assay;CHEMBL1151793;Non-molecular target assigned;N;;1;CHEMBL614541;;
CLD0;;KB ;CHEMBL953283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antitumor activity against human KB cells by MTT assay;CHEMBL1151793;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL965578;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOA;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3681;;
CLD0;;;CHEMBL965580;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOB;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3050;;
CLD0;;K562;CHEMBL959867;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Inhibition of erythroid differentiation in human K562 cell assessed benzidine positive cells at 200 uM after 6 days by benzidine staining assay;CHEMBL1139356;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;2209-23;CHEMBL1013705;[];Hepatitis C virus;[];;;11103.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Hepatitis C virus infected human 2209-23 cells by genotype 1b replicon assay;CHEMBL1139326;Non-molecular target assigned;N;;1;CHEMBL379;;
CLD0;;WST1;CHEMBL1013706;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human 2209-23 cells by WST1 cell ciability assay;CHEMBL1139326;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;2209-23;CHEMBL1013707;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human 2209-23 cells by [3H]thymidine incorporation scintillation proximity assay;CHEMBL1139326;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;K562;CHEMBL957685;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells;CHEMBL1153870;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL957686;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Induction of erythroid differentiation in human K562 cells assessed as benzidine-positive cells after 6 days;CHEMBL1153870;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL957693;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Induction of erythroid differentiation in human K562 cells assessed as benzidine-positive cells at 500 mM after 6 days;CHEMBL1153870;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;;CHEMBL1027767;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Volume of distribution at steady state in human administered 1 to 12 g doses with 2 to 3.5 hrs iv infusion;CHEMBL1158480;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;HCT-116;CHEMBL1053106;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells by sulforhodamine B method;CHEMBL1152442;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;A549;CHEMBL1053107;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells by sulforhodamine B method;CHEMBL1152442;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;SNU-638;CHEMBL1053108;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307747;Target assigned is non-molecular;1;Cytotoxicity against human SNU638 cells by sulforhodamine B method;CHEMBL1152442;Non-molecular target assigned;N;;1;CHEMBL614935;;
CLD0;;T47D;CHEMBL1053109;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;Cytotoxicity against human T47D cells by sulforhodamine B method;CHEMBL1152442;Non-molecular target assigned;N;;1;CHEMBL614361;;
CLD0;;PC-3;CHEMBL1053110;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells by sulforhodamine B method;CHEMBL1152442;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;K562;CHEMBL1053111;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells by sulforhodamine B method;CHEMBL1152442;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL1055751;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1055752;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM/C2 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL1055754;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL60/MX2;CHEMBL1055755;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;CCRF S-180;CHEMBL1061700;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor weight at 89.28 umol/kg/day, ip administered for 7 consecutive days after 24 hrs of tumor implantation measured after 24 hrs post dose;CHEMBL1153507;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;NCI-H441;CHEMBL1059099;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308121;Target assigned is non-molecular;1;Cytotoxicity against human H441 cells after 72 hrs by trypan blue cell exclusion assay;CHEMBL1154024;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;NCI-H441;CHEMBL1059100;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308121;Target assigned is non-molecular;1;Cytotoxicity in human H441 cells at 2 uM after 72 hrs by trypan blue cell exclusion assay;CHEMBL1154024;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;NCI-H441;CHEMBL1059104;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308121;Target assigned is non-molecular;1;Cytotoxicity against human H441 cells by serum lactate dehydrogenase assay;CHEMBL1154024;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;NCI-H441;CHEMBL1059105;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308121;Target assigned is non-molecular;1;Cytotoxicity against human H441 cells by glucosaminidase assay;CHEMBL1154024;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL1059210;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs by MTT assay;CHEMBL1153578;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HeLa;CHEMBL1059211;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 48 hrs by MTT assay;CHEMBL1153578;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;;CHEMBL1059214;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Lipophilicity, log P of the compound;CHEMBL1153578;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;CCRF S-180;CHEMBL1043046;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as inhibition of tumor growth at 89 umol/kg, ip administered 24 hrs after tumor implantation once daily for 7 consecutive days measured after 24 hrs last post dose;CHEMBL1154089;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL1043049;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as decrease in tumor weight at 89 umol/kg, ip administered 24 hrs after tumor implantation once daily for 7 consecutive days measured after 24 hrs last post dose;CHEMBL1154089;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;HeLa;CHEMBL1045386;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as inhibition of cell proliferation after 48 hrs;CHEMBL1156792;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;CCRF-CEM;CHEMBL1045387;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CEM cells assessed as inhibition of cell proliferation after 48 hrs;CHEMBL1156792;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;L1210;CHEMBL1045388;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against mouse L1210 cells assessed as inhibition of cell proliferation after 48 hrs;CHEMBL1156792;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;CCRF-CEM;CHEMBL1041582;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against deoxynucleoside analogue-sensitive human CCRF-CEM cells after 3 days by MTT assay;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CEM/ARAC8C;CHEMBL1041583;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against nucleoside transporter deficient and deoxynucleoside analogue-resistant human CEM/ARAC8C cells after 3 days by MTT assay;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;L1210;CHEMBL1041584;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against deoxynucleoside analogue-sensitive mouse L1210 cells after 3 days by MTT assay;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL1041585;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against deoxycytidine kinase deficient and nucleoside analogue-resistant mouse L1210 10K cells after 3 days by MTT assay;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;MES-SA ;CHEMBL1041586;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;Cytotoxicity against deoxynucleoside analogue-sensitive human MESSA cells after 3 days by MTT assay;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MESSA 10K;CHEMBL1041587;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against deoxycytidine kinase deficient and deoxynucleoside analogue-resistant human MESSA 10K cells after 3 days by MTT assay;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MCF7;CHEMBL1041588;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against deoxynucleoside analogue-sensitive human MCF7 cells after 3 days by MTT assay;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL1041589;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against deoxynucleoside analogue-resistant human MCF7 1K cells overexpressing ribonucleotide reductase after 3 days by MTT assay;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;CCRF-CEM;CHEMBL1041598;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Resistance ratio of IC50 for deoxynucleoside analogue-resistant human CEM/ARAC8C cells to IC50 for deoxynucleoside analogue-sensitive human CCRF-CEM cells;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;L1210;CHEMBL1041599;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Resistance ratio of IC50 for deoxynucleoside analogue-resistant mouse L1210 10K cells to IC50 for deoxynucleoside analogue-sensitive mouse L1210 cells;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;MES-SA ;CHEMBL1041600;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Default value - Target unknown or has yet to be assigned;0;Resistance ratio of IC50 for deoxynucleoside analogue-resistant human MESSA 10K cells to IC50 for deoxynucleoside analogue-sensitive human MESSA cells;CHEMBL1152537;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;MCF7;CHEMBL1041601;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Resistance ratio of IC50 for deoxynucleoside analogue-resistant human MCF7 1K cells to IC50 for deoxynucleoside analogue-sensitive human MCF7 cells;CHEMBL1152537;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MV4-11;CHEMBL1106929;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308063;Target assigned is non-molecular;1;Antiproliferative activity against wild type FLT3 expressing human MV411 cells after 72 hrs by WST8 assay;CHEMBL1155384;Non-molecular target assigned;N;;1;CHEMBL613835;;
CLD0;;RS4-11;CHEMBL1106055;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308247;Target assigned is non-molecular;1;Antiproliferative activity against human RS4:11 cells having FLT3-ITD mutation after 72 hrs by WST8 assay;CHEMBL1155384;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;L1210;CHEMBL1102063;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against mouse L1210 cells after 2 days;CHEMBL1153735;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;CCRF-CEM;CHEMBL1102065;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CEM cells after 2 days;CHEMBL1153735;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;MOLT-4;CHEMBL1106339;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;Antitumor activity against human MOLT4 cells after 24 hrs by MTT assay;CHEMBL1156336;Non-molecular target assigned;N;;1;CHEMBL614177;;
CLD0;;HCT-116;CHEMBL1106340;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Antitumor activity against human HCT116 cells after 24 hrs by MTT assay;CHEMBL1156336;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;SW-620;CHEMBL1106341;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;Antitumor activity against human SW620 cells after 24 hrs by MTT assay;CHEMBL1156336;Non-molecular target assigned;N;;1;CHEMBL612262;;
CLD0;;MCF7;CHEMBL1106342;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antitumor activity against human MCF7 cells after 24 hrs by MTT assay;CHEMBL1156336;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI-H460;CHEMBL1106343;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Antitumor activity against human H460 cells after 24 hrs by MTT assay;CHEMBL1156336;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;;CHEMBL1108963;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Octanol-water partition coefficient, log P of the compound;CHEMBL1157036;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;SF-268;CHEMBL1168911;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Cytotoxicity against human SF268 cells after 3 days by MTT assay;CHEMBL1165908;Non-molecular target assigned;N;;1;CHEMBL613977;;
CLD0;;SFME;CHEMBL1175569;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against mouse SFME cells after 24 hrs by MTT assay;CHEMBL1177862;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1175570;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against mouse r/m HM-SFME-1 cells after 24 hrs by MTT assay;CHEMBL1177862;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1216998;[];Trypanosoma cruzi;[];;;5693.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trypanosoma cruzi;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL368;;
CLD0;;;CHEMBL1216999;[];Trypanosoma brucei brucei;[];;;5702.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trypanosoma brucei brucei;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612851;;
CLD0;;;CHEMBL1217000;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Plasmodium falciparum;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1217001;[];Trypanosoma brucei;[];;;5691.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trypanosoma brucei;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612849;;
CLD0;;;CHEMBL1217002;[];Leishmania;[];;;5658.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1217004;[];Trichomonas vaginalis;[];;;5722.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trichomonas vaginalis;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612884;;
CLD0;;;CHEMBL1217005;[];Toxoplasma gondii;[];;;5811.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Toxoplasma gondii;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612888;;
CLD0;;;CHEMBL1217006;[];Leishmania mexicana;[];;;5665.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania mexicana;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612880;;
CLD0;;;CHEMBL1217007;[];Entamoeba histolytica;[];;;5759.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Entamoeba histolytica;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612853;;
CLD0;;;CHEMBL1217008;[];Leishmania amazonensis;[];;;5659.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania amazonensis;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612877;;
CLD0;;;CHEMBL1217009;[];Leishmania donovani;[];;;5661.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania donovani;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL367;;
CLD0;;;CHEMBL1217010;[];Leishmania infantum;[];;;5671.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania infantum;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612848;;
CLD0;;;CHEMBL1217011;[];Leishmania major;[];;;5664.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania major;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612879;;
CLD0;;;CHEMBL1217012;[];Cryptosporidium parvum;[];;;5807.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Cryptosporidium parvum;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612855;;
CLD0;;;CHEMBL1217013;[];Trypanosoma brucei rhodesiense;[];;;31286.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trypanosoma brucei rhodesiense;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612348;;
CLD0;;;CHEMBL1217186;[];Pneumocystis carinii;[];;;4754.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Pneumocystis carinii;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL613064;;
CLD0;;HepG2;CHEMBL1225703;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay;CHEMBL1221334;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;Bel-7402;CHEMBL1225705;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307770;Target assigned is non-molecular;1;Cytotoxicity against human Bel7402 cells after 24 hrs by MTT assay;CHEMBL1221334;Non-molecular target assigned;N;;1;CHEMBL614279;;
CLD0;;K562;CHEMBL1225706;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 24 hrs by MTT assay;CHEMBL1221334;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;CCRF S-180;CHEMBL1225708;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells transplanted in ICR mouse assessed as inhibition of tumor weight at 8.9 umol/kg, ip;CHEMBL1221334;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL1225709;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells transplanted in ICR mouse assessed as inhibition of tumor weight at 89 umol/kg, ip;CHEMBL1221334;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL1225710;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells transplanted in ICR mouse assessed as inhibition of tumor weight at 0.89 umol/kg, ip;CHEMBL1221334;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;;CHEMBL1266185;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay;CHEMBL1255231;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614171;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1967;7;CHEMBL1293298;;
CLD0;confirmatory;;CHEMBL1614174;[];Bacillus subtilis;[];;;1423.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1490;7;CHEMBL1293248;;
CLD0;confirmatory;;CHEMBL1614310;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation of Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1459;7;CHEMBL1293235;;
CLD0;confirmatory;;CHEMBL1614317;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;435019;7;CHEMBL612545;;
CLD0;confirmatory;Epithelial cell;CHEMBL1614318;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307627;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Luminescence-based dose response cell-based high throughput screening assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line. (Class of assay: confirmatory) [Related pubchem assays: 1858 (Summary AID.), 1825 (Counterscreen.), 1907 (Confirmation screen.)];CHEMBL1201862;Default value - Target has yet to be curated;U;1972;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))];CHEMBL1201862;Direct protein target assigned;D;1030;7;CHEMBL3577;;
CLD0;confirmatory;;CHEMBL1614459;[];Drosophila;[];;;7215.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;2685;7;CHEMBL612545;;
CLD0;confirmatory;MEF;CHEMBL1613805;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307598;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2668;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL1614544;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1487;7;CHEMBL1293235;;
CLD0;confirmatory;;CHEMBL1614550;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Luminescence Cell-Based HTS Dose Confirmation to Identify Inhibitors of of 5&apos;UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]";CHEMBL1201862;Default value - Target has yet to be curated;U;2454;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613869;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)];CHEMBL1201862;Default value - Target has yet to be curated;U;1990;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613871;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of Luciferase Translation or Activity in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)];CHEMBL1201862;Default value - Target has yet to be curated;U;2458;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613914;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2147;7;CHEMBL1293226;;
CLD0;confirmatory;;CHEMBL1614009;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2660;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL1614052;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1461;7;CHEMBL5162;;
CLD0;confirmatory;;CHEMBL1614065;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of 5&apos;UTR Stem-Loop Driven Prion Protein mRNA Translation in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";CHEMBL1201862;Default value - Target has yet to be curated;U;2452;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614079;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485314;7;CHEMBL2392;;
CLD0;confirmatory;;CHEMBL1614137;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of of 5&apos;UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";CHEMBL1201862;Default value - Target has yet to be curated;U;1988;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614211;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2517;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1614217;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1472, 1467 ];CHEMBL1201862;Direct protein target assigned;D;2107;7;CHEMBL2524;;
CLD0;confirmatory;;CHEMBL1614293;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2667;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL1614433;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV. (Class of assay: confirmatory) [Related pubchem assays: 1705, 1707 ];CHEMBL1201862;Homologous protein target assigned;H;1708;7;CHEMBL1293285;;
CLD0;confirmatory;;CHEMBL1613776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1479;7;CHEMBL1947;;
CLD0;confirmatory;;CHEMBL1613842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1458;7;CHEMBL1293232;;
CLD0;confirmatory;;CHEMBL1613941;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;463097;7;CHEMBL1293278;;
CLD0;;KB ;CHEMBL1647299;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells assessed as inhibition of protein biosynthesis;CHEMBL1641486;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;;CHEMBL1697778;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697779;[];Rodentia;[];;;9989.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697780;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697797;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA HLAED, liver enzyme composite activity;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697798;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, alkaline phosphatase increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697799;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697800;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697801;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, lactate dehydrogenase (LDH) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697802;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, gamma-glutamyl transferase (GGT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697855;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset;CHEMBL1697821;Non-molecular target assigned;N;;1;CHEMBL1626541;;
CLD0;confirmatory;;CHEMBL1738312;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391];CHEMBL1201862;Direct protein target assigned;D;504333;7;CHEMBL1741220;;
CLD0;confirmatory;;CHEMBL1614221;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774];CHEMBL1201862;Non-molecular target assigned;N;488745;7;CHEMBL364;;
CLD0;confirmatory;HEK-293T;CHEMBL1738479;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489020, AID489029];CHEMBL1201862;Default value - Target has yet to be curated;U;489019;7;CHEMBL612545;;
CLD0;confirmatory;HEK-293T;CHEMBL1738599;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489019, AID489029];CHEMBL1201862;Default value - Target has yet to be curated;U;489020;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738600;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504591];CHEMBL1201862;Direct protein target assigned;D;504536;7;CHEMBL2288;;
CLD0;confirmatory;;CHEMBL1613933;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375];CHEMBL1201862;Direct protein target assigned;D;1477;7;CHEMBL2093862;;
CLD0;confirmatory;;CHEMBL1737980;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493163, AID504444, AID504648];CHEMBL1201862;Direct protein target assigned;D;493153;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL1738043;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489029];CHEMBL1201862;Default value - Target has yet to be curated;U;489034;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648];CHEMBL1201862;Direct protein target assigned;D;504444;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL1738442;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404];CHEMBL1201862;Direct protein target assigned;D;504332;7;CHEMBL6032;;
CLD0;confirmatory;;CHEMBL1738444;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1477, AID1484];CHEMBL1201862;Direct protein target assigned;D;504370;7;CHEMBL2093862;;
CLD0;confirmatory;;CHEMBL1614279;[];Trypanosoma brucei;[];;;185431.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961];CHEMBL1201862;Homologous protein target assigned;H;485368;7;CHEMBL5686;;
CLD0;confirmatory;;CHEMBL1738610;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962];CHEMBL1201862;Direct protein target assigned;D;488953;7;CHEMBL1741193;;
CLD0;confirmatory;Jurkat;CHEMBL1738197;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Dose response confirmation of uHTS of chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489029];CHEMBL1201862;Non-molecular target assigned;N;489004;7;CHEMBL397;;
CLD0;confirmatory;;CHEMBL1738402;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;488949;7;CHEMBL1741210;;
CLD0;;CCRF S-180;CHEMBL1772302;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor growth inhibition at 100 umol/kg/day, ip qd for 7 days measured 24 hrs after last dose relative to control;CHEMBL1770136;Non-molecular target assigned;N;364262;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL1772309;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as decrease of tumor weight at 100 umol/kg, ip qd for 7 days measured 24 hrs after last dose;CHEMBL1770136;Non-molecular target assigned;N;373894;1;CHEMBL614027;;
CLD0;confirmatory;;CHEMBL1794355;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504586];CHEMBL1201862;Homologous protein target assigned;H;504882;7;CHEMBL1795089;;
CLD0;confirmatory;;CHEMBL1794367;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588349, AID588380];CHEMBL1201862;Homologous protein target assigned;H;588378;7;CHEMBL1795085;;
CLD0;confirmatory;HEK293;CHEMBL1794303;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504586];CHEMBL1201862;Non-molecular target assigned;N;588343;7;CHEMBL614818;;
CLD0;confirmatory;HEK293;CHEMBL1794308;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249];CHEMBL1201862;Non-molecular target assigned;N;540256;7;CHEMBL614818;;
CLD0;confirmatory;;CHEMBL1794375;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278];CHEMBL1201862;Default value - Target has yet to be curated;U;540276;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1794384;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: TES1 - eGFP vs TES2 -dsRED Pathway Differentiation Measured in Cell-Based System Using Imaging - 2122-04_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504586];CHEMBL1201862;Homologous protein target assigned;H;588398;7;CHEMBL1795089;;
CLD0;confirmatory;;CHEMBL1794345;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504834;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794424;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771];CHEMBL1201862;Homologous protein target assigned;H;588453;7;CHEMBL6035;;
CLD0;confirmatory;;CHEMBL1794483;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623];CHEMBL1201862;Homologous protein target assigned;H;588590;7;CHEMBL5391;;
CLD0;confirmatory;HepG2;CHEMBL1794553;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860];CHEMBL1201862;Non-molecular target assigned;N;588856;7;CHEMBL395;;
CLD0;;CCRF S-180;CHEMBL1809503;[];Mus musculus;[];ICR;;10090.0;;Liver;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Toxicity in ICR mouse xenografted with mouse S180 cells assessed as effect on liver weight at 2 umol/kg;CHEMBL1806449;Non-molecular target assigned;N;391720;1;CHEMBL375;CHEMBL3559723;
CLD0;;CCRF S-180;CHEMBL1809504;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antiproliferative activity against mouse S180 cells after 48 hrs by MTT assay;CHEMBL1806449;Non-molecular target assigned;N;390568;1;CHEMBL614027;;
CLD0;;K562;CHEMBL1810511;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 48 hrs by MTT assay;CHEMBL1806449;Non-molecular target assigned;N;390569;1;CHEMBL385;;
CLD0;;B16;CHEMBL1810512;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antiproliferative activity against mouse B16 cells after 48 hrs by MTT assay;CHEMBL1806449;Non-molecular target assigned;N;390570;1;CHEMBL381;;
CLD0;;H22;CHEMBL1810513;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antiproliferative activity against mouse H22 cells after 48 hrs by MTT assay;CHEMBL1806449;Non-molecular target assigned;N;390571;1;CHEMBL614998;;
CLD0;;HepG2;CHEMBL1810514;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay;CHEMBL1806449;Non-molecular target assigned;N;390572;1;CHEMBL395;;
CLD0;;CCRF S-180;CHEMBL1810516;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor growth inhibition at 8.9 umol/kg, ip administered 1 day after tumor inoculation qd for 7 days;CHEMBL1806449;Non-molecular target assigned;N;390576;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL1810521;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor growth inhibition at 0.089 umol/kg, ip qd administered 1 day after tumor inoculation for 7 days;CHEMBL1806449;Non-molecular target assigned;N;390583;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL1810801;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor growth inhibition at 0.89 umol/kg, ip administered 1 day after tumor inoculation qd for 7 days;CHEMBL1806449;Non-molecular target assigned;N;390604;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL1810802;[];Mus musculus;[];ICR;;10090.0;;Brain;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Toxicity in ICR mouse xenografted with mouse S180 cells assessed as effect on brain weight at 2 umol/kg;CHEMBL1806449;Non-molecular target assigned;N;391721;1;CHEMBL375;CHEMBL3638188;
CLD0;;CCRF S-180;CHEMBL1810803;[];Mus musculus;[];ICR;;10090.0;;Kidney;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Toxicity in ICR mouse xenografted with mouse S180 cells assessed as effect on kidney weight at 2 umol/kg;CHEMBL1806449;Non-molecular target assigned;N;391722;1;CHEMBL375;CHEMBL3638241;
CLD0;;CCRF S-180;CHEMBL1810804;[];Mus musculus;[];ICR;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Toxicity in ICR mouse xenografted with mouse S180 cells assessed as increase in body weight at 2 umol/kg;CHEMBL1806449;Non-molecular target assigned;N;391723;1;CHEMBL375;;
CLD0;;CCRF S-180;CHEMBL1810805;[];Mus musculus;[];ICR;;10090.0;;Spleen;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Toxicity in ICR mouse xenografted with mouse S180 cells assessed as increase in spleen index at 2 umol/kg;CHEMBL1806449;Non-molecular target assigned;N;391724;1;CHEMBL375;CHEMBL3559722;
CLD0;;HL-60;CHEMBL1820600;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL1817624;Non-molecular target assigned;N;394355;1;CHEMBL383;;
CLD0;;K562;CHEMBL1820601;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for homoharringtonine300-resistant human K562 cells to IC50 for human K562 cells;CHEMBL1817624;Non-molecular target assigned;N;394356;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL1820602;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for vinblastine100-resistant human CCRF-CEM cells to IC50 for human CCRF-CEM cells;CHEMBL1817624;Non-molecular target assigned;N;394357;1;CHEMBL382;;
CLD0;;;CHEMBL1909163;[];Cavia porcellus;[];;;10141.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4);CHEMBL1909046;Direct protein target assigned;D;67;15;CHEMBL1909043;CHEMBL3638235;
CLD0;;CHO-K1;CHEMBL1909164;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4);CHEMBL1909046;Homologous protein target assigned;H;68;15;CHEMBL1798;;
CLD0;;Reticulocytes;CHEMBL1909165;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid);CHEMBL1909046;Direct protein target assigned;D;69;15;CHEMBL4358;;
CLD0;;HEK293;CHEMBL1909166;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;70;15;CHEMBL4644;;
CLD0;;HEK293;CHEMBL1909167;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;71;15;CHEMBL259;;
CLD0;;HEK293;CHEMBL1909168;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;72;15;CHEMBL4608;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909169;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine);CHEMBL1909046;Homologous protein target assigned;H;73;15;CHEMBL1951;;
CLD0;;CHO-K1;CHEMBL1909170;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;74;15;CHEMBL216;;
CLD0;;CHO-K1;CHEMBL1909171;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;75;15;CHEMBL211;;
CLD0;;CHO-K1;CHEMBL1909172;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;76;15;CHEMBL245;;
CLD0;;CHO-K1;CHEMBL1909173;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;77;15;CHEMBL1821;;
CLD0;;CHO-K1;CHEMBL1909174;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;78;15;CHEMBL2035;;
CLD0;;SK-N-MC;CHEMBL1909175;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307551;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;79;15;CHEMBL4777;;
CLD0;;KAN-TS;CHEMBL1909176;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;80;15;CHEMBL4018;;
CLD0;;IMR-32;CHEMBL1909177;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307656;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine);CHEMBL1909046;Default value - Target has yet to be curated;U;81;15;CHEMBL612545;;
CLD0;;;CHEMBL1909178;[];Rattus norvegicus;[];;;10116.0;In vitro;Cerebellum;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine);CHEMBL1909046;Direct protein target assigned;D;82;15;CHEMBL3048;CHEMBL3638233;
CLD0;;;CHEMBL1909179;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine);CHEMBL1909046;Homologous protein target assigned;H;83;15;CHEMBL3464;;
CLD0;;HEK293;CHEMBL1909180;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole);CHEMBL1909046;Homologous protein target assigned;H;84;15;CHEMBL236;;
CLD0;;HEK293;CHEMBL1909181;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;85;15;CHEMBL237;;
CLD0;;CHO-K1;CHEMBL1909182;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;86;15;CHEMBL233;;
CLD0;;;CHEMBL1909183;[];Mus musculus;[];ICR;Membrane;10090.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu);CHEMBL1909046;Default value - Target has yet to be curated;U;87;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Platelet;CHEMBL1909184;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;88;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909185;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;89;15;CHEMBL612545;;
CLD0;;Platelet;CHEMBL1909186;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP);CHEMBL1909046;Direct protein target assigned;D;90;15;CHEMBL1827;;
CLD0;;Platelet;CHEMBL1909187;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF);CHEMBL1909046;Direct protein target assigned;D;91;15;CHEMBL250;;
CLD0;;NIH3T3;CHEMBL1909188;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF);CHEMBL1909046;Default value - Target has yet to be curated;U;92;15;CHEMBL612545;;
CLD0;;HIT-T15;CHEMBL1909189;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide);CHEMBL1909046;Default value - Target has yet to be curated;U;93;15;CHEMBL612545;;
CLD0;;HEK293;CHEMBL1909190;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);CHEMBL1909046;Homologous protein target assigned;H;94;15;CHEMBL240;;
CLD0;;;CHEMBL1909191;[];Bos taurus;[];;;9913.0;In vitro;Uterus;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020);CHEMBL1909046;Direct protein target assigned;D;95;15;CHEMBL1909044;CHEMBL3638197;
CLD0;;;CHEMBL1909192;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG);CHEMBL1909046;Direct protein target assigned;D;96;15;CHEMBL4074;CHEMBL3638235;
CLD0;;;CHEMBL1909193;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC);CHEMBL1909046;Homologous protein target assigned;H;97;15;CHEMBL4801;;
CLD0;;Neutrophil;CHEMBL1909194;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC);CHEMBL1909046;Direct protein target assigned;D;98;15;CHEMBL4071;;
CLD0;;Neutrophil;CHEMBL1909195;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA);CHEMBL1909046;Direct protein target assigned;D;99;15;CHEMBL248;;
CLD0;;;CHEMBL1909196;[];Homo sapiens;[];;;9606.0;In vitro;Rheumatoid synovial fibroblasts;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Direct protein target assigned;D;100;15;CHEMBL332;;
CLD0;;;CHEMBL1909197;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Homologous protein target assigned;H;101;15;CHEMBL321;;
CLD0;;Sf9;CHEMBL1909198;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone);CHEMBL1909046;Homologous protein target assigned;H;102;15;CHEMBL299;;
CLD0;;;CHEMBL1909199;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;103;15;CHEMBL3385;;
CLD0;;;CHEMBL1909200;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;104;15;CHEMBL4040;;
CLD0;;;CHEMBL1909201;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;105;15;CHEMBL260;;
CLD0;;;CHEMBL1909202;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;106;15;CHEMBL4445;;
CLD0;;Insect cells;CHEMBL1909203;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;107;15;CHEMBL203;;
CLD0;;Insect cells;CHEMBL1909204;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;108;15;CHEMBL1841;;
CLD0;;Insect cells;CHEMBL1909205;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;109;15;CHEMBL1824;;
CLD0;;Insect cells;CHEMBL1909206;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;110;15;CHEMBL258;;
CLD0;;;CHEMBL1909207;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;111;15;CHEMBL3243;;
CLD0;;;CHEMBL1909208;[];Oryctolagus cuniculus;[];New Zealand albino;Membrane;9986.0;In vitro;Urinary bladder;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;112;15;CHEMBL612545;CHEMBL3638205;
CLD0;;CHO-K1;CHEMBL1909209;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT);CHEMBL1909046;Homologous protein target assigned;H;113;15;CHEMBL273;;
CLD0;;;CHEMBL1909210;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Direct protein target assigned;D;114;15;CHEMBL3459;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909211;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin);CHEMBL1909046;Homologous protein target assigned;H;115;15;CHEMBL224;;
CLD0;;HEK293;CHEMBL1909212;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine);CHEMBL1909046;Homologous protein target assigned;H;1;15;CHEMBL220;;
CLD0;;CHO;CHEMBL1909213;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX);CHEMBL1909046;Homologous protein target assigned;H;2;15;CHEMBL226;;
CLD0;;HEK293;CHEMBL1909214;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;3;15;CHEMBL251;;
CLD0;;CHO-K1;CHEMBL1909215;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;4;15;CHEMBL256;;
CLD0;;;CHEMBL1909084;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine);CHEMBL1909046;Default value - Target has yet to be curated;U;5;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909085;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Submaxillary gland;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;6;15;CHEMBL319;CHEMBL3987361;
CLD0;;;CHEMBL1909086;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;7;15;CHEMBL315;CHEMBL3559723;
CLD0;;HEK293;CHEMBL1909087;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Homologous protein target assigned;H;8;15;CHEMBL223;;
CLD0;;Sf9;CHEMBL1909088;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912);CHEMBL1909046;Homologous protein target assigned;H;9;15;CHEMBL1867;;
CLD0;;CHO-K1;CHEMBL1909089;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine);CHEMBL1909046;Homologous protein target assigned;H;10;15;CHEMBL1942;;
CLD0;;Sf9;CHEMBL1909090;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912);CHEMBL1909046;Homologous protein target assigned;H;11;15;CHEMBL1916;;
CLD0;;CHO-K1;CHEMBL1909091;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;12;15;CHEMBL213;;
CLD0;;CHO;CHEMBL1909092;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177);CHEMBL1909046;Homologous protein target assigned;H;13;15;CHEMBL210;;
CLD0;;HEK293;CHEMBL1909093;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;14;15;CHEMBL246;;
CLD0;;MDCK;CHEMBL1909094;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308370;Homologous single protein target assigned;8;DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;15;15;CHEMBL222;;
CLD0;;;CHEMBL1909095;[];Rattus norvegicus;[];;;10116.0;In vitro;Lens of camera-type eye;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde);CHEMBL1909046;Direct protein target assigned;D;16;15;CHEMBL2622;CHEMBL3638191;
CLD0;;CHO-K1;CHEMBL1909096;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A);CHEMBL1909046;Homologous protein target assigned;H;17;15;CHEMBL4607;;
CLD0;;;CHEMBL1909097;[];Sus scrofa;[];;;9823.0;In vitro;Heart;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;18;15;CHEMBL612545;CHEMBL3638187;
CLD0;;;CHEMBL1909098;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Adrenal gland;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat));CHEMBL1909046;Default value - Target has yet to be curated;U;19;15;CHEMBL612545;CHEMBL3638251;
CLD0;;;CHEMBL1909099;[];Bacillus cereus;[];;;1396.0;In vitro;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin);CHEMBL1909046;Default value - Target has yet to be curated;U;20;15;CHEMBL612545;;
CLD0;;Chem-1;CHEMBL1909100;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin);CHEMBL1909046;Homologous protein target assigned;H;21;15;CHEMBL3157;;
CLD0;;T47D;CHEMBL1909101;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307606;Homologous single protein target assigned;8;DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon));CHEMBL1909046;Homologous protein target assigned;H;22;15;CHEMBL1832;;
CLD0;;;CHEMBL1909102;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem);CHEMBL1909046;Default value - Target has yet to be curated;U;23;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909103;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine);CHEMBL1909046;Default value - Target has yet to be curated;U;24;15;CHEMBL612545;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909104;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;116;15;CHEMBL1833;;
CLD0;;CHO-K1;CHEMBL1909105;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine);CHEMBL1909046;Homologous protein target assigned;H;117;15;CHEMBL225;;
CLD0;;HEK293;CHEMBL1909106;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630);CHEMBL1909046;Default value - Target has yet to be curated;U;118;15;CHEMBL612545;;
CLD0;;;CHEMBL1909107;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Striatum;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808);CHEMBL1909046;Direct protein target assigned;D;119;15;CHEMBL5017;CHEMBL3638255;
CLD0;;HeLa;CHEMBL1909108;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;120;15;CHEMBL3371;;
CLD0;;HEK293;CHEMBL1909109;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine);CHEMBL1909046;Homologous protein target assigned;H;121;15;CHEMBL228;;
CLD0;;Jurkat;CHEMBL1909110;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307526;Homologous single protein target assigned;8;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CHEMBL1909046;Homologous protein target assigned;H;122;15;CHEMBL287;;
CLD0;;;CHEMBL1909111;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil);CHEMBL1909046;Default value - Target has yet to be curated;U;123;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909112;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin);CHEMBL1909046;Default value - Target has yet to be curated;U;124;15;CHEMBL612545;CHEMBL3638188;
CLD0;;CHO;CHEMBL1909113;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P);CHEMBL1909046;Homologous protein target assigned;H;125;15;CHEMBL249;;
CLD0;;CHO;CHEMBL1909114;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968);CHEMBL1909046;Homologous protein target assigned;H;126;15;CHEMBL2327;;
CLD0;;;CHEMBL1909115;[];Escherichia coli;[];;Membrane;562.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone);CHEMBL1909046;Homologous protein target assigned;H;127;15;CHEMBL3072;;
CLD0;;Platelet;CHEMBL1909116;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2);CHEMBL1909046;Direct protein target assigned;D;128;15;CHEMBL1835;;
CLD0;;U-937;CHEMBL1909117;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha);CHEMBL1909046;Default value - Target has yet to be curated;U;129;15;CHEMBL612545;;
CLD0;;HUVEC;CHEMBL1909118;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307501;Homologous single protein target assigned;8;DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF);CHEMBL1909046;Homologous protein target assigned;H;130;15;CHEMBL1868;;
CLD0;;HT-29;CHEMBL1909119;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307768;Homologous single protein target assigned;8;DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP);CHEMBL1909046;Homologous protein target assigned;H;131;15;CHEMBL5144;;
CLD0;;HEK293;CHEMBL1909120;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr);CHEMBL1909046;Homologous protein target assigned;H;132;15;CHEMBL1889;;
CLD0;;;CHEMBL1909121;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888));CHEMBL1909046;Default value - Target has yet to be curated;U;25;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Chem-1;CHEMBL1909122;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A);CHEMBL1909046;Homologous protein target assigned;H;26;15;CHEMBL218;;
CLD0;;Erythrocyte;CHEMBL1909123;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833281;Direct single protein target assigned;9;DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA));CHEMBL1909046;Direct protein target assigned;D;27;15;CHEMBL205;;
CLD0;;CHO-K1;CHEMBL1909124;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1);CHEMBL1909046;Homologous protein target assigned;H;28;15;CHEMBL4015;;
CLD0;;Chem-1;CHEMBL1909125;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC);CHEMBL1909046;Homologous protein target assigned;H;29;15;CHEMBL2414;;
CLD0;;HEK293;CHEMBL1909126;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha);CHEMBL1909046;Homologous protein target assigned;H;30;15;CHEMBL274;;
CLD0;;;CHEMBL1909127;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR1 (IL-8A);CHEMBL1909046;Homologous protein target assigned;H;31;15;CHEMBL4029;;
CLD0;;CHO-K1;CHEMBL1909128;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8);CHEMBL1909046;Homologous protein target assigned;H;32;15;CHEMBL2434;;
CLD0;;1321-N1;CHEMBL1909129;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718);CHEMBL1909046;Homologous protein target assigned;H;33;15;CHEMBL1901;;
CLD0;;Platelet;CHEMBL1909130;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Direct protein target assigned;D;34;15;CHEMBL221;;
CLD0;;Sf21;CHEMBL1909131;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL4106362;Homologous single protein target assigned;8;DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Homologous protein target assigned;H;35;15;CHEMBL230;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909132;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;36;15;CHEMBL3356;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909133;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;37;15;CHEMBL5282;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909134;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;38;15;CHEMBL3622;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909135;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;39;15;CHEMBL3397;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909136;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;40;15;CHEMBL289;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909137;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;41;15;CHEMBL5281;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909138;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin);CHEMBL1909046;Homologous protein target assigned;H;42;15;CHEMBL340;;
CLD0;;CHO;CHEMBL1909139;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390);CHEMBL1909046;Homologous protein target assigned;H;43;15;CHEMBL2056;;
CLD0;;CHO;CHEMBL1909140;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;44;15;CHEMBL217;;
CLD0;;CHO;CHEMBL1909141;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;45;15;CHEMBL234;;
CLD0;;CHO-K1;CHEMBL1909142;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;46;15;CHEMBL219;;
CLD0;;CHO-K1;CHEMBL1909143;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;47;15;CHEMBL238;;
CLD0;;CHO-K1;CHEMBL1909144;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1);CHEMBL1909046;Homologous protein target assigned;H;48;15;CHEMBL252;;
CLD0;;Sf9;CHEMBL1909145;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;49;15;CHEMBL206;;
CLD0;;Sf9;CHEMBL1909146;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;50;15;CHEMBL242;;
CLD0;;;CHEMBL1909147;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol);CHEMBL1909046;Default value - Target has yet to be curated;U;51;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909148;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam);CHEMBL1909046;Default value - Target has yet to be curated;U;52;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909149;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB);CHEMBL1909046;Default value - Target has yet to be curated;U;53;15;CHEMBL612545;CHEMBL3559724;
CLD0;;HeLa S3;CHEMBL1909150;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Homologous single protein target assigned;8;DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone);CHEMBL1909046;Homologous protein target assigned;H;54;15;CHEMBL2034;;
CLD0;;;CHEMBL1909151;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA);CHEMBL1909046;Default value - Target has yet to be curated;U;55;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909152;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid);CHEMBL1909046;Default value - Target has yet to be curated;U;56;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909153;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653);CHEMBL1909046;Default value - Target has yet to be curated;U;57;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909154;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP);CHEMBL1909046;Default value - Target has yet to be curated;U;58;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909155;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Spinal cord;B;Binding;BAO_0000249;cell membrane format;;Multiple direct protein targets may be assigned;5;DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine);CHEMBL1909046;Direct protein target assigned;D;59;15;CHEMBL3392921;CHEMBL3638246;
CLD0;;CHO-K1;CHEMBL1909156;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine);CHEMBL1909046;Homologous protein target assigned;H;60;15;CHEMBL231;;
CLD0;;CHO-K1;CHEMBL1909157;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine);CHEMBL1909046;Homologous protein target assigned;H;61;15;CHEMBL1941;;
CLD0;;;CHEMBL1909158;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA);CHEMBL1909046;Homologous protein target assigned;H;62;15;CHEMBL402;;
CLD0;;;CHEMBL1909159;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan);CHEMBL1909046;Default value - Target has yet to be curated;U;63;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909160;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin);CHEMBL1909046;Direct protein target assigned;D;64;15;CHEMBL5486;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL1909161;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta);CHEMBL1909046;Default value - Target has yet to be curated;U;65;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909162;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4);CHEMBL1909046;Default value - Target has yet to be curated;U;66;15;CHEMBL612545;;
CLD0;;;CHEMBL1909291;[];;[];;;;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of most concern for DILI;CHEMBL1909281;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909307;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";CHEMBL1909294;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909308;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";CHEMBL1909294;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909309;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";CHEMBL1909294;Non-molecular target assigned;N;3;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909310;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";CHEMBL1909294;Non-molecular target assigned;N;4;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909311;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";CHEMBL1909294;Non-molecular target assigned;N;5;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909312;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";CHEMBL1909294;Non-molecular target assigned;N;6;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909313;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";CHEMBL1909294;Non-molecular target assigned;N;7;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909314;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";CHEMBL1909294;Non-molecular target assigned;N;8;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909315;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";CHEMBL1909294;Non-molecular target assigned;N;9;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909316;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";CHEMBL1909294;Non-molecular target assigned;N;10;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909317;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";CHEMBL1909294;Non-molecular target assigned;N;11;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909318;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";CHEMBL1909294;Non-molecular target assigned;N;12;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909319;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";CHEMBL1909294;Non-molecular target assigned;N;13;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909320;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";CHEMBL1909294;Non-molecular target assigned;N;14;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;KB ;CHEMBL1918585;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells assessed as cell survival after 72 hrs by sulforhodamine B colorimetric assay;CHEMBL1914360;Non-molecular target assigned;N;409174;1;CHEMBL398;;
CLD0;;MCF7;CHEMBL1918586;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as cell survival after 72 hrs by sulforhodamine B colorimetric assay;CHEMBL1914360;Non-molecular target assigned;N;409175;1;CHEMBL387;;
CLD0;confirmatory;;CHEMBL1963969;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3). (Class of assay: confirmatory) ";CHEMBL1201862;Homologous protein target assigned;H;602234;7;CHEMBL1615382;;
CLD0;confirmatory;;CHEMBL1964023;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). (Class of assay: confirmatory) ";CHEMBL1201862;Homologous protein target assigned;H;602236;7;CHEMBL4218;;
CLD0;confirmatory;Schwann;CHEMBL1964055;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624044;7;CHEMBL2007624;;
CLD0;confirmatory;Schwann;CHEMBL1964081;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624032;7;CHEMBL2007624;;
CLD0;confirmatory;;CHEMBL1963838;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;"PUBCHEM_BIOASSAY: Luminescence-based cell-based high throughput dose response assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). (Class of assay: confirmatory) ";CHEMBL1201862;Homologous protein target assigned;H;602235;7;CHEMBL1615387;;
CLD0;;A549;CHEMBL2013701;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Growth inhibition of human A549 cells after 24 hrs by WST-1 assay;CHEMBL2010709;Non-molecular target assigned;N;439431;1;CHEMBL392;;
CLD0;;BALL-1;CHEMBL2013702;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308839;Target assigned is non-molecular;1;Growth inhibition of human BALL-1 cells after 24 hrs by WST-1 assay;CHEMBL2010709;Non-molecular target assigned;N;439432;1;CHEMBL2366269;;
CLD0;;HCT-116;CHEMBL2013703;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Growth inhibition of against human HCT116 cells after 24 hrs by WST-1 assay;CHEMBL2010709;Non-molecular target assigned;N;439433;1;CHEMBL394;;
CLD0;;HeLa;CHEMBL2013704;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Growth inhibition of human HeLa cells after 24 hrs by WST-1 assay;CHEMBL2010709;Non-molecular target assigned;N;439434;1;CHEMBL399;;
CLD0;;NUGC-3;CHEMBL2013705;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307562;Target assigned is non-molecular;1;Growth inhibition of human NUGC3 cells after 24 hrs by WST-1 assay;CHEMBL2010709;Non-molecular target assigned;N;439435;1;CHEMBL614208;;
CLD0;;HDF;CHEMBL2013706;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Growth inhibition of HDF cells after 72 hrs by WST-1 assay;CHEMBL2010709;Default value - Target has yet to be curated;U;439436;1;CHEMBL612558;;
CLD0;;HUVEC;CHEMBL2013707;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307501;Target assigned is non-molecular;1;Growth inhibition of HUVEC cells after 72 hrs by WST-1 assay;CHEMBL2010709;Non-molecular target assigned;N;439437;1;CHEMBL613979;;
CLD0;;;CHEMBL2071962;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467794;1;CHEMBL3356;;
CLD0;;;CHEMBL2071963;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467795;1;CHEMBL3397;;
CLD0;;;CHEMBL2071964;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467796;1;CHEMBL3622;;
CLD0;;;CHEMBL2071965;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467797;1;CHEMBL289;;
CLD0;;;CHEMBL2071966;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467798;1;CHEMBL340;;
CLD0;;;CHEMBL2071967;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467799;1;CHEMBL340;;
CLD0;;;CHEMBL2071971;[];Homo sapiens;[];;Microsome;9606.0;;Liver;A;ADME;BAO_0000251;microsome format;;Target assigned is subcellular fraction;2;Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis;CHEMBL2069259;Subcellular target assigned;S;467803;1;CHEMBL613373;CHEMBL3559723;
CLD0;;;CHEMBL2071972;[];Homo sapiens;[];;Microsome;9606.0;;Liver;A;ADME;BAO_0000251;microsome format;;Target assigned is subcellular fraction;2;Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH;CHEMBL2069259;Subcellular target assigned;S;467804;1;CHEMBL613373;CHEMBL3559723;
CLD0;;Oocyte;CHEMBL2077569;[];Xenopus laevis;[];;;8355.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308859;Homologous single protein target assigned;8;TP_TRANSPORTER: uptake in Xenopus laevis oocytes;CHEMBL2074159;Homologous protein target assigned;H;298;18;CHEMBL2073670;;
CLD0;;Oocyte;CHEMBL2076870;[];Xenopus laevis;[];;;8355.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308859;Homologous single protein target assigned;8;TP_TRANSPORTER: uptake in Xenopus laevis oocytes;CHEMBL2074159;Homologous protein target assigned;H;383;18;CHEMBL1770032;;
CLD0;confirmatory;;CHEMBL2114843;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624296;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL2114775;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651820;7;CHEMBL612545;;
CLD0;confirmatory;SW480;CHEMBL2114780;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Direct single protein target assigned;9;PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624297;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL2114788;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624417;7;CHEMBL1784;;
CLD0;;HL-60;CHEMBL2150100;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;473954;1;CHEMBL383;;
CLD0;;K562;CHEMBL2150101;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;474020;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL2150102;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;474023;1;CHEMBL382;;
CLD0;;HL-60;CHEMBL2150103;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474028;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150104;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for human HL60/ADR cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474029;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150105;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474030;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150106;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for doxorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474031;1;CHEMBL383;;
CLD0;;K562;CHEMBL2150107;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for doxorubicin-resistant human K562 cells to IC50 for human K562 cells;CHEMBL2146381;Non-molecular target assigned;N;474032;1;CHEMBL385;;
CLD0;;K562;CHEMBL2150108;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for human K562/HHT300 cells to IC50 for human K562 cells;CHEMBL2146381;Non-molecular target assigned;N;474033;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL2150109;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/C2 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474034;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL2150110;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/VM-1-5 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474035;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL2150111;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/VLB100 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474036;1;CHEMBL382;;
CLD0;;BXPC-3;CHEMBL2212310;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307637;Target assigned is non-molecular;1;Antitumor activity against human BxPC3 cells xenografted in SCID mouse assessed as tumor growth inhibition at 10 mg/kg, ip administered 5 times a week for one cycle relative to control;CHEMBL2202989;Non-molecular target assigned;N;494552;1;CHEMBL614530;;
CLD0;;CCRF S-180;CHEMBL3047252;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against Mus musculus (mouse) S180 cells xenografted in ICR Mus musculus (mouse) assessed as tumor growth inhibition at 89 umol/kg, ip qd for 7 days measured after 24 hr of last dose relative to control;CHEMBL3044617;Non-molecular target assigned;N;503542;1;CHEMBL612567;;
CLD0;;K562;CHEMBL3078117;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against Homo sapiens (human) K562 cells assessed as growth inhibition at 2 ug/ml after 24 hr by MTT assay relative to untreated control;CHEMBL3045269;Non-molecular target assigned;N;536821;1;CHEMBL385;;
CLD0;;K562;CHEMBL3078118;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against Homo sapiens (human) K562 cells assessed as growth inhibition at 2 ug/ml after 48 hr by MTT assay relative to untreated control;CHEMBL3045269;Non-molecular target assigned;N;536822;1;CHEMBL385;;
CLD0;;U-937;CHEMBL3078119;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Cytotoxicity against Homo sapiens (human) U937 cells assessed as growth inhibition at 2 ug/ml after 48 hr by MTT assay relative to untreated control;CHEMBL3045269;Non-molecular target assigned;N;536820;1;CHEMBL612794;;
CLD0;;U-937;CHEMBL3078120;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Cytotoxicity against Homo sapiens (human) U937 cells assessed as growth inhibition at 2 ug/ml after 24 hr by MTT assay relative to untreated control;CHEMBL3045269;Non-molecular target assigned;N;536819;1;CHEMBL612794;;
CLD0;confirmatory;;CHEMBL2354211;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;686971;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354220;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624360;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354221;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686978;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354225;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624359;7;CHEMBL612545;;
CLD0;confirmatory;HepG2;CHEMBL2354245;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Viability counterscreen of potential LMP-1 inhibitors in HepG2 cell line Measured in Cell-Based System Using Plate Reader - 2122-07_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624365;7;CHEMBL2362975;;
CLD0;confirmatory;;CHEMBL2354254;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686979;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354290;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624375;7;CHEMBL612545;;
CLD0;;NCI-H1563;CHEMBL2363475;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308457;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1563 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;438;5;CHEMBL1075514;;
CLD0;;NCI-H1573;CHEMBL2363476;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308117;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1573 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;439;5;CHEMBL1075515;;
CLD0;;NCI-H1581;CHEMBL2363477;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308765;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1581 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;440;5;CHEMBL1075516;;
CLD0;;NCI-H1623;CHEMBL2363479;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308766;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1623 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;442;5;CHEMBL1075517;;
CLD0;;NCI-H1648;CHEMBL2363480;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308315;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1648 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;443;5;CHEMBL2366214;;
CLD0;;NCI-H1650;CHEMBL2363481;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308800;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1650 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;444;5;CHEMBL1075518;;
CLD0;;NCI-H1651;CHEMBL2363482;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308383;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1651 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;445;5;CHEMBL1075519;;
CLD0;;NCI-H1666;CHEMBL2363483;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308118;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1666 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;446;5;CHEMBL1075520;;
CLD0;;NCI-H1693;CHEMBL2363484;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308458;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1693 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;447;5;CHEMBL1075521;;
CLD0;;NCI-H1703;CHEMBL2363486;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308503;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1703 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;449;5;CHEMBL1075522;;
CLD0;;NCI-H1755;CHEMBL2363488;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308768;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1755 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;451;5;CHEMBL1075524;;
CLD0;;NCI-H1770;CHEMBL2363489;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308316;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1770 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;452;5;CHEMBL2366171;;
CLD0;;NCI-H1792;CHEMBL2363490;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308816;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1792 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;453;5;CHEMBL1075525;;
CLD0;;NCI-H1793;CHEMBL2363491;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308579;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1793 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;454;5;CHEMBL1075526;;
CLD0;;NCI-H1838;CHEMBL2363492;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308317;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1838 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;455;5;CHEMBL2366346;;
CLD0;;NCI-H1975;CHEMBL2363496;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307601;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1975 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;459;5;CHEMBL614348;;
CLD0;;NCI-H1993;CHEMBL2363497;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308138;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1993 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;460;5;CHEMBL1075527;;
CLD0;;NCI-H2009;CHEMBL2363498;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308459;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2009 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;461;5;CHEMBL1075528;;
CLD0;;NCI-H2029;CHEMBL2363499;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308473;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2029 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;462;5;CHEMBL1075529;;
CLD0;;NCI-H2030;CHEMBL2363500;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308769;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2030 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;463;5;CHEMBL1075530;;
CLD0;;NCI-H2052;CHEMBL2363501;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308119;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2052 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;464;5;CHEMBL1075531;;
CLD0;;NCI-H2087;CHEMBL2363503;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308770;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2087 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;466;5;CHEMBL1075532;;
CLD0;;NCI-H209;CHEMBL2363504;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308293;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H209 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;467;5;CHEMBL2366365;;
CLD0;;NCI-H2122;CHEMBL2363506;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308771;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2122 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;469;5;CHEMBL1075533;;
CLD0;;NCI-H2126;CHEMBL2363507;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308894;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2126 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;470;5;CHEMBL2366160;;
CLD0;;NCI-H2170;CHEMBL2363509;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308460;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2170 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;472;5;CHEMBL1075534;;
CLD0;;NCI-H2228;CHEMBL2363513;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308120;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2228 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;476;5;CHEMBL1075536;;
CLD0;;NCI-H226;CHEMBL2363514;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307697;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H226 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;477;5;CHEMBL614740;;
CLD0;;NCI-H2291;CHEMBL2363515;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308880;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2291 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;478;5;CHEMBL2366197;;
CLD0;;NCI-H23;CHEMBL2363516;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H23 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;479;5;CHEMBL614997;;
CLD0;;NCI-H2342;CHEMBL2363517;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308773;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2342 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;480;5;CHEMBL1075537;;
CLD0;;NCI-H2347;CHEMBL2363518;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308386;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2347 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;481;5;CHEMBL1075538;;
CLD0;;NCI-H2405;CHEMBL2363519;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308774;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2405 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;482;5;CHEMBL1075539;;
CLD0;;NCI-H2452;CHEMBL2363520;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308580;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H2452 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;483;5;CHEMBL1075540;;
CLD0;;NCI-H28;CHEMBL2363522;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308775;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H28 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;485;5;CHEMBL1075541;;
CLD0;;NCI-H292;CHEMBL2363523;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308637;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H292 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;486;5;CHEMBL614733;;
CLD0;;NCI-H358;CHEMBL2363526;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307543;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H358 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;489;5;CHEMBL614135;;
CLD0;;NCI-H441;CHEMBL2363528;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308121;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H441 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;491;5;CHEMBL1075542;;
CLD0;;NCI-H446;CHEMBL2363529;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307760;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H446 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;492;5;CHEMBL612440;;
CLD0;;NCI-H460;CHEMBL2363530;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H460 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;493;5;CHEMBL396;;
CLD0;;NCI-H510A;CHEMBL2363531;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308322;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H510A cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;494;5;CHEMBL2366332;;
CLD0;;NCI-H520;CHEMBL2363532;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307864;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H520 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;495;5;CHEMBL614099;;
CLD0;;NCI-H526;CHEMBL2363535;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308881;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H526 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;498;5;CHEMBL2366102;;
CLD0;;NCI-H596;CHEMBL2363536;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307791;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H596 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;499;5;CHEMBL612256;;
CLD0;;NCI-H630;CHEMBL2363537;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307966;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H630 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;500;5;CHEMBL612540;;
CLD0;;NCI-H650;CHEMBL2363539;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308461;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H650 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;502;5;CHEMBL1075543;;
CLD0;;NCI-H661;CHEMBL2363540;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308139;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H661 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;503;5;CHEMBL1075544;;
CLD0;;NCI-H69;CHEMBL2363541;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307712;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H69 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;504;5;CHEMBL614805;;
CLD0;;NCI-H720;CHEMBL2363544;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308851;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H720 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;507;5;CHEMBL2366105;;
CLD0;;NCI-H727;CHEMBL2363545;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308393;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H727 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;508;5;CHEMBL1075545;;
CLD0;;NCI-H747;CHEMBL2363546;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308895;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H747 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;509;5;CHEMBL2366087;;
CLD0;;NCI-H810;CHEMBL2363548;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308483;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H810 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;511;5;CHEMBL1075546;;
CLD0;;NCI-H82;CHEMBL2363549;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308882;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H82 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;512;5;CHEMBL2366077;;
CLD0;;NCI-N87;CHEMBL2363552;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307326;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-N87 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;515;5;CHEMBL614197;;
CLD0;;SNU1;CHEMBL2363553;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307455;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-SNU-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;516;5;CHEMBL614931;;
CLD0;;SNU-5;CHEMBL2363555;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307458;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-SNU-5 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;518;5;CHEMBL614934;;
CLD0;;NEC8;CHEMBL2363556;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308176;Target assigned is non-molecular;1;SANGER: Inhibition of human NEC8 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;519;5;CHEMBL2366340;;
CLD0;;NH-12;CHEMBL2363557;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308211;Target assigned is non-molecular;1;SANGER: Inhibition of human NH-12 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;520;5;CHEMBL2366263;;
CLD0;;NKM-1;CHEMBL2363558;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308212;Target assigned is non-molecular;1;SANGER: Inhibition of human NKM-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;521;5;CHEMBL2366133;;
CLD0;;NMC-G1;CHEMBL2363559;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308842;Target assigned is non-molecular;1;SANGER: Inhibition of human NMC-G1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;522;5;CHEMBL2366349;;
CLD0;;NOMO-1;CHEMBL2363560;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308243;Target assigned is non-molecular;1;SANGER: Inhibition of human NOMO-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;523;5;CHEMBL2366198;;
CLD0;;NOS-1;CHEMBL2363561;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308836;Target assigned is non-molecular;1;SANGER: Inhibition of human NOS-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;524;5;CHEMBL2366141;;
CLD0;;NTERA-2-cl-D1;CHEMBL2363562;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307482;Target assigned is non-molecular;1;SANGER: Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;525;5;CHEMBL614206;;
CLD0;;NUGC-3;CHEMBL2363563;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307562;Target assigned is non-molecular;1;SANGER: Inhibition of human NUGC-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;526;5;CHEMBL614208;;
CLD0;;NY;CHEMBL2363564;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308123;Target assigned is non-molecular;1;SANGER: Inhibition of human NY cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;527;5;CHEMBL1075552;;
CLD0;;OAW-28;CHEMBL2363565;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308479;Target assigned is non-molecular;1;SANGER: Inhibition of human OAW-28 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;528;5;CHEMBL1075553;;
CLD0;;OAW-42;CHEMBL2363566;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308397;Target assigned is non-molecular;1;SANGER: Inhibition of human OAW-42 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;529;5;CHEMBL1075554;;
CLD0;;OC-314;CHEMBL2363567;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308244;Target assigned is non-molecular;1;SANGER: Inhibition of human OC-314 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;530;5;CHEMBL2366288;;
CLD0;;OCI-AML2;CHEMBL2363568;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308300;Target assigned is non-molecular;1;SANGER: Inhibition of human OCI-AML2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;531;5;CHEMBL2366220;;
CLD0;;OCUB-M;CHEMBL2363569;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308245;Target assigned is non-molecular;1;SANGER: Inhibition of human OCUB-M cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;532;5;CHEMBL2366121;;
CLD0;;OE19;CHEMBL2363570;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308462;Target assigned is non-molecular;1;SANGER: Inhibition of human OE19 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;533;5;CHEMBL1075555;;
CLD0;;OE33;CHEMBL2363571;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308776;Target assigned is non-molecular;1;SANGER: Inhibition of human OE33 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;534;5;CHEMBL1075556;;
CLD0;;OMC-1;CHEMBL2363572;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308213;Target assigned is non-molecular;1;SANGER: Inhibition of human OMC-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;535;5;CHEMBL2366339;;
CLD0;;ONS-76;CHEMBL2363573;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308540;Target assigned is non-molecular;1;SANGER: Inhibition of human ONS-76 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;536;5;CHEMBL2366068;;
CLD0;;OS-RC-2;CHEMBL2363575;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308274;Target assigned is non-molecular;1;SANGER: Inhibition of human OS-RC-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;538;5;CHEMBL2366188;;
CLD0;;OVCAR-3;CHEMBL2363576;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;SANGER: Inhibition of human OVCAR-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;539;5;CHEMBL614213;;
CLD0;;OVCAR-4;CHEMBL2363577;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307517;Target assigned is non-molecular;1;SANGER: Inhibition of human OVCAR-4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;540;5;CHEMBL614051;;
CLD0;;OVCAR-5;CHEMBL2363578;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307565;Target assigned is non-molecular;1;SANGER: Inhibition of human OVCAR-5 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;541;5;CHEMBL614214;;
CLD0;;OVCAR-8;CHEMBL2363579;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307975;Target assigned is non-molecular;1;SANGER: Inhibition of human OVCAR-8 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;542;5;CHEMBL612555;;
CLD0;;P12-Ichikawa;CHEMBL2363580;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307676;Target assigned is non-molecular;1;SANGER: Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;543;5;CHEMBL614660;;
CLD0;;P30-OHK;CHEMBL2363581;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308275;Target assigned is non-molecular;1;SANGER: Inhibition of human P30-OHK cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;544;5;CHEMBL2366165;;
CLD0;;PA-1;CHEMBL2363583;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308812;Target assigned is non-molecular;1;SANGER: Inhibition of human PA-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;546;5;CHEMBL614949;;
CLD0;;PANC-03-27;CHEMBL2363584;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308124;Target assigned is non-molecular;1;SANGER: Inhibition of human PANC-03-27 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;547;5;CHEMBL1075557;;
CLD0;;PANC-08-13;CHEMBL2363585;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308777;Target assigned is non-molecular;1;SANGER: Inhibition of human PANC-08-13 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;548;5;CHEMBL1075558;;
CLD0;;Panc1005;CHEMBL2363586;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307991;Target assigned is non-molecular;1;SANGER: Inhibition of human PANC-10-05 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;549;5;CHEMBL612583;;
CLD0;;PC-14;CHEMBL2363587;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307306;Target assigned is non-molecular;1;SANGER: Inhibition of human PC-14 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;550;5;CHEMBL614140;;
CLD0;;PC-3;CHEMBL2363588;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;SANGER: Inhibition of human PC-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;551;5;CHEMBL390;;
CLD0;;PFSK-1;CHEMBL2363590;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308802;Target assigned is non-molecular;1;SANGER: Inhibition of human PFSK-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;553;5;CHEMBL1075560;;
CLD0;;PSN1;CHEMBL2363592;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307348;Target assigned is non-molecular;1;SANGER: Inhibition of human PSN1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;555;5;CHEMBL614241;;
CLD0;;QIMR-WIL;CHEMBL2363593;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308301;Target assigned is non-molecular;1;SANGER: Inhibition of human QIMR-WIL cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;556;5;CHEMBL2366337;;
CLD0;;RCC10RGB;CHEMBL2363594;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308302;Target assigned is non-molecular;1;SANGER: Inhibition of human RCC10RGB cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;557;5;CHEMBL2366191;;
CLD0;;RCM-1;CHEMBL2363595;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308125;Target assigned is non-molecular;1;SANGER: Inhibition of human RCM-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;558;5;CHEMBL1075562;;
CLD0;;RD;CHEMBL2363596;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307547;Target assigned is non-molecular;1;SANGER: Inhibition of human RD cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;559;5;CHEMBL614144;;
CLD0;;RERF-LC-MS;CHEMBL2363598;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308463;Target assigned is non-molecular;1;SANGER: Inhibition of human RERF-LC-MS cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;561;5;CHEMBL1075563;;
CLD0;;RH-1;CHEMBL2363599;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308524;Target assigned is non-molecular;1;SANGER: Inhibition of human RH-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;562;5;CHEMBL2366078;;
CLD0;;RH-18;CHEMBL2363600;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308533;Target assigned is non-molecular;1;SANGER: Inhibition of human RH-18 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;563;5;CHEMBL2366350;;
CLD0;;RKO;CHEMBL2363601;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307731;Target assigned is non-molecular;1;SANGER: Inhibition of human RKO cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;564;5;CHEMBL614879;;
CLD0;;RMG-I;CHEMBL2363604;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308778;Target assigned is non-molecular;1;SANGER: Inhibition of human RMG-I cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;567;5;CHEMBL1075564;;
CLD0;;RO82-W-1;CHEMBL2363605;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308779;Target assigned is non-molecular;1;SANGER: Inhibition of human RO82-W-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;568;5;CHEMBL1075565;;
CLD0;;RPMI-2650;CHEMBL2363606;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308780;Target assigned is non-molecular;1;SANGER: Inhibition of human RPMI-2650 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;569;5;CHEMBL1075566;;
CLD0;;RPMI-7951;CHEMBL2363608;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307962;Target assigned is non-molecular;1;SANGER: Inhibition of human RPMI-7951 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;571;5;CHEMBL612447;;
CLD0;;RPMI-8226;CHEMBL2363609;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;SANGER: Inhibition of human RPMI-8226 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;572;5;CHEMBL614882;;
CLD0;;RPMI-8866;CHEMBL2363611;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308323;Target assigned is non-molecular;1;SANGER: Inhibition of human RPMI-8866 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;574;5;CHEMBL2366341;;
CLD0;;RS4-11;CHEMBL2363612;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308247;Target assigned is non-molecular;1;SANGER: Inhibition of human RS4-11 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;575;5;CHEMBL2366159;;
CLD0;;RT-112;CHEMBL2363613;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307307;Target assigned is non-molecular;1;SANGER: Inhibition of human RT-112 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;576;5;CHEMBL614145;;
CLD0;;RVH-421;CHEMBL2363615;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308126;Target assigned is non-molecular;1;SANGER: Inhibition of human RVH-421 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;578;5;CHEMBL1075567;;
CLD0;;RXF 393;CHEMBL2363616;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307734;Target assigned is non-molecular;1;SANGER: Inhibition of human RXF393 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;579;5;CHEMBL614886;;
CLD0;;Ramos-2G6-4C10;CHEMBL2363618;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308341;Target assigned is non-molecular;1;SANGER: Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;581;5;CHEMBL2366170;;
CLD0;;S-117;CHEMBL2363619;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308464;Target assigned is non-molecular;1;SANGER: Inhibition of human S-117 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;582;5;CHEMBL1075568;;
CLD0;;SAS;CHEMBL2363620;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308781;Target assigned is non-molecular;1;SANGER: Inhibition of human SAS cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;583;5;CHEMBL1075569;;
CLD0;;SBC-1;CHEMBL2363621;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308214;Target assigned is non-molecular;1;SANGER: Inhibition of human SBC-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;584;5;CHEMBL2366327;;
CLD0;;SBC-5;CHEMBL2363622;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308493;Target assigned is non-molecular;1;SANGER: Inhibition of human SBC-5 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;585;5;CHEMBL614896;;
CLD0;;SCC-15;CHEMBL2363623;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307438;Target assigned is non-molecular;1;SANGER: Inhibition of human SCC-15 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;586;5;CHEMBL614899;;
CLD0;;SCC-25;CHEMBL2363624;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307440;Target assigned is non-molecular;1;SANGER: Inhibition of human SCC-25 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;587;5;CHEMBL614901;;
CLD0;;SCC-4;CHEMBL2363626;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308803;Target assigned is non-molecular;1;SANGER: Inhibition of human SCC-4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;589;5;CHEMBL1075570;;
CLD0;;SCC-9;CHEMBL2363627;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308782;Target assigned is non-molecular;1;SANGER: Inhibition of human SCC-9 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;590;5;CHEMBL1075571;;
CLD0;;SCH;CHEMBL2363628;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308783;Target assigned is non-molecular;1;SANGER: Inhibition of human SCH cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;591;5;CHEMBL1075573;;
CLD0;;SF-126;CHEMBL2363630;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307444;Target assigned is non-molecular;1;SANGER: Inhibition of human SF126 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;593;5;CHEMBL614905;;
CLD0;;SF-268;CHEMBL2363631;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;SANGER: Inhibition of human SF268 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;594;5;CHEMBL613977;;
CLD0;;SF-295;CHEMBL2363632;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307738;Target assigned is non-molecular;1;SANGER: Inhibition of human SF295 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;595;5;CHEMBL614908;;
CLD0;;SF-539;CHEMBL2363633;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307721;Target assigned is non-molecular;1;SANGER: Inhibition of human SF539 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;596;5;CHEMBL614860;;
CLD0;;SH-4;CHEMBL2363634;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308177;Target assigned is non-molecular;1;SANGER: Inhibition of human SH-4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;597;5;CHEMBL2366309;;
CLD0;;SHP-77;CHEMBL2363635;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human SHP-77 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;598;5;CHEMBL612569;;
CLD0;;SJRH30;CHEMBL2363638;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308364;Target assigned is non-molecular;1;SANGER: Inhibition of human SJRH30 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;601;5;CHEMBL1075575;;
CLD0;;SJSA-1;CHEMBL2363639;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308885;Target assigned is non-molecular;1;SANGER: Inhibition of human SJSA-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;602;5;CHEMBL2366298;;
CLD0;;SK-HEP-1;CHEMBL2363641;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-HEP-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;604;5;CHEMBL614912;;
CLD0;;SK-LMS-1;CHEMBL2363642;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308552;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-LMS-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;605;5;CHEMBL2366096;;
CLD0;;SK-LU-1;CHEMBL2363643;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307447;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-LU-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;606;5;CHEMBL614913;;
CLD0;;SK-MEL-1;CHEMBL2363644;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308365;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-MEL-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;607;5;CHEMBL614916;;
CLD0;;SK-MEL-2;CHEMBL2363645;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307743;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-MEL-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;608;5;CHEMBL614917;;
CLD0;;SK-MEL-24;CHEMBL2363646;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308324;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-MEL-24 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;609;5;CHEMBL2366314;;
CLD0;;SK-MEL-28;CHEMBL2363647;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-MEL-28 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;610;5;CHEMBL614919;;
CLD0;;SK-MEL-3;CHEMBL2363648;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-MEL-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;611;5;CHEMBL614920;;
CLD0;;SK-MEL-30;CHEMBL2363649;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308128;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-MEL-30 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;612;5;CHEMBL1075577;;
CLD0;;SK-MES-1;CHEMBL2363651;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307450;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-MES-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;614;5;CHEMBL614923;;
CLD0;;SK-N-AS;CHEMBL2363654;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308785;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-N-AS cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;617;5;CHEMBL1075578;;
CLD0;;SK-N-DZ;CHEMBL2363655;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308474;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-N-DZ cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;618;5;CHEMBL1075579;;
CLD0;;SK-N-FI;CHEMBL2363656;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308278;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-N-FI cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;619;5;CHEMBL2366120;;
CLD0;;SK-NEP-1;CHEMBL2363657;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308141;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-NEP-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;620;5;CHEMBL1075580;;
CLD0;;SK-OV-3;CHEMBL2363658;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-OV-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;621;5;CHEMBL614925;;
CLD0;;SK-PN-DW;CHEMBL2363659;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308886;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-PN-DW cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;622;5;CHEMBL2366108;;
CLD0;;SK-UT-1;CHEMBL2363660;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308848;Target assigned is non-molecular;1;SANGER: Inhibition of human SK-UT-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;623;5;CHEMBL2366316;;
CLD0;;SKG-IIIa;CHEMBL2363661;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308786;Target assigned is non-molecular;1;SANGER: Inhibition of human SKG-IIIa cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;624;5;CHEMBL1075581;;
CLD0;;SN12C;CHEMBL2363663;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307518;Target assigned is non-molecular;1;SANGER: Inhibition of human SN12C cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;626;5;CHEMBL614054;;
CLD0;;SNB-75;CHEMBL2363664;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307616;Target assigned is non-molecular;1;SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;627;5;CHEMBL614451;;
CLD0;;SNU-387;CHEMBL2363666;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308817;Target assigned is non-molecular;1;SANGER: Inhibition of human SNU-387 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;629;5;CHEMBL1075583;;
CLD0;;SNU-423;CHEMBL2363667;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308367;Target assigned is non-molecular;1;SANGER: Inhibition of human SNU-423 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;630;5;CHEMBL1075584;;
CLD0;;SNU-449;CHEMBL2363668;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308480;Target assigned is non-molecular;1;SANGER: Inhibition of human SNU-449 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;631;5;CHEMBL1075585;;
CLD0;;SNU-C2B;CHEMBL2363671;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308279;Target assigned is non-molecular;1;SANGER: Inhibition of human SNU-C2B cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;634;5;CHEMBL2366279;;
CLD0;;SW1088;CHEMBL2363676;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307573;Target assigned is non-molecular;1;SANGER: Inhibition of human SW1088 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;639;5;CHEMBL614243;;
CLD0;;SW 1116;CHEMBL2363677;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308495;Target assigned is non-molecular;1;SANGER: Inhibition of human SW1116 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;640;5;CHEMBL614942;;
CLD0;;SW13;CHEMBL2363678;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308467;Target assigned is non-molecular;1;SANGER: Inhibition of human SW13 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;641;5;CHEMBL1075587;;
CLD0;;SW1417;CHEMBL2363679;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308129;Target assigned is non-molecular;1;SANGER: Inhibition of human SW1417 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;642;5;CHEMBL1075588;;
CLD0;;SW1463;CHEMBL2363680;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308788;Target assigned is non-molecular;1;SANGER: Inhibition of human SW1463 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;643;5;CHEMBL1075589;;
CLD0;;SW1573;CHEMBL2363681;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307980;Target assigned is non-molecular;1;SANGER: Inhibition of human SW1573 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;644;5;CHEMBL612570;;
CLD0;;SW1710;CHEMBL2363682;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308804;Target assigned is non-molecular;1;SANGER: Inhibition of human SW1710 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;645;5;CHEMBL1075590;;
CLD0;;SW1783;CHEMBL2363683;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308369;Target assigned is non-molecular;1;SANGER: Inhibition of human SW1783 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;646;5;CHEMBL1075591;;
CLD0;;SW1990;CHEMBL2363684;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308789;Target assigned is non-molecular;1;SANGER: Inhibition of human SW1990 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;647;5;CHEMBL1075592;;
CLD0;;SW48;CHEMBL2363685;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307292;Target assigned is non-molecular;1;SANGER: Inhibition of human SW48 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;648;5;CHEMBL614055;;
CLD0;;SW-620;CHEMBL2363686;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;SANGER: Inhibition of human SW620 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;649;5;CHEMBL612262;;
CLD0;;SW626;CHEMBL2363687;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308130;Target assigned is non-molecular;1;SANGER: Inhibition of human SW626 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;650;5;CHEMBL1075593;;
CLD0;;SW684;CHEMBL2363688;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308217;Target assigned is non-molecular;1;SANGER: Inhibition of human SW684 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;651;5;CHEMBL2366143;;
CLD0;;SW756;CHEMBL2363689;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308790;Target assigned is non-molecular;1;SANGER: Inhibition of human SW756 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;652;5;CHEMBL1075594;;
CLD0;;SW780;CHEMBL2363690;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308468;Target assigned is non-molecular;1;SANGER: Inhibition of human SW780 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;653;5;CHEMBL1075595;;
CLD0;;SW837;CHEMBL2363691;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308361;Target assigned is non-molecular;1;SANGER: Inhibition of human SW837 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;654;5;CHEMBL1075596;;
CLD0;;SW872;CHEMBL2363692;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308837;Target assigned is non-molecular;1;SANGER: Inhibition of human SW872 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;655;5;CHEMBL2366302;;
CLD0;;SW900;CHEMBL2363693;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308819;Target assigned is non-molecular;1;SANGER: Inhibition of human SW900 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;656;5;CHEMBL1075597;;
CLD0;;SW948;CHEMBL2363694;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308131;Target assigned is non-molecular;1;SANGER: Inhibition of human SW948 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;657;5;CHEMBL1075598;;
CLD0;;SW 954;CHEMBL2363695;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307461;Target assigned is non-molecular;1;SANGER: Inhibition of human SW954 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;658;5;CHEMBL614943;;
CLD0;;SW 962;CHEMBL2363696;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307274;Target assigned is non-molecular;1;SANGER: Inhibition of human SW962 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;659;5;CHEMBL613530;;
CLD0;;SW982;CHEMBL2363697;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308534;Target assigned is non-molecular;1;SANGER: Inhibition of human SW982 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;660;5;CHEMBL2366238;;
CLD0;;SAOS-2;CHEMBL2363698;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307737;Target assigned is non-molecular;1;SANGER: Inhibition of human Saos-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;661;5;CHEMBL614894;;
CLD0;;SiHa;CHEMBL2363699;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307968;Target assigned is non-molecular;1;SANGER: Inhibition of human SiHa cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;662;5;CHEMBL612542;;
CLD0;;T-24;CHEMBL2363700;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;SANGER: Inhibition of human T-24 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;663;5;CHEMBL614774;;
CLD0;;T47D;CHEMBL2363701;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;SANGER: Inhibition of human T47D cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;664;5;CHEMBL614361;;
CLD0;;T84;CHEMBL2363702;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307275;Target assigned is non-molecular;1;SANGER: Inhibition of human T84 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;665;5;CHEMBL613531;;
CLD0;;T98G;CHEMBL2363703;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307777;Target assigned is non-molecular;1;SANGER: Inhibition of human T98G cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;666;5;CHEMBL614775;;
CLD0;;TCC-SUP;CHEMBL2363706;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307466;Target assigned is non-molecular;1;SANGER: Inhibition of human TCCSUP cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;669;5;CHEMBL615010;;
CLD0;;TE-1;CHEMBL2363707;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308178;Target assigned is non-molecular;1;SANGER: Inhibition of human TE-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;670;5;CHEMBL2366092;;
CLD0;;CWR22R;CHEMBL2363708;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308004;Target assigned is non-molecular;1;SANGER: Inhibition of human 22RV1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;1;5;CHEMBL612657;;
CLD0;;23132-87;CHEMBL2363709;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308702;Target assigned is non-molecular;1;SANGER: Inhibition of human 23132-87 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;2;5;CHEMBL1075382;;
CLD0;;5637;CHEMBL2363710;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308352;Target assigned is non-molecular;1;SANGER: Inhibition of human 5637 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;3;5;CHEMBL612565;;
CLD0;;639-V;CHEMBL2363711;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308703;Target assigned is non-molecular;1;SANGER: Inhibition of human 639-V cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;4;5;CHEMBL1075383;;
CLD0;;647-V;CHEMBL2363712;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308704;Target assigned is non-molecular;1;SANGER: Inhibition of human 647-V cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;5;5;CHEMBL1075384;;
CLD0;;697;CHEMBL2363713;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308147;Target assigned is non-molecular;1;SANGER: Inhibition of human 697 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;6;5;CHEMBL2366253;;
CLD0;;769-P;CHEMBL2363714;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308705;Target assigned is non-molecular;1;SANGER: Inhibition of human 769-P cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;7;5;CHEMBL1075385;;
CLD0;;786-0;CHEMBL2363715;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;SANGER: Inhibition of human 786-0 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;8;5;CHEMBL613102;;
CLD0;;8-MG-BA;CHEMBL2363716;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308251;Target assigned is non-molecular;1;SANGER: Inhibition of human 8-MG-BA cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;9;5;CHEMBL2366115;;
CLD0;;8305C;CHEMBL2363717;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308706;Target assigned is non-molecular;1;SANGER: Inhibition of human 8305C cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;10;5;CHEMBL1075386;;
CLD0;;8505C;CHEMBL2363718;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308353;Target assigned is non-molecular;1;SANGER: Inhibition of human 8505C cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;11;5;CHEMBL1075387;;
CLD0;;A101D;CHEMBL2363719;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308182;Target assigned is non-molecular;1;SANGER: Inhibition of human A101D cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;12;5;CHEMBL2366306;;
CLD0;;A 172;CHEMBL2363720;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308491;Target assigned is non-molecular;1;SANGER: Inhibition of human A172 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;13;5;CHEMBL614512;;
CLD0;;A204;CHEMBL2363721;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308354;Target assigned is non-molecular;1;SANGER: Inhibition of human A204 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;14;5;CHEMBL614514;;
CLD0;;A2058;CHEMBL2363722;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308030;Target assigned is non-molecular;1;SANGER: Inhibition of human A2058 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;15;5;CHEMBL613503;;
CLD0;;A2780;CHEMBL2363724;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;SANGER: Inhibition of human A2780 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;17;5;CHEMBL614004;;
CLD0;;A3-KAW;CHEMBL2363725;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308225;Target assigned is non-molecular;1;SANGER: Inhibition of human A3-KAW cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;18;5;CHEMBL2366273;;
CLD0;;A-375;CHEMBL2363726;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308077;Target assigned is non-molecular;1;SANGER: Inhibition of human A375 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;19;5;CHEMBL613859;;
CLD0;;A388;CHEMBL2363727;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308159;Target assigned is non-molecular;1;SANGER: Inhibition of human A388 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;20;5;CHEMBL2366355;;
CLD0;;A4-Fuk;CHEMBL2363728;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308226;Target assigned is non-molecular;1;SANGER: Inhibition of human A4-Fuk cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;21;5;CHEMBL2366356;;
CLD0;;A-427;CHEMBL2363729;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307775;Target assigned is non-molecular;1;SANGER: Inhibition of human A427 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;22;5;CHEMBL614515;;
CLD0;;A-431;CHEMBL2363730;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307523;Target assigned is non-molecular;1;SANGER: Inhibition of human A431 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;23;5;CHEMBL614069;;
CLD0;;A498;CHEMBL2363731;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;SANGER: Inhibition of human A498 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;24;5;CHEMBL614516;;
CLD0;;A549;CHEMBL2363732;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;SANGER: Inhibition of human A549 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;25;5;CHEMBL392;;
CLD0;;A673;CHEMBL2363733;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307384;Target assigned is non-molecular;1;SANGER: Inhibition of human A673 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;26;5;CHEMBL614517;;
CLD0;;A704;CHEMBL2363734;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307650;Target assigned is non-molecular;1;SANGER: Inhibition of human A704 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;27;5;CHEMBL614567;;
CLD0;;ABC-1;CHEMBL2363735;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308707;Target assigned is non-molecular;1;SANGER: Inhibition of human ABC-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;28;5;CHEMBL1075391;;
CLD0;;ACHN;CHEMBL2363736;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;SANGER: Inhibition of human ACHN cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;29;5;CHEMBL614519;;
CLD0;;ACN;CHEMBL2363737;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308148;Target assigned is non-molecular;1;SANGER: Inhibition of human ACN cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;30;5;CHEMBL2366195;;
CLD0;;AGS;CHEMBL2363738;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308078;Target assigned is non-molecular;1;SANGER: Inhibition of human AGS cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;31;5;CHEMBL613860;;
CLD0;;ALL-PO;CHEMBL2363739;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308227;Target assigned is non-molecular;1;SANGER: Inhibition of human ALL-PO cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;32;5;CHEMBL2366294;;
CLD0;;AM-38;CHEMBL2363740;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308829;Target assigned is non-molecular;1;SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;33;5;CHEMBL2366192;;
CLD0;;AN3-CA;CHEMBL2363741;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308708;Target assigned is non-molecular;1;SANGER: Inhibition of human AN3-CA cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;34;5;CHEMBL1075392;;
CLD0;;ATN-1;CHEMBL2363743;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308183;Target assigned is non-molecular;1;SANGER: Inhibition of human ATN-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;36;5;CHEMBL2366277;;
CLD0;;AU565;CHEMBL2363744;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308095;Target assigned is non-molecular;1;SANGER: Inhibition of human AU565 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;37;5;CHEMBL1075393;;
CLD0;;ASPC1;CHEMBL2363745;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307994;Target assigned is non-molecular;1;SANGER: Inhibition of human AsPC-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;38;5;CHEMBL612588;;
CLD0;;BALL-1;CHEMBL2363746;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308839;Target assigned is non-molecular;1;SANGER: Inhibition of human BALL-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;39;5;CHEMBL2366269;;
CLD0;;BB30-HNC;CHEMBL2363747;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308548;Target assigned is non-molecular;1;SANGER: Inhibition of human BB30-HNC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;40;5;CHEMBL2366271;;
CLD0;;BB49-HNC;CHEMBL2363748;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308282;Target assigned is non-molecular;1;SANGER: Inhibition of human BB49-HNC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;41;5;CHEMBL2366295;;
CLD0;;BB65-RCC;CHEMBL2363749;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308283;Target assigned is non-molecular;1;SANGER: Inhibition of human BB65-RCC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;42;5;CHEMBL2366247;;
CLD0;;BCPAP;CHEMBL2363752;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308356;Target assigned is non-molecular;1;SANGER: Inhibition of human BCPAP cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;45;5;CHEMBL1075394;;
CLD0;;BE-13;CHEMBL2363753;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308184;Target assigned is non-molecular;1;SANGER: Inhibition of human BE-13 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;46;5;CHEMBL2366303;;
CLD0;;BEN;CHEMBL2363754;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308709;Target assigned is non-molecular;1;SANGER: Inhibition of human BEN cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;47;5;CHEMBL1075395;;
CLD0;;BFTC-905;CHEMBL2363755;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308470;Target assigned is non-molecular;1;SANGER: Inhibition of human BFTC-905 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;48;5;CHEMBL1075396;;
CLD0;;BFTC-909;CHEMBL2363756;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308710;Target assigned is non-molecular;1;SANGER: Inhibition of human BFTC-909 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;49;5;CHEMBL1075397;;
CLD0;;BHT-101;CHEMBL2363757;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308096;Target assigned is non-molecular;1;SANGER: Inhibition of human BHT-101 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;50;5;CHEMBL1075398;;
CLD0;;BHY;CHEMBL2363758;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308711;Target assigned is non-molecular;1;SANGER: Inhibition of human BHY cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;51;5;CHEMBL1075399;;
CLD0;;BPH-1;CHEMBL2363762;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308186;Target assigned is non-molecular;1;SANGER: Inhibition of human BPH-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;55;5;CHEMBL2366131;;
CLD0;;BT-20;CHEMBL2363763;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307766;Target assigned is non-molecular;1;SANGER: Inhibition of human BT-20 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;56;5;CHEMBL613870;;
CLD0;;BT-474;CHEMBL2363764;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307636;Target assigned is non-molecular;1;SANGER: Inhibition of human BT-474 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;57;5;CHEMBL614529;;
CLD0;;BT-549;CHEMBL2363765;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308490;Target assigned is non-molecular;1;SANGER: Inhibition of human BT-549 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;58;5;CHEMBL614072;;
CLD0;;BV-173;CHEMBL2363766;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308228;Target assigned is non-molecular;1;SANGER: Inhibition of human BV-173 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;59;5;CHEMBL2366145;;
CLD0;;Becker;CHEMBL2363767;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308229;Target assigned is non-molecular;1;SANGER: Inhibition of human Becker cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;60;5;CHEMBL2366230;;
CLD0;;BXPC-3;CHEMBL2363768;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307637;Target assigned is non-molecular;1;SANGER: Inhibition of human BxPC-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;61;5;CHEMBL614530;;
CLD0;;C-33-A;CHEMBL2363769;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308230;Target assigned is non-molecular;1;SANGER: Inhibition of human C-33-A cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;62;5;CHEMBL2366313;;
CLD0;;C2BBe1;CHEMBL2363771;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308231;Target assigned is non-molecular;1;SANGER: Inhibition of human C2BBe1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;64;5;CHEMBL2366283;;
CLD0;;C32;CHEMBL2363772;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308713;Target assigned is non-molecular;1;SANGER: Inhibition of human C32 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;65;5;CHEMBL1075401;;
CLD0;;C3A;CHEMBL2363773;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308377;Target assigned is non-molecular;1;SANGER: Inhibition of human C3A cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;66;5;CHEMBL1075402;;
CLD0;;C8166;CHEMBL2363774;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307638;Target assigned is non-molecular;1;SANGER: Inhibition of human C8166 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;67;5;CHEMBL614533;;
CLD0;;CAKI-1;CHEMBL2363776;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;SANGER: Inhibition of human CAKI-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;69;5;CHEMBL614067;;
CLD0;;CAL-120;CHEMBL2363777;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308577;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-120 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;70;5;CHEMBL1075405;;
CLD0;;CAL-12T;CHEMBL2363778;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308132;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-12T cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;71;5;CHEMBL1075406;;
CLD0;;CAL-27;CHEMBL2363780;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308098;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-27 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;73;5;CHEMBL1075408;;
CLD0;;CAL-33;CHEMBL2363781;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308715;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-33 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;74;5;CHEMBL1075409;;
CLD0;;CAL-39;CHEMBL2363782;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308716;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-39 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;75;5;CHEMBL1075410;;
CLD0;;CAL-51;CHEMBL2363783;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308717;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-51 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;76;5;CHEMBL1075411;;
CLD0;;CAL-54;CHEMBL2363784;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308346;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-54 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;77;5;CHEMBL1075412;;
CLD0;;CAL-62;CHEMBL2363785;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308099;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-62 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;78;5;CHEMBL1075413;;
CLD0;;CAL-72;CHEMBL2363786;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308718;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-72 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;79;5;CHEMBL1075414;;
CLD0;;CAL-85-1;CHEMBL2363787;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308700;Target assigned is non-molecular;1;SANGER: Inhibition of human CAL-85-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;80;5;CHEMBL1075415;;
CLD0;;TE-10;CHEMBL2363788;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308218;Target assigned is non-molecular;1;SANGER: Inhibition of human TE-10 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;671;5;CHEMBL2366308;;
CLD0;;TE-11;CHEMBL2363789;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308219;Target assigned is non-molecular;1;SANGER: Inhibition of human TE-11 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;672;5;CHEMBL2366166;;
CLD0;;TE-12;CHEMBL2363790;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308220;Target assigned is non-molecular;1;SANGER: Inhibition of human TE-12 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;673;5;CHEMBL2366278;;
CLD0;;TE-5;CHEMBL2363793;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308179;Target assigned is non-molecular;1;SANGER: Inhibition of human TE-5 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;676;5;CHEMBL2366245;;
CLD0;;TE-6;CHEMBL2363794;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308180;Target assigned is non-molecular;1;SANGER: Inhibition of human TE-6 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;677;5;CHEMBL2366144;;
CLD0;;TE-8;CHEMBL2363795;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308525;Target assigned is non-molecular;1;SANGER: Inhibition of human TE-8 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;678;5;CHEMBL2366182;;
CLD0;;TE-9;CHEMBL2363796;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308181;Target assigned is non-molecular;1;SANGER: Inhibition of human TE-9 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;679;5;CHEMBL2366147;;
CLD0;;TGBC11TKB;CHEMBL2363797;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308557;Target assigned is non-molecular;1;SANGER: Inhibition of human TGBC11TKB cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;680;5;CHEMBL2366374;;
CLD0;;TGBC1TKB;CHEMBL2363798;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308852;Target assigned is non-molecular;1;SANGER: Inhibition of human TGBC1TKB cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;681;5;CHEMBL2366089;;
CLD0;;TGBC24TKB;CHEMBL2363799;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308856;Target assigned is non-molecular;1;SANGER: Inhibition of human TGBC24TKB cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;682;5;CHEMBL2366093;;
CLD0;;TI-73;CHEMBL2363802;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308222;Target assigned is non-molecular;1;SANGER: Inhibition of human TI-73 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;685;5;CHEMBL2366158;;
CLD0;;TK-10;CHEMBL2363803;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308453;Target assigned is non-molecular;1;SANGER: Inhibition of human TK10 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;686;5;CHEMBL614056;;
CLD0;;TYK-nu;CHEMBL2363806;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308805;Target assigned is non-molecular;1;SANGER: Inhibition of human TYK-nu cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;689;5;CHEMBL1075601;;
CLD0;;U-118-MG;CHEMBL2363807;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308793;Target assigned is non-molecular;1;SANGER: Inhibition of human U-118-MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;690;5;CHEMBL1075602;;
CLD0;;U-2-OS;CHEMBL2363808;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human U-2-OS cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;691;5;CHEMBL615023;;
CLD0;;U-266;CHEMBL2363809;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308535;Target assigned is non-molecular;1;SANGER: Inhibition of human U-266 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;692;5;CHEMBL2366315;;
CLD0;;U-87MG ATCC;CHEMBL2363811;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307575;Target assigned is non-molecular;1;SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;694;5;CHEMBL614247;;
CLD0;;UO-31;CHEMBL2363812;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;SANGER: Inhibition of human U031 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;695;5;CHEMBL614388;;
CLD0;;U-251;CHEMBL2363813;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;SANGER: Inhibition of human U251 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;696;5;CHEMBL615022;;
CLD0;;UACC-257;CHEMBL2363814;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308008;Target assigned is non-molecular;1;SANGER: Inhibition of human UACC-257 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;697;5;CHEMBL612796;;
CLD0;;UACC-62;CHEMBL2363815;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307660;Target assigned is non-molecular;1;SANGER: Inhibition of human UACC-62 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;698;5;CHEMBL614610;;
CLD0;;UACC-893;CHEMBL2363817;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308807;Target assigned is non-molecular;1;SANGER: Inhibition of human UACC-893 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;700;5;CHEMBL1075605;;
CLD0;;UMUC3;CHEMBL2363818;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307245;Target assigned is non-molecular;1;SANGER: Inhibition of human UM-UC-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;701;5;CHEMBL612799;;
CLD0;;UMC-11;CHEMBL2363819;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308343;Target assigned is non-molecular;1;SANGER: Inhibition of human UMC-11 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;702;5;CHEMBL1075606;;
CLD0;;VA-ES-BJ;CHEMBL2363820;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308888;Target assigned is non-molecular;1;SANGER: Inhibition of human VA-ES-BJ cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;703;5;CHEMBL2366259;;
CLD0;;VM-CUB-1;CHEMBL2363821;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308476;Target assigned is non-molecular;1;SANGER: Inhibition of human VM-CUB-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;704;5;CHEMBL1075607;;
CLD0;;VMRC-RCZ;CHEMBL2363822;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308810;Target assigned is non-molecular;1;SANGER: Inhibition of human VMRC-RCZ cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;705;5;CHEMBL1075610;;
CLD0;;WM-115;CHEMBL2363823;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308813;Target assigned is non-molecular;1;SANGER: Inhibition of human WM-115 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;706;5;CHEMBL1075611;;
CLD0;;YAPC;CHEMBL2363825;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307253;Target assigned is non-molecular;1;SANGER: Inhibition of human YAPC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;708;5;CHEMBL612815;;
CLD0;;YH-13;CHEMBL2363826;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308223;Target assigned is non-molecular;1;SANGER: Inhibition of human YH-13 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;709;5;CHEMBL2366164;;
CLD0;;YKG-1;CHEMBL2363827;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308093;Target assigned is non-molecular;1;SANGER: Inhibition of human YKG-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;710;5;CHEMBL1075612;;
CLD0;;ZR-75-30;CHEMBL2363829;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308094;Target assigned is non-molecular;1;SANGER: Inhibition of human ZR-75-30 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;712;5;CHEMBL1075613;;
CLD0;;no-10;CHEMBL2363830;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308838;Target assigned is non-molecular;1;SANGER: Inhibition of human no-10 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;713;5;CHEMBL2366071;;
CLD0;;no-11;CHEMBL2363831;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308224;Target assigned is non-molecular;1;SANGER: Inhibition of human no-11 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;714;5;CHEMBL2366326;;
CLD0;;CAMA-1;CHEMBL2363832;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308719;Target assigned is non-molecular;1;SANGER: Inhibition of human CAMA-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;81;5;CHEMBL1075416;;
CLD0;;CAPAN-1;CHEMBL2363833;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307640;Target assigned is non-molecular;1;SANGER: Inhibition of human CAPAN-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;82;5;CHEMBL614536;;
CLD0;;CAS-1;CHEMBL2363834;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308187;Target assigned is non-molecular;1;SANGER: Inhibition of human CAS-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;83;5;CHEMBL2366100;;
CLD0;;CCRF-CEM;CHEMBL2363836;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;SANGER: Inhibition of human CCRF-CEM cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;85;5;CHEMBL382;;
CLD0;;CFPAC-1;CHEMBL2363838;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308032;Target assigned is non-molecular;1;SANGER: Inhibition of human CFPAC-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;87;5;CHEMBL613506;;
CLD0;;CGTH-W-1;CHEMBL2363839;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308849;Target assigned is non-molecular;1;SANGER: Inhibition of human CGTH-W-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;88;5;CHEMBL2366300;;
CLD0;;CHL-1;CHEMBL2363840;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308722;Target assigned is non-molecular;1;SANGER: Inhibition of human CHL-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;89;5;CHEMBL1075422;;
CLD0;;CHP-212;CHEMBL2363843;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308101;Target assigned is non-molecular;1;SANGER: Inhibition of human CHP-212 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;92;5;CHEMBL1075423;;
CLD0;;COLO-320-HSR;CHEMBL2363846;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308337;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-320-HSR cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;95;5;CHEMBL2366265;;
CLD0;;COLO-668;CHEMBL2363847;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308864;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-668 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;96;5;CHEMBL2366215;;
CLD0;;COLO-678;CHEMBL2363848;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308349;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-678 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;97;5;CHEMBL1075425;;
CLD0;;COLO-679;CHEMBL2363849;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308723;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-679 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;98;5;CHEMBL1075426;;
CLD0;;COLO-680N;CHEMBL2363850;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308724;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-680N cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;99;5;CHEMBL1075427;;
CLD0;;COLO-684;CHEMBL2363851;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308284;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-684 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;100;5;CHEMBL2366176;;
CLD0;;COLO-741;CHEMBL2363138;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308102;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-741 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;101;5;CHEMBL1075428;;
CLD0;;COLO-792;CHEMBL2363139;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308796;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-792 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;102;5;CHEMBL1075429;;
CLD0;;COLO-800;CHEMBL2363140;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308285;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-800 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;103;5;CHEMBL2366224;;
CLD0;;COLO-824;CHEMBL2363141;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308725;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-824 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;104;5;CHEMBL1075430;;
CLD0;;COLO-829;CHEMBL2363142;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308286;Target assigned is non-molecular;1;SANGER: Inhibition of human COLO-829 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;105;5;CHEMBL2366275;;
CLD0;;COR-L105;CHEMBL2363143;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308350;Target assigned is non-molecular;1;SANGER: Inhibition of human COR-L105 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;106;5;CHEMBL1075431;;
CLD0;;COR-L23;CHEMBL2363144;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308073;Target assigned is non-molecular;1;SANGER: Inhibition of human COR-L23 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;107;5;CHEMBL613854;;
CLD0;;COR-L88;CHEMBL2363146;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308865;Target assigned is non-molecular;1;SANGER: Inhibition of human COR-L88 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;109;5;CHEMBL2366329;;
CLD0;;CP50-MEL-B;CHEMBL2363147;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308325;Target assigned is non-molecular;1;SANGER: Inhibition of human CP50-MEL-B cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;110;5;CHEMBL2366076;;
CLD0;;CP66-MEL;CHEMBL2363148;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308287;Target assigned is non-molecular;1;SANGER: Inhibition of human CP66-MEL cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;111;5;CHEMBL2366363;;
CLD0;;CTB-1;CHEMBL2363152;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308188;Target assigned is non-molecular;1;SANGER: Inhibition of human CTB-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;115;5;CHEMBL2366344;;
CLD0;;CTV-1;CHEMBL2363153;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308189;Target assigned is non-molecular;1;SANGER: Inhibition of human CTV-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;116;5;CHEMBL2366360;;
CLD0;;CW-2;CHEMBL2363154;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308161;Target assigned is non-molecular;1;SANGER: Inhibition of human CW-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;117;5;CHEMBL2366174;;
CLD0;;Ca-Ski;CHEMBL2363155;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308097;Target assigned is non-molecular;1;SANGER: Inhibition of human Ca-Ski cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;118;5;CHEMBL1075403;;
CLD0;;Ca9-22;CHEMBL2363156;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308714;Target assigned is non-molecular;1;SANGER: Inhibition of human Ca9-22 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;119;5;CHEMBL1075404;;
CLD0;;CaR-1;CHEMBL2363157;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308100;Target assigned is non-molecular;1;SANGER: Inhibition of human CaR-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;120;5;CHEMBL1075418;;
CLD0;;Calu-3;CHEMBL2363159;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307390;Target assigned is non-molecular;1;SANGER: Inhibition of human Calu-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;122;5;CHEMBL614534;;
CLD0;;Calu-6;CHEMBL2363160;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307639;Target assigned is non-molecular;1;SANGER: Inhibition of human Calu-6 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;123;5;CHEMBL614535;;
CLD0;;Capan-2;CHEMBL2363163;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308720;Target assigned is non-molecular;1;SANGER: Inhibition of human Capan-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;126;5;CHEMBL1075417;;
CLD0;;ChaGo-K-1;CHEMBL2363164;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308489;Target assigned is non-molecular;1;SANGER: Inhibition of human ChaGo-K-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;127;5;CHEMBL1075421;;
CLD0;;D-247MG;CHEMBL2363165;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308542;Target assigned is non-molecular;1;SANGER: Inhibition of human D-247MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;128;5;CHEMBL2366237;;
CLD0;;D-263MG;CHEMBL2363166;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308255;Target assigned is non-molecular;1;SANGER: Inhibition of human D-263MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;129;5;CHEMBL2366183;;
CLD0;;D283 Med;CHEMBL2363167;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307938;Target assigned is non-molecular;1;SANGER: Inhibition of human D-283MED cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;130;5;CHEMBL614476;;
CLD0;;D-336MG;CHEMBL2363168;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308844;Target assigned is non-molecular;1;SANGER: Inhibition of human D-336MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;131;5;CHEMBL2366113;;
CLD0;;D-392MG;CHEMBL2363169;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308256;Target assigned is non-molecular;1;SANGER: Inhibition of human D-392MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;132;5;CHEMBL2366161;;
CLD0;;D-423MG;CHEMBL2363170;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308257;Target assigned is non-molecular;1;SANGER: Inhibition of human D-423MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;133;5;CHEMBL2366134;;
CLD0;;D-502MG;CHEMBL2363171;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308258;Target assigned is non-molecular;1;SANGER: Inhibition of human D-502MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;134;5;CHEMBL2366343;;
CLD0;;D-542MG;CHEMBL2363172;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308259;Target assigned is non-molecular;1;SANGER: Inhibition of human D-542MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;135;5;CHEMBL2366208;;
CLD0;;D-566MG;CHEMBL2363173;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308543;Target assigned is non-molecular;1;SANGER: Inhibition of human D-566MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;136;5;CHEMBL2366336;;
CLD0;;DB;CHEMBL2363174;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308866;Target assigned is non-molecular;1;SANGER: Inhibition of human DB cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;137;5;CHEMBL2366331;;
CLD0;;DBTRG-05MG;CHEMBL2363175;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308485;Target assigned is non-molecular;1;SANGER: Inhibition of human DBTRG-05MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;138;5;CHEMBL614801;;
CLD0;;DEL;CHEMBL2363176;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308516;Target assigned is non-molecular;1;SANGER: Inhibition of human DEL cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;139;5;CHEMBL2366186;;
CLD0;;DJM-1;CHEMBL2363178;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308190;Target assigned is non-molecular;1;SANGER: Inhibition of human DJM-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;141;5;CHEMBL2366264;;
CLD0;;DK-MG;CHEMBL2363179;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308814;Target assigned is non-molecular;1;SANGER: Inhibition of human DK-MG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;142;5;CHEMBL1075433;;
CLD0;;DMS-114;CHEMBL2363180;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307670;Target assigned is non-molecular;1;SANGER: Inhibition of human DMS-114 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;143;5;CHEMBL614642;;
CLD0;;DMS-273;CHEMBL2363182;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308487;Target assigned is non-molecular;1;SANGER: Inhibition of human DMS-273 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;145;5;CHEMBL614034;;
CLD0;;DMS-79;CHEMBL2363184;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307581;Target assigned is non-molecular;1;SANGER: Inhibition of human DMS-79 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;147;5;CHEMBL614286;;
CLD0;;DOHH-2;CHEMBL2363185;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308537;Target assigned is non-molecular;1;SANGER: Inhibition of human DOHH-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;148;5;CHEMBL2366181;;
CLD0;;DOK;CHEMBL2363186;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308727;Target assigned is non-molecular;1;SANGER: Inhibition of human DOK cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;149;5;CHEMBL1075435;;
CLD0;;DSH1;CHEMBL2363187;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308520;Target assigned is non-molecular;1;SANGER: Inhibition of human DSH1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;150;5;CHEMBL2366079;;
CLD0;;DU-145;CHEMBL2363188;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;SANGER: Inhibition of human DU-145 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;151;5;CHEMBL613508;;
CLD0;;DU-4475;CHEMBL2363189;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308261;Target assigned is non-molecular;1;SANGER: Inhibition of human DU-4475 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;152;5;CHEMBL2366246;;
CLD0;;Daoy;CHEMBL2363191;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308510;Target assigned is non-molecular;1;SANGER: Inhibition of human Daoy cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;154;5;CHEMBL612519;;
CLD0;;Detroit 562;CHEMBL2363193;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308486;Target assigned is non-molecular;1;SANGER: Inhibition of human Detroit562 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;156;5;CHEMBL1075432;;
CLD0;;DoTc2-4510;CHEMBL2363194;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308728;Target assigned is non-molecular;1;SANGER: Inhibition of human DoTc2-4510 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;157;5;CHEMBL1075436;;
CLD0;;EC-GI-10;CHEMBL2363197;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308289;Target assigned is non-molecular;1;SANGER: Inhibition of human EC-GI-10 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;160;5;CHEMBL2366240;;
CLD0;;ECC10;CHEMBL2363198;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308191;Target assigned is non-molecular;1;SANGER: Inhibition of human ECC10 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;161;5;CHEMBL2366117;;
CLD0;;EFM-19;CHEMBL2363202;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308502;Target assigned is non-molecular;1;SANGER: Inhibition of human EFM-19 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;165;5;CHEMBL1075439;;
CLD0;;EFO-21;CHEMBL2363203;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308730;Target assigned is non-molecular;1;SANGER: Inhibition of human EFO-21 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;166;5;CHEMBL1075440;;
CLD0;;EFO-27;CHEMBL2363204;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308134;Target assigned is non-molecular;1;SANGER: Inhibition of human EFO-27 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;167;5;CHEMBL1075441;;
CLD0;;EGI-1;CHEMBL2363205;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308731;Target assigned is non-molecular;1;SANGER: Inhibition of human EGI-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;168;5;CHEMBL1075442;;
CLD0;;EKVX ;CHEMBL2363207;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307626;Target assigned is non-molecular;1;SANGER: Inhibition of human EKVX cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;170;5;CHEMBL614487;;
CLD0;;EM-2;CHEMBL2363208;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308889;Target assigned is non-molecular;1;SANGER: Inhibition of human EM-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;171;5;CHEMBL2366281;;
CLD0;;EPLC-272H;CHEMBL2363209;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308104;Target assigned is non-molecular;1;SANGER: Inhibition of human EPLC-272H cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;172;5;CHEMBL1075443;;
CLD0;;ES1;CHEMBL2363210;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308820;Target assigned is non-molecular;1;SANGER: Inhibition of human ES1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;173;5;CHEMBL2366146;;
CLD0;;ES3;CHEMBL2363211;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308150;Target assigned is non-molecular;1;SANGER: Inhibition of human ES3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;174;5;CHEMBL2366135;;
CLD0;;ES4;CHEMBL2363212;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308151;Target assigned is non-molecular;1;SANGER: Inhibition of human ES4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;175;5;CHEMBL2366118;;
CLD0;;ES5;CHEMBL2363213;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308517;Target assigned is non-molecular;1;SANGER: Inhibition of human ES5 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;176;5;CHEMBL2366312;;
CLD0;;ES6;CHEMBL2363214;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308152;Target assigned is non-molecular;1;SANGER: Inhibition of human ES6 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;177;5;CHEMBL2366373;;
CLD0;;ES7;CHEMBL2363215;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308821;Target assigned is non-molecular;1;SANGER: Inhibition of human ES7 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;178;5;CHEMBL2366297;;
CLD0;;ES8;CHEMBL2363216;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308153;Target assigned is non-molecular;1;SANGER: Inhibition of human ES8 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;179;5;CHEMBL2366069;;
CLD0;;ESS-1;CHEMBL2363217;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308384;Target assigned is non-molecular;1;SANGER: Inhibition of human ESS-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;180;5;CHEMBL1075444;;
CLD0;;ETK-1;CHEMBL2363218;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308831;Target assigned is non-molecular;1;SANGER: Inhibition of human ETK-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;181;5;CHEMBL2366116;;
CLD0;;EW-1;CHEMBL2363220;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308164;Target assigned is non-molecular;1;SANGER: Inhibition of human EW-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;183;5;CHEMBL2366364;;
CLD0;;EW-11;CHEMBL2363221;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308193;Target assigned is non-molecular;1;SANGER: Inhibition of human EW-11 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;184;5;CHEMBL2366223;;
CLD0;;EW-13;CHEMBL2363223;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308194;Target assigned is non-molecular;1;SANGER: Inhibition of human EW-13 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;186;5;CHEMBL2366124;;
CLD0;;EW-16;CHEMBL2363224;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308195;Target assigned is non-molecular;1;SANGER: Inhibition of human EW-16 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;187;5;CHEMBL2366358;;
CLD0;;EW-18;CHEMBL2363225;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308832;Target assigned is non-molecular;1;SANGER: Inhibition of human EW-18 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;188;5;CHEMBL2366097;;
CLD0;;EW-22;CHEMBL2363226;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308196;Target assigned is non-molecular;1;SANGER: Inhibition of human EW-22 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;189;5;CHEMBL2366162;;
CLD0;;EW-24;CHEMBL2363227;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308197;Target assigned is non-molecular;1;SANGER: Inhibition of human EW-24 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;190;5;CHEMBL2366206;;
CLD0;;EW-3;CHEMBL2363228;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308521;Target assigned is non-molecular;1;SANGER: Inhibition of human EW-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;191;5;CHEMBL2366307;;
CLD0;;EOL1;CHEMBL2363230;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308381;Target assigned is non-molecular;1;SANGER: Inhibition of human EoL-1-cell cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;193;5;CHEMBL614489;;
CLD0;;FaDu;CHEMBL2363231;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307943;Target assigned is non-molecular;1;SANGER: Inhibition of human FADU cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;194;5;CHEMBL612250;;
CLD0;;FTC-133;CHEMBL2363232;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308732;Target assigned is non-molecular;1;SANGER: Inhibition of human FTC-133 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;195;5;CHEMBL1075445;;
CLD0;;G-361;CHEMBL2363233;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307514;Target assigned is non-molecular;1;SANGER: Inhibition of human G-361 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;196;5;CHEMBL614036;;
CLD0;;G-401;CHEMBL2363234;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308394;Target assigned is non-molecular;1;SANGER: Inhibition of human G-401 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;197;5;CHEMBL613509;;
CLD0;;G-402;CHEMBL2363235;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308733;Target assigned is non-molecular;1;SANGER: Inhibition of human G-402 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;198;5;CHEMBL1075446;;
CLD0;;GAK;CHEMBL2363236;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308154;Target assigned is non-molecular;1;SANGER: Inhibition of human GAK cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;199;5;CHEMBL2366301;;
CLD0;;GAMG;CHEMBL2363237;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308734;Target assigned is non-molecular;1;SANGER: Inhibition of human GAMG cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;200;5;CHEMBL1075447;;
CLD0;;GB-1;CHEMBL2363238;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308166;Target assigned is non-molecular;1;SANGER: Inhibition of human GB-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;201;5;CHEMBL2366292;;
CLD0;;GCIY;CHEMBL2363239;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308825;Target assigned is non-molecular;1;SANGER: Inhibition of human GCIY cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;202;5;CHEMBL2366234;;
CLD0;;GCT;CHEMBL2363240;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308471;Target assigned is non-molecular;1;SANGER: Inhibition of human GCT cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;203;5;CHEMBL1075448;;
CLD0;;GI-1;CHEMBL2363242;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308167;Target assigned is non-molecular;1;SANGER: Inhibition of human GI-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;205;5;CHEMBL2366272;;
CLD0;;GI-ME-N;CHEMBL2363243;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308868;Target assigned is non-molecular;1;SANGER: Inhibition of human GI-ME-N cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;206;5;CHEMBL2366074;;
CLD0;;GMS-10;CHEMBL2363244;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308105;Target assigned is non-molecular;1;SANGER: Inhibition of human GMS-10 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;207;5;CHEMBL1075449;;
CLD0;;GOTO;CHEMBL2363245;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308168;Target assigned is non-molecular;1;SANGER: Inhibition of human GOTO cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;208;5;CHEMBL2366179;;
CLD0;;GP5d;CHEMBL2363246;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308735;Target assigned is non-molecular;1;SANGER: Inhibition of human GP5d cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;209;5;CHEMBL1075450;;
CLD0;;GR-ST;CHEMBL2363247;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308529;Target assigned is non-molecular;1;SANGER: Inhibition of human GR-ST cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;210;5;CHEMBL2366111;;
CLD0;;GT3TKB;CHEMBL2363248;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308840;Target assigned is non-molecular;1;SANGER: Inhibition of human GT3TKB cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;211;5;CHEMBL2366148;;
CLD0;;H-EMC-SS;CHEMBL2363249;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308736;Target assigned is non-molecular;1;SANGER: Inhibition of human H-EMC-SS cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;212;5;CHEMBL1075451;;
CLD0;;H4;CHEMBL2363250;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308507;Target assigned is non-molecular;1;SANGER: Inhibition of human H4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;213;5;CHEMBL1075452;;
CLD0;;H9;CHEMBL2363251;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308402;Target assigned is non-molecular;1;SANGER: Inhibition of human H9 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;214;5;CHEMBL614806;;
CLD0;;HAL-01;CHEMBL2363252;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308233;Target assigned is non-molecular;1;SANGER: Inhibition of human HAL-01 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;215;5;CHEMBL2366142;;
CLD0;;HC-1;CHEMBL2363253;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308522;Target assigned is non-molecular;1;SANGER: Inhibition of human HC-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;216;5;CHEMBL2366299;;
CLD0;;HCC1187;CHEMBL2363255;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308845;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC1187 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;218;5;CHEMBL2366202;;
CLD0;;HCC1395;CHEMBL2363256;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308106;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC1395 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;219;5;CHEMBL1075454;;
CLD0;;HCC1419;CHEMBL2363257;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308738;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC1419 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;220;5;CHEMBL1075455;;
CLD0;;HCC1569;CHEMBL2363258;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308497;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC1569 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;221;5;CHEMBL1075456;;
CLD0;;HCC1806;CHEMBL2363260;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308135;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC1806 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;223;5;CHEMBL1075457;;
CLD0;;HCC1937;CHEMBL2363261;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308371;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC1937 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;224;5;CHEMBL1075458;;
CLD0;;HCC1954;CHEMBL2363262;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308107;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC1954 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;225;5;CHEMBL1075459;;
CLD0;;HCC2218;CHEMBL2363264;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308869;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC2218 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;227;5;CHEMBL2366221;;
CLD0;;HCC 2998;CHEMBL2363265;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308074;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC2998 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;228;5;CHEMBL613855;;
CLD0;;HCC38;CHEMBL2363266;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308578;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC38 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;229;5;CHEMBL1075460;;
CLD0;;HCC70;CHEMBL2363267;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308739;Target assigned is non-molecular;1;SANGER: Inhibition of human HCC70 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;230;5;CHEMBL1075461;;
CLD0;;HCE-4;CHEMBL2363268;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308199;Target assigned is non-molecular;1;SANGER: Inhibition of human HCE-4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;231;5;CHEMBL2366207;;
CLD0;;HCE-T;CHEMBL2363269;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308200;Target assigned is non-molecular;1;SANGER: Inhibition of human HCE-T cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;232;5;CHEMBL2366139;;
CLD0;;HCT-116;CHEMBL2363270;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;SANGER: Inhibition of human HCT-116 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;233;5;CHEMBL394;;
CLD0;;HCT-15;CHEMBL2363271;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;SANGER: Inhibition of human HCT-15 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;234;5;CHEMBL612263;;
CLD0;;HD-MY-Z;CHEMBL2363272;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308544;Target assigned is non-molecular;1;SANGER: Inhibition of human HD-MY-Z cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;235;5;CHEMBL2366322;;
CLD0;;HDLM-2;CHEMBL2363273;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308234;Target assigned is non-molecular;1;SANGER: Inhibition of human HDLM-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;236;5;CHEMBL2366231;;
CLD0;;HEC-1;CHEMBL2363274;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308740;Target assigned is non-molecular;1;SANGER: Inhibition of human HEC-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;237;5;CHEMBL1075462;;
CLD0;;HEL;CHEMBL2363275;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;SANGER: Inhibition of human HEL cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;238;5;CHEMBL613888;;
CLD0;;HGC-27;CHEMBL2363276;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308741;Target assigned is non-molecular;1;SANGER: Inhibition of human HGC-27 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;239;5;CHEMBL1075463;;
CLD0;;HH;CHEMBL2363277;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308142;Target assigned is non-molecular;1;SANGER: Inhibition of human HH cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;240;5;CHEMBL2366310;;
CLD0;;HL-60;CHEMBL2363278;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;SANGER: Inhibition of human HL-60 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;241;5;CHEMBL383;;
CLD0;;HLE;CHEMBL2363279;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308108;Target assigned is non-molecular;1;SANGER: Inhibition of human HLE cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;242;5;CHEMBL1075464;;
CLD0;;HMV-2 cell line;CHEMBL2363280;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308667;Target assigned is non-molecular;1;SANGER: Inhibition of human HMV-II cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;243;5;CHEMBL614826;;
CLD0;;HN;CHEMBL2363281;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308742;Target assigned is non-molecular;1;SANGER: Inhibition of human HN cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;244;5;CHEMBL1075465;;
CLD0;;HO-1-N-1;CHEMBL2363282;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308743;Target assigned is non-molecular;1;SANGER: Inhibition of human HO-1-N-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;245;5;CHEMBL1075466;;
CLD0;;HOP-62;CHEMBL2363283;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307671;Target assigned is non-molecular;1;SANGER: Inhibition of human HOP-62 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;246;5;CHEMBL614643;;
CLD0;;HOP-92;CHEMBL2363284;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308091;Target assigned is non-molecular;1;SANGER: Inhibition of human HOP-92 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;247;5;CHEMBL613889;;
CLD0;;HOS;CHEMBL2363285;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308811;Target assigned is non-molecular;1;SANGER: Inhibition of human HOS cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;248;5;CHEMBL614736;;
CLD0;;HPAF-II;CHEMBL2363286;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308744;Target assigned is non-molecular;1;SANGER: Inhibition of human HPAF-II cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;249;5;CHEMBL1075467;;
CLD0;;HSC-2;CHEMBL2363287;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308482;Target assigned is non-molecular;1;SANGER: Inhibition of human HSC-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;250;5;CHEMBL1075468;;
CLD0;;HSC-3;CHEMBL2363288;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307947;Target assigned is non-molecular;1;SANGER: Inhibition of human HSC-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;251;5;CHEMBL612279;;
CLD0;;HSC-4;CHEMBL2363289;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308109;Target assigned is non-molecular;1;SANGER: Inhibition of human HSC-4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;252;5;CHEMBL1075469;;
CLD0;;HT;CHEMBL2363290;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308143;Target assigned is non-molecular;1;SANGER: Inhibition of human HT cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;253;5;CHEMBL2366130;;
CLD0;;HT-1080;CHEMBL2363291;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308396;Target assigned is non-molecular;1;SANGER: Inhibition of human HT-1080 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;254;5;CHEMBL614580;;
CLD0;;HT-1197;CHEMBL2363292;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human HT-1197 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;255;5;CHEMBL614836;;
CLD0;;HT-1376;CHEMBL2363293;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308398;Target assigned is non-molecular;1;SANGER: Inhibition of human HT-1376 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;256;5;CHEMBL612258;;
CLD0;;HT-144;CHEMBL2363294;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308870;Target assigned is non-molecular;1;SANGER: Inhibition of human HT-144 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;257;5;CHEMBL2366291;;
CLD0;;HT-29;CHEMBL2363295;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;SANGER: Inhibition of human HT-29 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;258;5;CHEMBL384;;
CLD0;;HT-3;CHEMBL2363296;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308745;Target assigned is non-molecular;1;SANGER: Inhibition of human HT-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;259;5;CHEMBL1075470;;
CLD0;;HT55;CHEMBL2363297;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308746;Target assigned is non-molecular;1;SANGER: Inhibition of human HT55 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;260;5;CHEMBL1075471;;
CLD0;;HTC-C3;CHEMBL2363298;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308747;Target assigned is non-molecular;1;SANGER: Inhibition of human HTC-C3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;261;5;CHEMBL1075472;;
CLD0;;HUTU-80;CHEMBL2363299;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human HUTU-80 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;262;5;CHEMBL614582;;
CLD0;;Hs-578-T;CHEMBL2363300;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human Hs-578-T cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;263;5;CHEMBL614645;;
CLD0;;HuCCT1;CHEMBL2363301;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human HuCCT1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;264;5;CHEMBL614581;;
CLD0;;Huh-7 ;CHEMBL2363302;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307515;Target assigned is non-molecular;1;SANGER: Inhibition of human HuH-7 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;265;5;CHEMBL614039;;
CLD0;;HuO-3N1;CHEMBL2363303;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308818;Target assigned is non-molecular;1;SANGER: Inhibition of human HuO-3N1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;266;5;CHEMBL1075475;;
CLD0;;HuO9;CHEMBL2363304;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308748;Target assigned is non-molecular;1;SANGER: Inhibition of human HuO9 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;267;5;CHEMBL1075476;;
CLD0;;HuP-T3;CHEMBL2363305;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308399;Target assigned is non-molecular;1;SANGER: Inhibition of human HuP-T3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;268;5;CHEMBL1075477;;
CLD0;;HuP-T4;CHEMBL2363306;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308815;Target assigned is non-molecular;1;SANGER: Inhibition of human HuP-T4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;269;5;CHEMBL1075478;;
CLD0;;IA-LM;CHEMBL2363307;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308833;Target assigned is non-molecular;1;SANGER: Inhibition of human IA-LM cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;270;5;CHEMBL2366366;;
CLD0;;IGR-1;CHEMBL2363308;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308749;Target assigned is non-molecular;1;SANGER: Inhibition of human IGR-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;271;5;CHEMBL1075479;;
CLD0;;IGROV-1;CHEMBL2363309;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;SANGER: Inhibition of human IGROV-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;272;5;CHEMBL613984;;
CLD0;;IST-MEL1;CHEMBL2363313;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308290;Target assigned is non-molecular;1;SANGER: Inhibition of human IST-MEL1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;276;5;CHEMBL2366094;;
CLD0;;IST-MES1;CHEMBL2363314;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308291;Target assigned is non-molecular;1;SANGER: Inhibition of human IST-MES1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;277;5;CHEMBL2366194;;
CLD0;;IST-SL1;CHEMBL2363315;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308263;Target assigned is non-molecular;1;SANGER: Inhibition of human IST-SL1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;278;5;CHEMBL2366104;;
CLD0;;J-RT3-T3-5;CHEMBL2363317;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308326;Target assigned is non-molecular;1;SANGER: Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;280;5;CHEMBL2366219;;
CLD0;;J82;CHEMBL2363318;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308508;Target assigned is non-molecular;1;SANGER: Inhibition of human J82 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;281;5;CHEMBL614586;;
CLD0;;JAR;CHEMBL2363319;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307657;Target assigned is non-molecular;1;SANGER: Inhibition of human JAR cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;282;5;CHEMBL614587;;
CLD0;;JEG-3;CHEMBL2363320;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308202;Target assigned is non-molecular;1;SANGER: Inhibition of human JEG-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;283;5;CHEMBL2366348;;
CLD0;;JVM-2;CHEMBL2363321;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308530;Target assigned is non-molecular;1;SANGER: Inhibition of human JVM-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;284;5;CHEMBL2366359;;
CLD0;;JVM-3;CHEMBL2363322;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308203;Target assigned is non-molecular;1;SANGER: Inhibition of human JVM-3 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;285;5;CHEMBL2366372;;
CLD0;;K562;CHEMBL2363324;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;SANGER: Inhibition of human K-562 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;287;5;CHEMBL385;;
CLD0;;K5;CHEMBL2363326;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308144;Target assigned is non-molecular;1;SANGER: Inhibition of human K5 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;289;5;CHEMBL2366152;;
CLD0;;KALS-1;CHEMBL2363327;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308235;Target assigned is non-molecular;1;SANGER: Inhibition of human KALS-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;290;5;CHEMBL2366155;;
CLD0;;KARPAS-299;CHEMBL2363328;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308327;Target assigned is non-molecular;1;SANGER: Inhibition of human KARPAS-299 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;291;5;CHEMBL2366156;;
CLD0;;KARPAS-45;CHEMBL2363330;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308305;Target assigned is non-molecular;1;SANGER: Inhibition of human KARPAS-45 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;293;5;CHEMBL2366305;;
CLD0;;Kasumi 1;CHEMBL2363331;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307835;Target assigned is non-molecular;1;SANGER: Inhibition of human KASUMI-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;294;5;CHEMBL613988;;
CLD0;;KE-37;CHEMBL2363332;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308872;Target assigned is non-molecular;1;SANGER: Inhibition of human KE-37 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;295;5;CHEMBL2366287;;
CLD0;;KG-1;CHEMBL2363333;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307794;Target assigned is non-molecular;1;SANGER: Inhibition of human KG-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;296;5;CHEMBL612264;;
CLD0;;KGN;CHEMBL2363334;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308155;Target assigned is non-molecular;1;SANGER: Inhibition of human KGN cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;297;5;CHEMBL2366154;;
CLD0;;KINGS-1;CHEMBL2363335;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308264;Target assigned is non-molecular;1;SANGER: Inhibition of human KINGS-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;298;5;CHEMBL2366229;;
CLD0;;KLE;CHEMBL2363336;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308518;Target assigned is non-molecular;1;SANGER: Inhibition of human KLE cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;299;5;CHEMBL2366239;;
CLD0;;KM-H2;CHEMBL2363337;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308204;Target assigned is non-molecular;1;SANGER: Inhibition of human KM-H2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;300;5;CHEMBL2366250;;
CLD0;;KM12;CHEMBL2363338;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307689;Target assigned is non-molecular;1;SANGER: Inhibition of human KM12 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;301;5;CHEMBL614709;;
CLD0;;KMOE-2;CHEMBL2363339;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308236;Target assigned is non-molecular;1;SANGER: Inhibition of human KMOE-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;302;5;CHEMBL2366347;;
CLD0;;KNS-42;CHEMBL2363341;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308538;Target assigned is non-molecular;1;SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;304;5;CHEMBL2366261;;
CLD0;;KNS-62;CHEMBL2363342;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308237;Target assigned is non-molecular;1;SANGER: Inhibition of human KNS-62 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;305;5;CHEMBL2366244;;
CLD0;;KNS-81-FD;CHEMBL2363343;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308306;Target assigned is non-molecular;1;SANGER: Inhibition of human KNS-81-FD cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;306;5;CHEMBL2366203;;
CLD0;;KOSC-2;CHEMBL2363344;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308750;Target assigned is non-molecular;1;SANGER: Inhibition of human KOSC-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;307;5;CHEMBL1075481;;
CLD0;;KP-4;CHEMBL2363345;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308751;Target assigned is non-molecular;1;SANGER: Inhibition of human KP-4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;308;5;CHEMBL1075482;;
CLD0;;KP-N-YN;CHEMBL2363347;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308265;Target assigned is non-molecular;1;SANGER: Inhibition of human KP-N-YN cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;310;5;CHEMBL2366280;;
CLD0;;KP-N-YS;CHEMBL2363348;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308266;Target assigned is non-molecular;1;SANGER: Inhibition of human KP-N-YS cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;311;5;CHEMBL2366065;;
CLD0;;KS-1;CHEMBL2363349;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308170;Target assigned is non-molecular;1;SANGER: Inhibition of human KS-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;312;5;CHEMBL2366228;;
CLD0;;KU-19-19;CHEMBL2363350;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308111;Target assigned is non-molecular;1;SANGER: Inhibition of human KU-19-19 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;313;5;CHEMBL1075483;;
CLD0;;KU812 cell line;CHEMBL2363351;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308504;Target assigned is non-molecular;1;SANGER: Inhibition of human KU812 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;314;5;CHEMBL613997;;
CLD0;;KURAMOCHI;CHEMBL2363352;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308307;Target assigned is non-molecular;1;SANGER: Inhibition of human KURAMOCHI cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;315;5;CHEMBL2366119;;
CLD0;;KY821;CHEMBL2363353;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308834;Target assigned is non-molecular;1;SANGER: Inhibition of human KY821 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;316;5;CHEMBL2366190;;
CLD0;;KYSE-140;CHEMBL2363354;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308752;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-140 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;317;5;CHEMBL1075484;;
CLD0;;KYSE-150 cell line;CHEMBL2363355;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307840;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-150 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;318;5;CHEMBL613998;;
CLD0;;KYSE-180;CHEMBL2363356;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308389;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-180 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;319;5;CHEMBL1075485;;
CLD0;;KYSE-270;CHEMBL2363357;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308753;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-270 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;320;5;CHEMBL1075486;;
CLD0;;KYSE-410;CHEMBL2363358;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308754;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-410 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;321;5;CHEMBL1075487;;
CLD0;;KYSE-450;CHEMBL2363359;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308755;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-450 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;322;5;CHEMBL1075488;;
CLD0;;KYSE-510;CHEMBL2363360;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308081;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-510 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;323;5;CHEMBL613868;;
CLD0;;KYSE-520 cell line;CHEMBL2363361;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307804;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-520 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;324;5;CHEMBL612701;;
CLD0;;KYSE-70 cell line;CHEMBL2363362;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308390;Target assigned is non-molecular;1;SANGER: Inhibition of human KYSE-70 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;325;5;CHEMBL614012;;
CLD0;;L-363;CHEMBL2363363;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308205;Target assigned is non-molecular;1;SANGER: Inhibition of human L-363 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;326;5;CHEMBL2366267;;
CLD0;;L-428;CHEMBL2363364;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308873;Target assigned is non-molecular;1;SANGER: Inhibition of human L-428 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;327;5;CHEMBL2366233;;
CLD0;;LAMA-84;CHEMBL2363366;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308267;Target assigned is non-molecular;1;SANGER: Inhibition of human LAMA-84 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;329;5;CHEMBL2366090;;
CLD0;;LAN-6;CHEMBL2363367;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308206;Target assigned is non-molecular;1;SANGER: Inhibition of human LAN-6 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;330;5;CHEMBL2366123;;
CLD0;;LB1047-RCC;CHEMBL2363368;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308329;Target assigned is non-molecular;1;SANGER: Inhibition of human LB1047-RCC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;331;5;CHEMBL2366136;;
CLD0;;LB2241-RCC;CHEMBL2363369;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308330;Target assigned is non-molecular;1;SANGER: Inhibition of human LB2241-RCC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;332;5;CHEMBL2366330;;
CLD0;;LB2518-MEL;CHEMBL2363370;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308331;Target assigned is non-molecular;1;SANGER: Inhibition of human LB2518-MEL cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;333;5;CHEMBL2366335;;
CLD0;;LB373-MEL-D;CHEMBL2363371;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308336;Target assigned is non-molecular;1;SANGER: Inhibition of human LB373-MEL-D cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;334;5;CHEMBL2366296;;
CLD0;;LB771-HNC;CHEMBL2363373;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308308;Target assigned is non-molecular;1;SANGER: Inhibition of human LB771-HNC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;336;5;CHEMBL2366099;;
CLD0;;LB831-BLC;CHEMBL2363374;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308853;Target assigned is non-molecular;1;SANGER: Inhibition of human LB831-BLC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;337;5;CHEMBL2366222;;
CLD0;;LC-2-ad;CHEMBL2363377;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308545;Target assigned is non-molecular;1;SANGER: Inhibition of human LC-2-ad cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;340;5;CHEMBL2366260;;
CLD0;;LCLC-103H cell line;CHEMBL2363379;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307853;Target assigned is non-molecular;1;SANGER: Inhibition of human LCLC-103H cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;342;5;CHEMBL614066;;
CLD0;;LCLC-97TM1;CHEMBL2363380;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308112;Target assigned is non-molecular;1;SANGER: Inhibition of human LCLC-97TM1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;343;5;CHEMBL1075489;;
CLD0;;LK-2;CHEMBL2363381;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308472;Target assigned is non-molecular;1;SANGER: Inhibition of human LK-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;344;5;CHEMBL1075490;;
CLD0;;LN-405;CHEMBL2363382;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308756;Target assigned is non-molecular;1;SANGER: Inhibition of human LN-405 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;345;5;CHEMBL1075491;;
CLD0;;LNCaP-Clone-FGC;CHEMBL2363383;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308342;Target assigned is non-molecular;1;SANGER: Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;346;5;CHEMBL2366172;;
CLD0;;LOX IMVI ;CHEMBL2363385;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307535;Target assigned is non-molecular;1;SANGER: Inhibition of human LOXIMVI cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;348;5;CHEMBL614096;;
CLD0;;LS-1034;CHEMBL2363387;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308846;Target assigned is non-molecular;1;SANGER: Inhibition of human LS-1034 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;350;5;CHEMBL2366072;;
CLD0;;LS-123;CHEMBL2363388;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308874;Target assigned is non-molecular;1;SANGER: Inhibition of human LS-123 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;351;5;CHEMBL2366334;;
CLD0;;LS-411N;CHEMBL2363389;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308268;Target assigned is non-molecular;1;SANGER: Inhibition of human LS-411N cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;352;5;CHEMBL2366189;;
CLD0;;LS-513;CHEMBL2363390;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308841;Target assigned is non-molecular;1;SANGER: Inhibition of human LS-513 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;353;5;CHEMBL2366311;;
CLD0;;LU-134-A;CHEMBL2363391;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308292;Target assigned is non-molecular;1;SANGER: Inhibition of human LU-134-A cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;354;5;CHEMBL2366236;;
CLD0;;LU-135;CHEMBL2363392;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308136;Target assigned is non-molecular;1;SANGER: Inhibition of human LU-135 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;355;5;CHEMBL1075492;;
CLD0;;LU-139;CHEMBL2363393;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308238;Target assigned is non-molecular;1;SANGER: Inhibition of human LU-139 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;356;5;CHEMBL2366248;;
CLD0;;Lu-65;CHEMBL2363395;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308623;Target assigned is non-molecular;1;SANGER: Inhibition of human LU-65 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;358;5;CHEMBL614694;;
CLD0;;LU-99A;CHEMBL2363396;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308757;Target assigned is non-molecular;1;SANGER: Inhibition of human LU-99A cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;359;5;CHEMBL1075493;;
CLD0;;LXF-289 cell line;CHEMBL2363397;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307871;Target assigned is non-molecular;1;SANGER: Inhibition of human LXF-289 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;360;5;CHEMBL614107;;
CLD0;;LoVo;CHEMBL2363398;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;SANGER: Inhibition of human LoVo cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;361;5;CHEMBL614721;;
CLD0;;M059J;CHEMBL2363399;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308113;Target assigned is non-molecular;1;SANGER: Inhibition of human M059J cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;362;5;CHEMBL1075494;;
CLD0;;M14;CHEMBL2363400;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307591;Target assigned is non-molecular;1;SANGER: Inhibition of human M14 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;363;5;CHEMBL614317;;
CLD0;;MC-IXC;CHEMBL2363402;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308758;Target assigned is non-molecular;1;SANGER: Inhibition of human MC-IXC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;365;5;CHEMBL1075495;;
CLD0;;MC116;CHEMBL2363403;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308210;Target assigned is non-molecular;1;SANGER: Inhibition of human MC116 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;366;5;CHEMBL2366256;;
CLD0;;MCF7;CHEMBL2363404;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;SANGER: Inhibition of human MCF7 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;367;5;CHEMBL387;;
CLD0;;MDA-MB-157;CHEMBL2363406;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308759;Target assigned is non-molecular;1;SANGER: Inhibition of human MDA-MB-157 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;369;5;CHEMBL1075496;;
CLD0;;MDA-MB-175-VII;CHEMBL2363407;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308404;Target assigned is non-molecular;1;SANGER: Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;370;5;CHEMBL1075497;;
CLD0;;MDA-MB-231;CHEMBL2363408;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;SANGER: Inhibition of human MDA-MB-231 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;371;5;CHEMBL400;;
CLD0;;MDA-MB-361;CHEMBL2363409;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308405;Target assigned is non-molecular;1;SANGER: Inhibition of human MDA-MB-361 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;372;5;CHEMBL614129;;
CLD0;;MDA-MB-415;CHEMBL2363410;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308760;Target assigned is non-molecular;1;SANGER: Inhibition of human MDA-MB-415 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;373;5;CHEMBL1075498;;
CLD0;;MDA-MB-453;CHEMBL2363411;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307596;Target assigned is non-molecular;1;SANGER: Inhibition of human MDA-MB-453 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;374;5;CHEMBL614334;;
CLD0;;ME-180;CHEMBL2363413;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308114;Target assigned is non-molecular;1;SANGER: Inhibition of human ME-180 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;376;5;CHEMBL1075499;;
CLD0;;MEG-01;CHEMBL2363414;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308539;Target assigned is non-molecular;1;SANGER: Inhibition of human MEG-01 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;377;5;CHEMBL2366084;;
CLD0;;MEL-HO;CHEMBL2363415;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308798;Target assigned is non-molecular;1;SANGER: Inhibition of human MEL-HO cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;378;5;CHEMBL1075500;;
CLD0;;MEL-JUSO;CHEMBL2363416;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308761;Target assigned is non-molecular;1;SANGER: Inhibition of human MEL-JUSO cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;379;5;CHEMBL1075501;;
CLD0;;MFE-280;CHEMBL2363418;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308455;Target assigned is non-molecular;1;SANGER: Inhibition of human MFE-280 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;381;5;CHEMBL1075502;;
CLD0;;MFH-ino;CHEMBL2363420;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308269;Target assigned is non-molecular;1;SANGER: Inhibition of human MFH-ino cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;383;5;CHEMBL2366262;;
CLD0;;MFM-223;CHEMBL2363421;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308115;Target assigned is non-molecular;1;SANGER: Inhibition of human MFM-223 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;384;5;CHEMBL1075504;;
CLD0;;MG-63;CHEMBL2363422;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308498;Target assigned is non-molecular;1;SANGER: Inhibition of human MG-63 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;385;5;CHEMBL614347;;
CLD0;;MHH-ES-1;CHEMBL2363424;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308762;Target assigned is non-molecular;1;SANGER: Inhibition of human MHH-ES-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;387;5;CHEMBL1075505;;
CLD0;;MHH-NB-11;CHEMBL2363425;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308310;Target assigned is non-molecular;1;SANGER: Inhibition of human MHH-NB-11 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;388;5;CHEMBL2366185;;
CLD0;;MHH-PREB-1;CHEMBL2363426;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308334;Target assigned is non-molecular;1;SANGER: Inhibition of human MHH-PREB-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;389;5;CHEMBL2366127;;
CLD0;;MIA PaCa-2 ;CHEMBL2363427;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308500;Target assigned is non-molecular;1;SANGER: Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;390;5;CHEMBL614725;;
CLD0;;MKN-1 ;CHEMBL2363428;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307492;Target assigned is non-molecular;1;SANGER: Inhibition of human MKN1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;391;5;CHEMBL614352;;
CLD0;;MKN-28;CHEMBL2363429;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307602;Target assigned is non-molecular;1;SANGER: Inhibition of human MKN28 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;392;5;CHEMBL614353;;
CLD0;;MKN-45;CHEMBL2363430;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307603;Target assigned is non-molecular;1;SANGER: Inhibition of human MKN45 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;393;5;CHEMBL614354;;
CLD0;;MKN-7;CHEMBL2363431;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307377;Target assigned is non-molecular;1;SANGER: Inhibition of human MKN7 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;394;5;CHEMBL614355;;
CLD0;;ML-2;CHEMBL2363432;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human ML-2 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;395;5;CHEMBL614356;;
CLD0;;MLMA;CHEMBL2363433;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308826;Target assigned is non-molecular;1;SANGER: Inhibition of human MLMA cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;396;5;CHEMBL2366211;;
CLD0;;MMAC-SF;CHEMBL2363434;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308270;Target assigned is non-molecular;1;SANGER: Inhibition of human MMAC-SF cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;397;5;CHEMBL2366196;;
CLD0;;MN-60;CHEMBL2363435;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308532;Target assigned is non-molecular;1;SANGER: Inhibition of human MN-60 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;398;5;CHEMBL2366070;;
CLD0;;MOLT-13;CHEMBL2363436;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308875;Target assigned is non-molecular;1;SANGER: Inhibition of human MOLT-13 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;399;5;CHEMBL2366103;;
CLD0;;MOLT-16;CHEMBL2363437;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308271;Target assigned is non-molecular;1;SANGER: Inhibition of human MOLT-16 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;400;5;CHEMBL2366362;;
CLD0;;MOLT-4;CHEMBL2363438;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;SANGER: Inhibition of human MOLT-4 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;401;5;CHEMBL614177;;
CLD0;;MPP-89;CHEMBL2363440;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308241;Target assigned is non-molecular;1;SANGER: Inhibition of human MPP-89 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;403;5;CHEMBL2366357;;
CLD0;;MS-1;CHEMBL2363442;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308892;Target assigned is non-molecular;1;SANGER: Inhibition of human MS-1 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;405;5;CHEMBL2366125;;
CLD0;;MSTO-211H;CHEMBL2363443;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308116;Target assigned is non-molecular;1;SANGER: Inhibition of human MSTO-211H cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;406;5;CHEMBL1075509;;
CLD0;;MV-4-11;CHEMBL2363444;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;SANGER: Inhibition of human MV-4-11 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;407;5;CHEMBL613835;;
CLD0;;MZ1-PC;CHEMBL2363445;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308242;Target assigned is non-molecular;1;SANGER: Inhibition of human MZ1-PC cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;408;5;CHEMBL2366204;;
CLD0;;MZ2-MEL;CHEMBL2363446;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308272;Target assigned is non-molecular;1;SANGER: Inhibition of human MZ2-MEL cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;409;5;CHEMBL2366226;;
CLD0;;MZ7-mel;CHEMBL2363447;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308546;Target assigned is non-molecular;1;SANGER: Inhibition of human MZ7-mel cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;410;5;CHEMBL2366138;;
CLD0;;MeWo;CHEMBL2363448;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308024;Target assigned is non-molecular;1;SANGER: Inhibition of human Mewo cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;411;5;CHEMBL613300;;
CLD0;;NB10;CHEMBL2363452;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308172;Target assigned is non-molecular;1;SANGER: Inhibition of human NB10 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;415;5;CHEMBL2366243;;
CLD0;;NB12;CHEMBL2363453;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308173;Target assigned is non-molecular;1;SANGER: Inhibition of human NB12 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;416;5;CHEMBL2366285;;
CLD0;;NB13;CHEMBL2363454;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308174;Target assigned is non-molecular;1;SANGER: Inhibition of human NB13 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;417;5;CHEMBL2366225;;
CLD0;;NB14;CHEMBL2363455;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308827;Target assigned is non-molecular;1;SANGER: Inhibition of human NB14 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;418;5;CHEMBL2366212;;
CLD0;;NB17;CHEMBL2363456;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308175;Target assigned is non-molecular;1;SANGER: Inhibition of human NB17 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;419;5;CHEMBL2366064;;
CLD0;;NB5;CHEMBL2363457;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308156;Target assigned is non-molecular;1;SANGER: Inhibition of human NB5 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;420;5;CHEMBL2366328;;
CLD0;;NB6;CHEMBL2363458;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308157;Target assigned is non-molecular;1;SANGER: Inhibition of human NB6 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;421;5;CHEMBL2366318;;
CLD0;;NB69;CHEMBL2363459;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308799;Target assigned is non-molecular;1;SANGER: Inhibition of human NB69 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;422;5;CHEMBL1075510;;
CLD0;;NB7;CHEMBL2363460;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308158;Target assigned is non-molecular;1;SANGER: Inhibition of human NB7 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;423;5;CHEMBL2366345;;
CLD0;;NBsusSR;CHEMBL2363461;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308847;Target assigned is non-molecular;1;SANGER: Inhibition of human NBsusSR cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;424;5;CHEMBL2366150;;
CLD0;;NCI-H1048;CHEMBL2363463;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308763;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1048 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;426;5;CHEMBL1075512;;
CLD0;;NCI-H1092;CHEMBL2363464;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308311;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1092 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;427;5;CHEMBL2366351;;
CLD0;;NCI-H1155;CHEMBL2363465;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308312;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1155 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;428;5;CHEMBL2366073;;
CLD0;;NCI-H1299;CHEMBL2363467;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1299 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;430;5;CHEMBL612255;;
CLD0;;NCI-H1304;CHEMBL2363468;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308554;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1304 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;431;5;CHEMBL2366266;;
CLD0;;NCI-H1355;CHEMBL2363469;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308876;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1355 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;432;5;CHEMBL2366227;;
CLD0;;NCI-H1395;CHEMBL2363470;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308313;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1395 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;433;5;CHEMBL2366201;;
CLD0;;NCI-H1437;CHEMBL2363473;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308764;Target assigned is non-molecular;1;SANGER: Inhibition of human NCI-H1437 cell growth in a cell viability assay.;CHEMBL1201861;Non-molecular target assigned;N;436;5;CHEMBL1075513;;
CLD0;;;CHEMBL2382974;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Therapeutic index, ratio of IC50 for human CD34-positive blood stem/progenitor cells to IC50 for human MA9.3 cells;CHEMBL2380239;Default value - Target has yet to be curated;U;569358;1;CHEMBL612558;;
CLD0;;;CHEMBL2382975;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human MA9.3 cells after 48 hrs by MTT assay;CHEMBL2380239;Non-molecular target assigned;N;569357;1;CHEMBL3879801;;
CLD0;;;CHEMBL2382976;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human CD34-positive blood stem/progenitor cells after 48 hrs by MTT assay;CHEMBL2380239;Default value - Target has yet to be curated;U;569356;1;CHEMBL612558;;
CLD0;;;CHEMBL2401006;[];Francisella tularensis subsp. tularensis SCHU S4;[];;;177416.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of C-terminal His6-tagged Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate assessed as oxidation of NADH to NAD+ by fluorescence assay;CHEMBL2396561;Direct protein target assigned;D;578094;1;CHEMBL2150835;;
CLD0;;MCF7;CHEMBL2428705;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay;CHEMBL2424525;Non-molecular target assigned;N;593085;1;CHEMBL387;;
CLD0;;KB ;CHEMBL2428706;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 72 hrs by SRB assay;CHEMBL2424525;Non-molecular target assigned;N;593084;1;CHEMBL398;;
CLD0;;HeLa;CHEMBL2428707;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 72 hrs by SRB assay;CHEMBL2424525;Non-molecular target assigned;N;593083;1;CHEMBL399;;
CLD0;;CHO;CHEMBL3039488;[];Cricetulus griseus;[];;;10029.0;In vitro;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Homologous single protein target assigned;8;Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM;CHEMBL3039007;Homologous protein target assigned;H;1;1;CHEMBL1697668;;
CLD0;;CHO;CHEMBL3039491;[];Cricetulus griseus;[];;;10029.0;In vitro;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Homologous single protein target assigned;8;Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM;CHEMBL3039007;Homologous protein target assigned;H;4;1;CHEMBL1743121;;
CLD0;;;CHEMBL3137722;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;1;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137723;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;2;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137724;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;3;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137725;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source];CHEMBL3137667;Non-molecular target assigned;N;4;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137726;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;5;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137727;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;6;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137728;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;7;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137729;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;8;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137730;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;9;1;CHEMBL612545;;
CLD0;;;CHEMBL3137731;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source];CHEMBL3137667;Non-molecular target assigned;N;10;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137732;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;11;1;CHEMBL612545;;
CLD0;;;CHEMBL3137733;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;12;1;CHEMBL612545;;
CLD0;;;CHEMBL3137734;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;13;1;CHEMBL612545;;
CLD0;;;CHEMBL3137735;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source];CHEMBL3137667;Non-molecular target assigned;N;14;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137736;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Animal toxicity known. [column 'TOXIC' in source];CHEMBL3137667;Non-molecular target assigned;N;15;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137737;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Presence of at least one case with successful reintroduction. [column 'REINT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;16;1;CHEMBL612545;;
CLD0;;;CHEMBL3137738;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Comments (NB not yet translated). [column 'COMMENTAIRES' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;17;1;CHEMBL612545;;
CLD0;;;CHEMBL3137739;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source];CHEMBL3137667;Non-molecular target assigned;N;18;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137740;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Proposed mechanism(s) of liver damage. [column 'MEC' in source];CHEMBL3137667;Non-molecular target assigned;N;19;1;CHEMBL3879801;CHEMBL3559723;
CLD0;confirmatory;;CHEMBL3214929;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Luminescence cell-based Retest at Dose assay to determine EWS/Fli1 dependent TC71 mammalian cell cytotoxity  Measured in Cell-Based System Using Plate Reader - 7014-04_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720570;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214953;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;743255;7;CHEMBL1795087;;
CLD0;confirmatory;;CHEMBL3215017;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720579;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215038;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743267;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215040;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Luminescence cell-based Retest at Dose assay to determine EWS/Fli1 dependent A673 mammalian cell cytotoxity  Measured in Cell-Based System Using Plate Reader - 7014-03_Inhibitor_Dose_CherryPick_Activity. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720587;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215169;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720533;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215236;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;PubChem BioAssay. HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Other_Dose_CherryPick_Activity_Set2. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;743395;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL3215270;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720580;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214913;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720532;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214923;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;PubChem BioAssay. HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_CherryPick_Activity_Set3. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;720589;7;CHEMBL3879801;;
CLD0;;CCRF S-180;CHEMBL3223292;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antiproliferative activity against mouse S180 cells after 48 hrs by MTT assay;CHEMBL3217570;Non-molecular target assigned;N;637470;1;CHEMBL612567;;
CLD0;;K562;CHEMBL3223293;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 48 hrs by MTT assay;CHEMBL3217570;Non-molecular target assigned;N;637471;1;CHEMBL385;;
CLD0;;B16;CHEMBL3223294;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antiproliferative activity against mouse B16 cells after 48 hrs by MTT assay;CHEMBL3217570;Non-molecular target assigned;N;637472;1;CHEMBL381;;
CLD0;;H22;CHEMBL3223295;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antiproliferative activity against mouse H22 cells after 48 hrs by MTT assay;CHEMBL3217570;Non-molecular target assigned;N;637473;1;CHEMBL614998;;
CLD0;;HepG2;CHEMBL3223296;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay;CHEMBL3217570;Non-molecular target assigned;N;637474;1;CHEMBL395;;
CLD0;;CCRF S-180;CHEMBL3223297;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '8.9', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.9'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells allografted in ICR mouse assessed as tumor growth inhibition at 8.9 mg/kg, ip qd for 7 days relative to control;CHEMBL3217570;Non-molecular target assigned;N;637483;1;CHEMBL612567;;
CLD0;;CCRF S-180;CHEMBL3223548;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.89', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.89'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells allografted in ICR mouse assessed as tumor growth inhibition at 0.89 mg/kg, ip qd for 7 days relative to control;CHEMBL3217570;Non-molecular target assigned;N;637513;1;CHEMBL612567;;
CLD0;;CCRF S-180;CHEMBL3223549;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.089', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.089'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Antitumor activity against mouse S180 cells allografted in ICR mouse assessed as tumor growth inhibition at 0.089 mg/kg, ip qd for 7 days relative to control;CHEMBL3217570;Non-molecular target assigned;N;637514;1;CHEMBL612567;;
CLD0;;P815;CHEMBL3232063;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307568;Target assigned is non-molecular;1;Cytotoxicity against mouse P815 cells assessed as growth inhibition after 96 hrs;CHEMBL3227997;Non-molecular target assigned;N;651878;1;CHEMBL614226;;
CLD0;;Vero;CHEMBL3232065;[];Human herpesvirus 1;[];2931;;10298.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 1 ug/ml after 24 hrs relative to control;CHEMBL3227997;Non-molecular target assigned;N;651874;1;CHEMBL377;;
CLD0;;Vero;CHEMBL3232066;[];Human herpesvirus 1;[];2931;;10298.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 10 ug/ml after 24 hrs relative to control;CHEMBL3227997;Non-molecular target assigned;N;651875;1;CHEMBL377;;
CLD0;;Vero;CHEMBL3232067;[];Human herpesvirus 1;[];2931;;10298.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 100 ug/ml after 24 hrs relative to control;CHEMBL3227997;Non-molecular target assigned;N;651876;1;CHEMBL377;;
CLD0;;L5178Y;CHEMBL3232068;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307690;Target assigned is non-molecular;1;Cytotoxicity against mouse L5178Y cells assessed as growth inhibition after 96 hrs;CHEMBL3227997;Non-molecular target assigned;N;651877;1;CHEMBL614720;;
CLD0;;Vero;CHEMBL3232069;[];Human herpesvirus 1;[];2931;;10298.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 0.01 ug/ml after 24 hrs relative to control;CHEMBL3227997;Non-molecular target assigned;N;651872;1;CHEMBL377;;
CLD0;;Vero;CHEMBL3232070;[];Human herpesvirus 1;[];2931;;10298.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 0.1 ug/ml after 24 hrs relative to control;CHEMBL3227997;Non-molecular target assigned;N;651873;1;CHEMBL377;;
CLD0;;KB ;CHEMBL3232581;[];Human herpesvirus 1;[];;;10298.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus type 1 infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically;CHEMBL3227966;Non-molecular target assigned;N;656760;1;CHEMBL377;;
CLD0;;KB ;CHEMBL3232582;[];Vaccinia virus;[];;;10245.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiviral activity against Vaccinia virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically;CHEMBL3227966;Non-molecular target assigned;N;656761;1;CHEMBL613493;;
CLD0;;KB ;CHEMBL3232584;[];Myxoma virus;[];;;10273.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiviral activity against Myxoma virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically;CHEMBL3227966;Non-molecular target assigned;N;656763;1;CHEMBL398;;
CLD0;;KB ;CHEMBL3232585;[];Suid herpesvirus 1;[];;;10345.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiviral activity against Pseudorabies virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically;CHEMBL3227966;Non-molecular target assigned;N;656764;1;CHEMBL613133;;
CLD0;;;CHEMBL3232586;[];Human herpesvirus 1;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.14', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.14'}];;;10298.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus type 1 infected in Swiss albino mouse assessed as increase in mouse survival at 0.14 mg/kg, ic single dose after 6 hrs of infection relative to control;CHEMBL3227966;Non-molecular target assigned;N;656776;1;CHEMBL377;;
CLD0;;;CHEMBL3232587;[];Human herpesvirus 1;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.033', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.033'}];;;10298.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus type 1 infected in Swiss albino mouse assessed as increase in mouse survival at 0.033 mg/kg, ic single dose after 6 hrs of infection relative to control;CHEMBL3227966;Non-molecular target assigned;N;656777;1;CHEMBL377;;
CLD0;;kidney;CHEMBL3231972;[];Vesicular stomatitis virus;[];;;11276.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Vesicular stomatitis virus infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection;CHEMBL3227988;Non-molecular target assigned;N;656943;1;CHEMBL613739;;
CLD0;;kidney;CHEMBL3231973;[];Vaccinia virus;[];;;10245.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Vaccinia virus infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection;CHEMBL3227988;Non-molecular target assigned;N;656944;1;CHEMBL613493;;
CLD0;;Fibroblast;CHEMBL3231974;[];Vaccinia virus;[];;;10245.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308065;Target assigned is non-molecular;1;Antiviral activity against Vaccinia virus infected in human skin fibroblast cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection;CHEMBL3227988;Non-molecular target assigned;N;656946;1;CHEMBL613493;;
CLD0;;kidney;CHEMBL3231975;[];Human herpesvirus 1 strain KOS;[];;;10306.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus-1 KOS infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection;CHEMBL3227988;Non-molecular target assigned;N;656947;1;CHEMBL2367034;;
CLD0;;Fibroblast;CHEMBL3231976;[];Human herpesvirus 1 strain KOS;[];;;10306.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308065;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus-1 KOS infected in human skin fibroblast cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection;CHEMBL3227988;Non-molecular target assigned;N;656956;1;CHEMBL2367034;;
CLD0;;kidney;CHEMBL3231977;[];Human herpesvirus 2;[];LYONS;;10310.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus-2 LYONS infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection;CHEMBL3227988;Non-molecular target assigned;N;656958;1;CHEMBL370;;
CLD0;;kidney;CHEMBL3231978;[];Human herpesvirus 2;[];196;;10310.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus-2 196 infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection;CHEMBL3227988;Non-molecular target assigned;N;656959;1;CHEMBL370;;
CLD0;;kidney;CHEMBL3231979;[];Oryctolagus cuniculus;[];;;9986.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antimetabolic activity against primary rabbit kidney cells assessed as inhibition of [methyl-3H]dThd incorporation into DNA after 16 hrs;CHEMBL3227988;Default value - Target has yet to be curated;U;656960;1;CHEMBL612558;;
CLD0;;kidney;CHEMBL3231980;[];Oryctolagus cuniculus;[];;;9986.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antimetabolic activity against primary rabbit kidney cells assessed as inhibition of [2-14C]dUrd incorporation into DNA after 16 hrs;CHEMBL3227988;Default value - Target has yet to be curated;U;656961;1;CHEMBL612558;;
CLD0;;kidney;CHEMBL3257220;[];Vesicular stomatitis virus;[];;;11276.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Vesicular stomatitis virus infected in rabbit primary kidney cells assessed as inhibition of viral cytopathogenicity after 2 days;CHEMBL3244391;Non-molecular target assigned;N;657048;1;CHEMBL613739;;
CLD0;;kidney;CHEMBL3257221;[];Vaccinia virus;[];;;10245.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Vaccinia virus infected in rabbit primary kidney cells assessed as inhibition of viral cytopathogenicity after 3 days;CHEMBL3244391;Non-molecular target assigned;N;657049;1;CHEMBL613493;;
CLD0;;;CHEMBL3257230;[];Human herpesvirus 1;[];Sheely;;10298.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus 1 Sheely assessed as inhibition of virus-induced cytopathic effect at 37 degC after 72 hrs by two-fold dilution method;CHEMBL3244039;Non-molecular target assigned;N;673937;1;CHEMBL377;;
CLD0;;;CHEMBL3257231;[];Human herpesvirus 2;[];Curtis;;10310.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus 2 Curtis assessed as inhibition of virus-induced cytopathic effect at 37 degC after 72 hrs by two-fold dilution method;CHEMBL3244039;Non-molecular target assigned;N;673938;1;CHEMBL370;;
CLD0;;T-cell;CHEMBL3252706;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307588;Target assigned is non-molecular;1;Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 1 uM after 6 days by [3H]thymidine incorporation method relative to control;CHEMBL3244180;Non-molecular target assigned;N;666671;1;CHEMBL3879801;;
CLD0;;T-cell;CHEMBL3252707;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307588;Target assigned is non-molecular;1;Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 100 uM after 6 days by [3H]thymidine incorporation method relative to control;CHEMBL3244180;Non-molecular target assigned;N;666674;1;CHEMBL3879801;;
CLD0;;T-cell;CHEMBL3252708;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307588;Target assigned is non-molecular;1;Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 0.01 to 0.1 uM after 6 days by [3H]thymidine incorporation method relative to control;CHEMBL3244180;Non-molecular target assigned;N;666675;1;CHEMBL3879801;;
CLD0;;L1210;CHEMBL3254086;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against mouse L1210 cells assessed as growth inhibition measured at 72 hrs by trypan blue exclusion assay;CHEMBL3244344;Non-molecular target assigned;N;658467;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254088;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 50 mg/kg, ip qd administered for 5 days (Rvb = 9 days);CHEMBL3244344;Non-molecular target assigned;N;658497;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254093;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 25 mg/kg, ip qd administered for 5 days relative to control;CHEMBL3244344;Non-molecular target assigned;N;658506;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254094;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 50 mg/kg, ip qd administered for 5 days relative to control;CHEMBL3244344;Non-molecular target assigned;N;658509;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254097;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 25 mg/kg, ip qd administered for 5 days (Rvb = 8 days);CHEMBL3244344;Non-molecular target assigned;N;658994;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254100;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '18.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '18.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 18.2 mg/kg, ip qd administered for 5 days relative to control;CHEMBL3244344;Non-molecular target assigned;N;658516;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254101;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];C3D2F1/J;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 25 mg/kg, ip qd administered for 5 days measured on day 8 (Rvb = 1.81 +/- 0.79 g);CHEMBL3244344;Non-molecular target assigned;N;658520;1;CHEMBL375;;
CLD0;;L1210;CHEMBL3254102;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];C3D2F1/J;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 50 mg/kg, ip qd administered for 5 days measured on day 8 (Rvb = 1.81 +/- 0.79 g);CHEMBL3244344;Non-molecular target assigned;N;658522;1;CHEMBL375;;
CLD0;;L1210;CHEMBL3254573;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '18.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '18.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];C3D2F1/J;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 18.2 mg/kg, ip qd administered for 5 days measured on day 8 (Rvb = 1.81 +/- 0.79 g);CHEMBL3244344;Non-molecular target assigned;N;658533;1;CHEMBL375;;
CLD0;;L1210;CHEMBL3254576;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '18.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '18.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 18.2 mg/kg, ip qd administered for 5 days (Rvb = 10 days);CHEMBL3244344;Non-molecular target assigned;N;658544;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256346;[];Mus musculus;[];C3D2F1/J;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 18.2 mg/kg, ip qd administered for 5 days measured on day 8 co-administered with 27 mg/kg prednisolone (Rvb = 1.81 +/- 0.79 g);CHEMBL3244344;Non-molecular target assigned;N;666719;1;CHEMBL375;;
CLD0;;L1210;CHEMBL3256347;[];Mus musculus;[];C3D2F1/J;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 18.3 mg/kg, ip qd administered for 5 days measured on day 8 co-administered with 27 mg/kg prednisone (Rvb = 1.81 +/- 0.79 g);CHEMBL3244344;Non-molecular target assigned;N;666720;1;CHEMBL375;;
CLD0;;L1210;CHEMBL3256348;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 18.2 mg/kg, ip qd administered for 5 days co-administered with 27 mg/kg prednisolone (Rvb = 9 days);CHEMBL3244344;Non-molecular target assigned;N;666721;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256349;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 18.3 mg/kg, ip qd administered for 5 days co-administered with 27 mg/kg prednisone (Rvb = 9 days);CHEMBL3244344;Non-molecular target assigned;N;666724;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256350;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 18.2 mg/kg, ip qd administered for 5 days co-administered with 27 mg/kg prednisolone relative to control;CHEMBL3244344;Non-molecular target assigned;N;666726;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256351;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 18.3 mg/kg, ip qd administered for 5 days co-administered with 27 mg/kg prednisone relative to control;CHEMBL3244344;Non-molecular target assigned;N;666727;1;CHEMBL386;;
CLD0;;Vero;CHEMBL3256808;[];Herpes simplex virus (type 1 / strain CL101);[];;;10302.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Antiviral activity against HSV1 CL101 infected in African green monkey Vero cells assessed as inhibition of plaque formation at 200 uM after 40 hrs relative to control;CHEMBL3244133;Non-molecular target assigned;N;668996;1;CHEMBL3879801;;
CLD0;;CCRF S-180;CHEMBL3256813;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307278;Target assigned is non-molecular;1;Cytotoxicity against mouse S180 cells at 5 uM after 18 to 42 hrs relative to control;CHEMBL3244133;Non-molecular target assigned;N;669013;1;CHEMBL612567;;
CLD0;;;CHEMBL3257286;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Retention time of the compound by liquid chromatography;CHEMBL3244133;Default value - Target has yet to be curated;U;668981;1;CHEMBL2362975;;
CLD0;;L1210;CHEMBL3256543;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '80.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '80.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 80 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658136;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256545;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 40 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658139;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256546;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 25 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658140;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256547;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 20 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658141;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256548;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '12.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 12.5 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658142;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256549;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 10 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658143;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256550;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '6.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.25'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 6.25 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658145;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256551;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 5 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658146;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256552;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.12'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 3.12 mg/kg, ip administered as qd for 9 days relative to control;CHEMBL3244095;Non-molecular target assigned;N;658147;1;CHEMBL386;;
CLD0;;;CHEMBL3256555;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 200 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658151;1;CHEMBL375;;
CLD0;;;CHEMBL3256556;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 100 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658154;1;CHEMBL375;;
CLD0;;;CHEMBL3256557;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '80.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '80.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 80 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658155;1;CHEMBL375;;
CLD0;;;CHEMBL3256558;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 50 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658156;1;CHEMBL375;;
CLD0;;;CHEMBL3256559;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 40 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658157;1;CHEMBL375;;
CLD0;;;CHEMBL3256560;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 25 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658158;1;CHEMBL375;;
CLD0;;;CHEMBL3256561;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 20 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658159;1;CHEMBL375;;
CLD0;;;CHEMBL3257008;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '12.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 12.5 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658160;1;CHEMBL375;;
CLD0;;;CHEMBL3257009;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 10 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658161;1;CHEMBL375;;
CLD0;;;CHEMBL3257010;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '6.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.25'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 6.25 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658163;1;CHEMBL375;;
CLD0;;;CHEMBL3257011;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 5 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658165;1;CHEMBL375;;
CLD0;;;CHEMBL3257012;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.12'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in CDF1 mouse assessed as change in body weight at 3.12 mg/kg, ip measured on day 5 relative to control;CHEMBL3244095;Non-molecular target assigned;N;658167;1;CHEMBL375;;
CLD0;;;CHEMBL3257017;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Half life of the compound;CHEMBL3244095;Default value - Target has yet to be curated;U;658197;1;CHEMBL2362975;;
CLD0;;;CHEMBL3285493;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Half life in human;CHEMBL3271997;Non-molecular target assigned;N;685181;1;CHEMBL372;;
CLD0;;L1210;CHEMBL3284431;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 100 mg/kg, ip administered as single dose relative to vehicle-treated control;CHEMBL3272036;Non-molecular target assigned;N;683659;1;CHEMBL386;;
CLD0;;HeLa;CHEMBL3284432;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 48 hrs by Coulter counter analysis;CHEMBL3272036;Non-molecular target assigned;N;683600;1;CHEMBL399;;
CLD0;;;CHEMBL3284433;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Half life in human;CHEMBL3272036;Non-molecular target assigned;N;683596;1;CHEMBL372;;
CLD0;;BGM;CHEMBL3284434;[];Vaccinia virus;[];IHD;;10245.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Vaccinia virus IHD infected in African green monkey BGM cells assessed as plaque reduction measured on day 5 by disk diffusion assay;CHEMBL3272036;Non-molecular target assigned;N;683607;1;CHEMBL613493;;
CLD0;;BGM;CHEMBL3284435;[];unidentified herpesvirus;[];HF;;39059.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes Simplex virus HF infected in African green monkey BGM cells assessed as plaque reduction measured on day 5 by disk diffusion assay;CHEMBL3272036;Non-molecular target assigned;N;683610;1;CHEMBL613165;;
CLD0;;L1210;CHEMBL3284685;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 200 mg/kg, ip administered as single dose relative to vehicle-treated control;CHEMBL3272036;Non-molecular target assigned;N;683661;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3284686;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 500 mg/kg, ip administered as single dose relative to vehicle-treated control;CHEMBL3272036;Non-molecular target assigned;N;683663;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3284687;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 1000 mg/kg, ip administered as single dose relative to vehicle-treated control;CHEMBL3272036;Non-molecular target assigned;N;683665;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3284689;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 100 mg/kg, ip administered as single dose measured on day 30 relative to vehicle-treated control;CHEMBL3272036;Non-molecular target assigned;N;683667;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282175;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 100 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation;CHEMBL3272176;Non-molecular target assigned;N;682906;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282179;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 200 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation;CHEMBL3272176;Non-molecular target assigned;N;682910;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282183;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 400 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation;CHEMBL3272176;Non-molecular target assigned;N;682914;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282412;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 100 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation in presence of THU 10 mg/kg/day on days 1 to 5;CHEMBL3272176;Non-molecular target assigned;N;682918;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282413;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 200 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation in presence of THU 10 mg/kg/day on days 1 to 5;CHEMBL3272176;Non-molecular target assigned;N;682919;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282414;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 300 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation in presence of THU 10 mg/kg/day on days 1 to 5;CHEMBL3272176;Non-molecular target assigned;N;682920;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282415;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 100 umol/kg/day, ip using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation;CHEMBL3272176;Non-molecular target assigned;N;682921;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282416;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 200 umol/kg/day, ip using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation;CHEMBL3272176;Non-molecular target assigned;N;682922;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3282417;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 400 umol/kg/day, ip using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation;CHEMBL3272176;Non-molecular target assigned;N;682923;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3283266;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 200 mg/kg, ip administered as single dose measured on day 30 relative to vehicle-treated control;CHEMBL3272036;Non-molecular target assigned;N;683668;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3283267;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '500.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 500 mg/kg, ip administered as single dose measured on day 30 relative to vehicle-treated control;CHEMBL3272036;Non-molecular target assigned;N;683670;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3283268;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1000.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 1000 mg/kg, ip administered as single dose measured on day 30 relative to vehicle-treated control;CHEMBL3272036;Non-molecular target assigned;N;683671;1;CHEMBL386;;
CLD0;;;CHEMBL3285571;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 104, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Immunosuppressive Activity', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Immunosuppression activity in rat assessed as reduction of adjuvant-induced polyarthritis administered po for days 1 to 5 measured on day 15;CHEMBL3272176;Non-molecular target assigned;N;682936;1;CHEMBL376;;
CLD0;;;CHEMBL3285572;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 104, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Immunosuppressive Activity', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Immunosuppression activity in rat assessed as reduction of adjuvant-induced polyarthritis administered po for days 1 to 5 measured on day 21;CHEMBL3272176;Non-molecular target assigned;N;682937;1;CHEMBL376;;
CLD0;;;CHEMBL3285573;[{'assay_class_id': 104, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Immunosuppressive Activity', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Immunosuppression activity in rat assessed as reduction of adjuvant-induced acute inflammation administered po for days 1 to 5;CHEMBL3272176;Non-molecular target assigned;N;682946;1;CHEMBL376;;
CLD0;;;CHEMBL3285079;[];Human herpesvirus 1;[];Sheely;;10298.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus 1 Sheely assessed as inhibition of virus-induced cytopathic effect at 37 degC after 72 hrs by two-fold dilution method;CHEMBL3272294;Non-molecular target assigned;N;673764;1;CHEMBL377;;
CLD0;;;CHEMBL3285080;[];Human herpesvirus 2;[];Curtis;;10310.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against Herpes simplex virus 2 Curtis assessed as inhibition of virus-induced cytopathic effect at 37 degC after 72 hrs by two-fold dilution method;CHEMBL3272294;Non-molecular target assigned;N;673766;1;CHEMBL370;;
CLD0;;HCT-116;CHEMBL3299588;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells by SRB assay;CHEMBL3297674;Non-molecular target assigned;N;692119;1;CHEMBL394;;
CLD0;;A549;CHEMBL3299589;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells by SRB assay;CHEMBL3297674;Non-molecular target assigned;N;692120;1;CHEMBL392;;
CLD0;;SNU-638;CHEMBL3299590;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307747;Target assigned is non-molecular;1;Cytotoxicity against human SNU638 cells by SRB assay;CHEMBL3297674;Non-molecular target assigned;N;692121;1;CHEMBL3879801;;
CLD0;;T47D;CHEMBL3299591;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;Cytotoxicity against human T47D cells by SRB assay;CHEMBL3297674;Non-molecular target assigned;N;692122;1;CHEMBL614361;;
CLD0;;PC-3;CHEMBL3299592;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells by SRB assay;CHEMBL3297674;Non-molecular target assigned;N;692123;1;CHEMBL390;;
CLD0;;K562;CHEMBL3299593;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells by SRB assay;CHEMBL3297674;Non-molecular target assigned;N;692124;1;CHEMBL385;;
CLD0;;;CHEMBL3411293;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Stimulation of human OATP1B3-mediated [3H]CCK-8 at 100 uM after 5 mins relative to control;CHEMBL3407465;Direct protein target assigned;D;732533;1;CHEMBL1743121;;
CLD0;;;CHEMBL3541969;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activity of human recombinant N-terminal His-SUMO fused CDA Ala70Thr mutant expressed in Escherichia coli BL21(DE3) cells assessed as intrinsic clearance for arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Direct protein target assigned;D;641338;1;CHEMBL4502;;{'accession': 'P32320', 'isoform': 1, 'mutation': 'A70T', 'organism': 'Homo sapiens', 'sequence': 'MAQKRPACTLKPECVQQLLVCSQEAKKSAYCPYSHFPVGAALLTQEGRIFKGCNIENACYPLGICAERTTIQKAVSEGYKDFRAIAIASDMQDDFISPCGACRQVMREFGTNWPVYMTKPDGTYIVMTVQELLPSSFGPEDLQKTQ', 'tax_id': 9606, 'version': 2}
CLD0;;;CHEMBL3541970;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activity of human recombinant N-terminal His-SUMO fused CDA Lys27Gln mutant expressed in Escherichia coli BL21(DE3) cells assessed as intrinsic clearance for arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Direct protein target assigned;D;641337;1;CHEMBL4502;;{'accession': 'P32320', 'isoform': 1, 'mutation': 'K27N', 'organism': 'Homo sapiens', 'sequence': 'MAQKRPACTLKPECVQQLLVCSQEAKNSAYCPYSHFPVGAALLTQEGRIFKGCNIENACYPLGICAERTAIQKAVSEGYKDFRAIAIASDMQDDFISPCGACRQVMREFGTNWPVYMTKPDGTYIVMTVQELLPSSFGPEDLQKTQ', 'tax_id': 9606, 'version': 2}
CLD0;;;CHEMBL3541971;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activity of human recombinant N-terminal His-SUMO fused wild type CDA expressed in Escherichia coli BL21(DE3) cells assessed as intrinsic clearance for arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Direct protein target assigned;D;641336;1;CHEMBL4502;;
CLD0;;;CHEMBL3541972;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activity of human recombinant N-terminal His-SUMO fused CDA Ala70Thr mutant expressed in Escherichia coli BL21(DE3) cells assessed as arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Direct protein target assigned;D;641332;1;CHEMBL4502;;{'accession': 'P32320', 'isoform': 1, 'mutation': 'A70T', 'organism': 'Homo sapiens', 'sequence': 'MAQKRPACTLKPECVQQLLVCSQEAKKSAYCPYSHFPVGAALLTQEGRIFKGCNIENACYPLGICAERTTIQKAVSEGYKDFRAIAIASDMQDDFISPCGACRQVMREFGTNWPVYMTKPDGTYIVMTVQELLPSSFGPEDLQKTQ', 'tax_id': 9606, 'version': 2}
CLD0;;;CHEMBL3541973;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activity of human recombinant N-terminal His-SUMO fused CDA Lys27Gln mutant expressed in Escherichia coli BL21(DE3) cells assessed as arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Direct protein target assigned;D;641331;1;CHEMBL4502;;{'accession': 'P32320', 'isoform': 1, 'mutation': 'K27N', 'organism': 'Homo sapiens', 'sequence': 'MAQKRPACTLKPECVQQLLVCSQEAKNSAYCPYSHFPVGAALLTQEGRIFKGCNIENACYPLGICAERTAIQKAVSEGYKDFRAIAIASDMQDDFISPCGACRQVMREFGTNWPVYMTKPDGTYIVMTVQELLPSSFGPEDLQKTQ', 'tax_id': 9606, 'version': 2}
CLD0;;;CHEMBL3541974;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activity of human recombinant N-terminal His-SUMO fused wild type CDA expressed in Escherichia coli BL21(DE3) cells assessed as arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Direct protein target assigned;D;641330;1;CHEMBL4502;;
CLD0;;;CHEMBL3541979;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Ratio of Km for human recombinant N-terminal His-SUMO fused wild type CDA expressed in Escherichia coli BL21(DE3) cells to Km for human recombinant N-terminal His-SUMO fused CDA Ala70Thr mutant expressed in Escherichia coli BL21(DE3) cells;CHEMBL3525898;Default value - Target has yet to be curated;U;641372;1;CHEMBL612558;;
CLD0;;;CHEMBL3541980;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Ratio of Vmax for human recombinant N-terminal His-SUMO fused wild type CDA expressed in Escherichia coli BL21(DE3) cells to Vmax for human recombinant N-terminal His-SUMO fused CDA Ala70Thr mutant expressed in Escherichia coli BL21(DE3) cells;CHEMBL3525898;Default value - Target has yet to be curated;U;641373;1;CHEMBL612558;;
CLD0;;;CHEMBL3541982;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Ratio of Km for human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells to Km for human recombinant N-terminal His-tagged DCK Pro122Ser mutant expressed in Escherichia coli BL21(DE3) cells;CHEMBL3525898;Default value - Target has yet to be curated;U;641375;1;CHEMBL612558;;
CLD0;;;CHEMBL3541983;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Ratio of Vmax for human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells to Vmax for human recombinant N-terminal His-tagged DCK Pro122Ser mutant expressed in Escherichia coli BL21(DE3) cells;CHEMBL3525898;Default value - Target has yet to be curated;U;641376;1;CHEMBL612558;;
CLD0;;;CHEMBL3538237;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Drug metabolism assessed as intrinsic clearance for cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins in presence of human recombinant N-terminal His-tagged DCK Pro122Ser mutant expressed in Escherichia coli BL21(DE3) cells by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Default value - Target has yet to be curated;U;641359;1;CHEMBL612558;;
CLD0;;;CHEMBL3538238;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug metabolism assessed as intrinsic clearance for human recombinant N-terminal His-tagged DCK Ile24Val mutant-mediated cytosine-beta-D-arabinofuranoside-5'-MP formation expressed in Escherichia coli BL21(DE3) incubated for 3 mins by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Default value - Target has yet to be curated;U;641358;1;CHEMBL612558;;
CLD0;;;CHEMBL3538239;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug metabolism assessed as intrinsic clearance for human recombinant N-terminal His-tagged DCK Ala119Gly mutant-mediated cytosine-beta-D-arabinofuranoside-5'-MP formation expressed in Escherichia coli BL21(DE3) incubated for 3 mins by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Default value - Target has yet to be curated;U;641357;1;CHEMBL612558;;
CLD0;;;CHEMBL3538240;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Direct single protein target assigned;9;Drug metabolism assessed as intrinsic clearance for human recombinant N-terminal His-tagged wild type DCK-mediated cytosine-beta-D-arabinofuranoside-5'-MP formation expressed in Escherichia coli BL21(DE3) incubated for 3 mins by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Direct protein target assigned;D;641356;1;CHEMBL2447;;
CLD0;;;CHEMBL3538241;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Activity of human recombinant N-terminal His-tagged DCK Pro122Ser mutant expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Default value - Target has yet to be curated;U;641351;1;CHEMBL612558;;
CLD0;;;CHEMBL3538242;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Activity of human recombinant N-terminal His-tagged DCK Ile24Val mutant expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Default value - Target has yet to be curated;U;641350;1;CHEMBL612558;;
CLD0;;;CHEMBL3538243;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Activity of human recombinant N-terminal His-tagged DCK Ala119Gly mutant expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Default value - Target has yet to be curated;U;641349;1;CHEMBL612558;;
CLD0;;;CHEMBL3538244;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activity of human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry;CHEMBL3525898;Direct protein target assigned;D;641348;1;CHEMBL2447;;
CLD0;confirmatory;;CHEMBL3561973;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117303;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562085;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117318;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562088;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117315;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562112;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117311;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562133;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117302;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562135;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117301;7;CHEMBL612545;;
CLD0;;A549;CHEMBL3583610;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay;CHEMBL3580643;Non-molecular target assigned;N;748181;1;CHEMBL392;;
CLD0;;HCT-116;CHEMBL3583611;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay;CHEMBL3580643;Non-molecular target assigned;N;748182;1;CHEMBL394;;
CLD0;;MDA-MB-231;CHEMBL3583700;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay;CHEMBL3580643;Non-molecular target assigned;N;748183;1;CHEMBL400;;
CLD0;;PC-3;CHEMBL3583701;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay;CHEMBL3580643;Non-molecular target assigned;N;748184;1;CHEMBL390;;
CLD0;;SK-HEP1;CHEMBL3583702;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307741;Target assigned is non-molecular;1;Cytotoxicity against human SKHEP1 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay;CHEMBL3580643;Non-molecular target assigned;N;748185;1;CHEMBL3879801;;
CLD0;;SNU-638;CHEMBL3583703;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307747;Target assigned is non-molecular;1;Cytotoxicity against human SNU638 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay;CHEMBL3580643;Non-molecular target assigned;N;748186;1;CHEMBL3879801;;
CLD0;;KG-1;CHEMBL3749812;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307794;Target assigned is non-molecular;1;Antitumor activity against human KG1 cells xenografted in mouse assessed as tumor regression at 100 mg/kg, po qd measured after 11 days post tumor implantation;CHEMBL3745712;Non-molecular target assigned;N;780477;1;CHEMBL3879801;;
CLD0;;HeLa;CHEMBL3790089;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 72 hrs by SRB assay;CHEMBL3784993;Non-molecular target assigned;N;818391;1;CHEMBL399;;
CLD0;;KB ;CHEMBL3790090;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 72 hrs by SRB assay;CHEMBL3784993;Non-molecular target assigned;N;818392;1;CHEMBL398;;
CLD0;;MCF7;CHEMBL3790091;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7cells after 72 hrs by SRB assay;CHEMBL3784993;Non-molecular target assigned;N;818394;1;CHEMBL387;;
CLD0;;HepG2;CHEMBL3790092;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay;CHEMBL3784993;Non-molecular target assigned;N;818395;1;CHEMBL395;;
CLD0;;HDF;CHEMBL3790093;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against HDF cells after 72 hrs by SRB assay;CHEMBL3784993;Default value - Target has yet to be curated;U;818396;1;CHEMBL612558;;
CLD0;;HeLa;CHEMBL3790094;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 for HDF cells to IC50 for human HeLa cells;CHEMBL3784993;Non-molecular target assigned;N;818398;1;CHEMBL399;;
CLD0;;HDF;CHEMBL3790095;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for HDF cells to IC50 for human KB cells;CHEMBL3784993;Default value - Target has yet to be curated;U;818399;1;CHEMBL612545;;
CLD0;;MCF7;CHEMBL3790096;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 for HDF cells to IC50 for human MCF7 cells;CHEMBL3784993;Non-molecular target assigned;N;818400;1;CHEMBL387;;
CLD0;;HepG2;CHEMBL3790097;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 for HDF cells to IC50 for human HepG2 cells;CHEMBL3784993;Non-molecular target assigned;N;818402;1;CHEMBL395;;
CLD0;;143B;CHEMBL3790098;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307382;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 for HDF cells to IC50 for human 143B cells;CHEMBL3784993;Non-molecular target assigned;N;818403;1;CHEMBL614508;;
CLD0;;143B;CHEMBL3790099;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307382;Target assigned is non-molecular;1;Cytotoxicity against human 143B cells after 72 hrs by SRB assay;CHEMBL3784993;Non-molecular target assigned;N;818404;1;CHEMBL614508;;
CLD0;;143B;CHEMBL3790100;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307382;Target assigned is non-molecular;1;Cytotoxicity against human thymidine kinase deficient 143B cells after 72 hrs by SRB assay;CHEMBL3784993;Non-molecular target assigned;N;818420;1;CHEMBL614508;;
1;;;CHEMBL3885882;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daily Repeat', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daily Repeat', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 50 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
906943;;;CHEMBL4028921;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL6020;;
906944;;;CHEMBL4028922;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL5748;;
906945;;;CHEMBL4028923;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL5918;;
906946;;;CHEMBL4028924;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL1743128;;
911630;;;CHEMBL4029349;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
911633;;;CHEMBL4029350;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
952308;;MV4-11;CHEMBL4059216;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308063;Target assigned is non-molecular;1;Antitumor activity against human MV4-11 cells xenografted in nu/nu mouse assessed as tumor growth inhibition at 50 mg/kg, iv qd measured on day 21 relative to vehicle-treated control;CHEMBL4052828;Non-molecular target assigned;N;;1;CHEMBL613835;;
996856;;;CHEMBL4138020;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Growth inhibition of human umbilical cord cells;CHEMBL4130641;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
996858;;Bone marrow cell;CHEMBL4138021;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295341;Target assigned is non-molecular;1;Growth inhibition of human bone marrow cells;CHEMBL4130641;Non-molecular target assigned;N;;1;CHEMBL4296515;;
1034688;;SMMC-7721;CHEMBL4155616;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Cytotoxicity against human SMMC7721 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034691;;L02;CHEMBL4155617;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Cytotoxicity against human LO2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034697;;SMMC-7721;CHEMBL4155622;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 0.01 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034698;;SMMC-7721;CHEMBL4155623;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 0.1 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034700;;SMMC-7721;CHEMBL4155624;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 0.5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034701;;SMMC-7721;CHEMBL4155625;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 2.5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034703;;SMMC-7721;CHEMBL4155626;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Growth inhibition of human SMMC7721 cells at 5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL613831;;
1034706;;L02;CHEMBL4155627;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 0.01 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034707;;L02;CHEMBL4155628;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 0.1 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034708;;L02;CHEMBL4155629;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 0.5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034709;;L02;CHEMBL4155630;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 2.5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034710;;L02;CHEMBL4155631;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Growth inhibition of human LO2 cells at 5 ug/ml after 72 hrs by MTT assay relative to control;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1034745;;HeLa;CHEMBL4155646;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells;CHEMBL4152291;Non-molecular target assigned;N;;1;CHEMBL399;;
1034269;;A549;CHEMBL4155958;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells assessed as decrease in cell viability after 72 hrs by SRB assay;CHEMBL4152304;Non-molecular target assigned;N;;1;CHEMBL392;;
1034270;;HCT-116;CHEMBL4155959;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by SRB assay;CHEMBL4152304;Non-molecular target assigned;N;;1;CHEMBL394;;
1034271;;SNU-638;CHEMBL4155960;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307747;Target assigned is non-molecular;1;Cytotoxicity against human SNU638 cells assessed as decrease in cell viability after 72 hrs by SRB assay;CHEMBL4152304;Non-molecular target assigned;N;;1;CHEMBL614935;;
1034272;;MDA-MB-231;CHEMBL4155961;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 72 hrs by SRB assay;CHEMBL4152304;Non-molecular target assigned;N;;1;CHEMBL400;;
1034273;;SK-HEP1;CHEMBL4155962;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307741;Target assigned is non-molecular;1;Cytotoxicity against human SKHEP1 cells assessed as decrease in cell viability after 72 hrs by SRB assay;CHEMBL4152304;Non-molecular target assigned;N;;1;CHEMBL614912;;
1034274;;PC-3;CHEMBL4155963;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 72 hrs by SRB assay;CHEMBL4152304;Non-molecular target assigned;N;;1;CHEMBL390;;
966510;;HL-60;CHEMBL4189282;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antitumor activity against human HL60 cells xenografted in zebrafish embryo assessed as inhibition of cell proliferation at 200 ug/ml measured after 3 days of incubation by CM-Dil staining-based microscopic method relative to control;CHEMBL4184316;Non-molecular target assigned;N;;1;CHEMBL383;;
966511;;HL-60;CHEMBL4189283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antitumor activity against human HL60 cells xenografted in zebrafish embryo assessed as inhibition of cell migration at 200 ug/ml measured after 3 days of incubation by CM-Dil staining-based microscopic method relative to control;CHEMBL4184316;Non-molecular target assigned;N;;1;CHEMBL383;;
1006380;;;CHEMBL4255732;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Clearance in human;CHEMBL4251695;Non-molecular target assigned;N;;1;CHEMBL372;;
1049788;;;CHEMBL4268705;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of MDM2 (unknown origin);CHEMBL4265957;Direct protein target assigned;D;;1;CHEMBL5023;;
1041491;;HL-60;CHEMBL4274917;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human HL60 cells;CHEMBL4270610;Non-molecular target assigned;N;;1;CHEMBL383;;
1041493;;Jurkat E6.1;CHEMBL4274918;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295390;Target assigned is non-molecular;1;Antiproliferative activity against human Jurkat E6-1 cells;CHEMBL4270610;Non-molecular target assigned;N;;1;CHEMBL4296446;;
GP_020;;;CHEMBL4296184;[];Staphylococcus aureus subsp. aureus;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 43300;;46170.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL2366800;;
GN_001;;;CHEMBL4296185;[];Escherichia coli;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 25922;;562.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL354;;
GN_003;;;CHEMBL4296186;[];Klebsiella pneumoniae;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 700603;;573.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL350;;
GN_042;;;CHEMBL4296187;[];Pseudomonas aeruginosa;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 27853;;287.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL348;;
GN_034;;;CHEMBL4296188;[];Acinetobacter baumannii;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 19606;;470.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL614425;;
FG_001;;;CHEMBL4296189;[];Candida albicans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD530)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD530)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 90028;;5476.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL366;;
FG_002R;;;CHEMBL4296190;[];Cryptococcus neoformans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Absorption (OD600-OD570)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Absorption (OD600-OD570)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 208821;;5207.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL365;;
1_ELL;;Caco-2;CHEMBL4303805;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307519;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging;CHEMBL4303101;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_HEI;;HRCE;CHEMBL4303810;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4303839;Target assigned is non-molecular;1;Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits);CHEMBL4303122;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_TOU;;Vero C1008;CHEMBL4303819;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs;CHEMBL4303097;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1095936;;U-937;CHEMBL4339843;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Cytotoxicity against human U937 cells assessed as reduction in cell viability at 10 uM measured after 3 days by CCK8 assay;CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095938;;U-937;CHEMBL4339844;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Cytotoxicity against human U937 cells assessed as reduction in cell viability measured after 3 days by CCK8 assay;CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095944;;U-937;CHEMBL4339845;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as live cells at 0.3 uM measured after 1 day by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 95.05 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095945;;U-937;CHEMBL4339846;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as early apoptotic cells at 0.3 uM measured after 1 day by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 0.7 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095946;;U-937;CHEMBL4339847;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as late apoptotic cells at 0.3 uM measured after 1 day by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 1.75 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095947;;U-937;CHEMBL4339848;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as necrotic cells at 0.3 uM measured after 1 day by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 2.5 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095948;;U-937;CHEMBL4339849;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as live cells at 0.3 uM measured after 2 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 95.05 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095949;;U-937;CHEMBL4339850;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as early apoptotic cells at 0.3 uM measured after 2 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 0.7 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095950;;U-937;CHEMBL4339851;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as late apoptotic cells at 0.3 uM measured after 2 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 1.75 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095951;;U-937;CHEMBL4339852;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as necrotic cells at 0.3 uM measured after 2 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 2.5 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095952;;U-937;CHEMBL4339853;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as live cells at 0.3 uM measured after 3 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 95.05 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095953;;U-937;CHEMBL4339854;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as early apoptotic cells at 0.3 uM measured after 3 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 0.7 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095954;;U-937;CHEMBL4339855;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as late apoptotic cells at 0.3 uM measured after 3 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 1.75 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1095955;;U-937;CHEMBL4339856;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Induction of apoptosis in human U937 cells assessed as necrotic cells at 0.3 uM measured after 3 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 2.5 %);CHEMBL4339205;Non-molecular target assigned;N;;1;CHEMBL612794;;
1114650;;SMMC-7721;CHEMBL4346910;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Cytotoxicity against human SMMC7721 cells incubated for 72 hrs by MTT assay;CHEMBL4346655;Non-molecular target assigned;N;;1;CHEMBL613831;;
1114651;;L02;CHEMBL4346911;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Cytotoxicity against human L02 cells incubated for 72 hrs by MTT assay;CHEMBL4346655;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1113444;;HeLa;CHEMBL4387662;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity in human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4385668;Non-molecular target assigned;N;;1;CHEMBL399;;
1113445;;KB ;CHEMBL4387663;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity in human KB cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4385668;Non-molecular target assigned;N;;1;CHEMBL398;;
1113446;;A549;CHEMBL4387664;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4385668;Non-molecular target assigned;N;;1;CHEMBL392;;
1113447;;U-87MG ATCC;CHEMBL4387665;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307575;Target assigned is non-molecular;1;Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4385668;Non-molecular target assigned;N;;1;CHEMBL614247;;
1113448;;HepG2;CHEMBL4387666;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity in human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4385668;Non-molecular target assigned;N;;1;CHEMBL395;;
1113449;;NHDF;CHEMBL4387667;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307481;Target assigned is non-molecular;1;Cytotoxicity in human NHDF cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4385668;Non-molecular target assigned;N;;1;CHEMBL614200;;
1113450;;;CHEMBL4387668;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human HeLa cells;CHEMBL4385668;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1113451;;;CHEMBL4387669;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human KB cells;CHEMBL4385668;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1113452;;;CHEMBL4387670;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human A549 cells;CHEMBL4385668;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1113453;;;CHEMBL4387671;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human U87 cells;CHEMBL4385668;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1113454;;;CHEMBL4387672;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human HepG2 cells;CHEMBL4385668;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1122412;;Z-138;CHEMBL4394731;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL4483125;Target assigned is non-molecular;1;Antitumor activity against human Z138 cells xenografted in nu/nu mouse assessed as inhibition in tumor growth at 40 mg/kg, iv administered 5 times a week for 3 weeks and measured twice per week by caliper method relative to control;CHEMBL4393675;Non-molecular target assigned;N;;1;CHEMBL4483276;;
1122428;;Z-138;CHEMBL4394734;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL4483125;Target assigned is non-molecular;1;Antitumor activity against human Z138 cells xenografted in nu/nu mouse assessed as tumor weight at 40 mg/kg, iv administered 5 times a week for 3 weeks and measured after 21 days (Rvb = 1.74 g);CHEMBL4393675;Non-molecular target assigned;N;;1;CHEMBL4483276;;
1160271;;THP-1;CHEMBL4420581;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 (+/+) cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells with CRISP/CAS9 SAMHD1 knockout;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160272;;THP-1;CHEMBL4420582;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 cells with constitutively expressing high SAMHD1 expression to cytotoxic IC50 for parental human THP1 cells expressing low SAMHD1 expression;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160273;;U-251;CHEMBL4420583;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;Cytotoxic activity against human U251MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL615022;;
1160274;;U-251;CHEMBL4420584;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;Cytotoxic activity against human U251MG cells assessed as reduction in cell viability in presence of lentiviral protein X- virus-like particles incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL615022;;
1160299;;OCI-AML-3;CHEMBL4420585;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human OCI-AML3 cells to cytotoxic IC50 for human OCI-AML3 cells in presence of SAMHD1 shRNA;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160301;;SIG-M5;CHEMBL4420586;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308248;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human SIG-M5 cells to cytotoxic IC50 for human SIG-M5 cells in presence of SAMHD1 shRNA;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL2366251;;
1160304;;THP-1;CHEMBL4420587;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 cells to cytotoxic IC50 for human THP1 cells with CRISP/CAS9 SAMHD1 knockout;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160305;;THP-1;CHEMBL4420588;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells with low SAMHD1 expression;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160310;;;CHEMBL4420589;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Substrate activity at SAMHD1 in human THP1 cells assessed as reduction in cytarabine triphosphate formation at 10 ug/ml incubated for 6 hrs by liquid chromatography tandem mass spectrometry relative to control human THP1 cells with CRISP/CAS9 SAMHD1 knockout;CHEMBL4420068;Direct protein target assigned;D;;38;CHEMBL4523507;;
1160311;;;CHEMBL4420590;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Substrate activity at SAMHD1 (unknown origin) expressed in bacterial system expressed in bacteria assessed as triphospho-hydolase activity by measuring cytarabine tri-phosphate formation;CHEMBL4420068;Direct protein target assigned;D;;38;CHEMBL4523507;;
1160312;;THP-1;CHEMBL4420591;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells in presence of lentiviral protein X- virus-like particles;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160314;;HEL;CHEMBL4420592;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells assessed as reduction in cell viability at 10 to 50 ug/ml in presence of lentiviral protein X- virus-like particles incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160316;;HL-60;CHEMBL4420593;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxic activity against human HL60 cells assessed as reduction in cell viability at 10 to 50 ug/ml in presence of lentiviral protein X- virus-like particles incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL383;;
1160317;;MOLM-13;CHEMBL4420594;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706573;Target assigned is non-molecular;1;Cytotoxic activity against human MOLM13 cells assessed as reduction in cell viability at 10 to 50 ug/ml in presence of lentiviral protein X- virus-like particles incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL3706572;;
1160318;;U-251;CHEMBL4420595;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human U251MG cells expressing wild type SAMHD1 to cytotoxic IC50 for human U251MG cells in presence of lentiviral protein X- virus-like particles;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL615022;;
1160319;;THP-1;CHEMBL4420596;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxic activity against human THP1 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160320;;THP-1;CHEMBL4420597;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxic activity against human THP1 cells with CRISP/CAS9 SAMHD1 knockout assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160321;;OCI-AML-3;CHEMBL4420598;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of control shRNA incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160322;;OCI-AML-3;CHEMBL4420599;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of shSAMHD1 incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160323;;HEL;CHEMBL4420600;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells expressing wild type SAMHD1 assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160324;;HEL;CHEMBL4420601;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells expressing SAMHD1 D311A mutant assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160325;;THP-1;CHEMBL4420602;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxic activity against human THP1 cells assessed as reduction in cell viability in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160326;;THP-1;CHEMBL4420603;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxic activity against human THP1 cells with CRISP/CAS9 SAMHD1 knockout assessed as reduction in cell viability in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160327;;OCI-AML-3;CHEMBL4420604;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of control shRNA in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160328;;OCI-AML-3;CHEMBL4420605;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of shSAMHD1 in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160329;;HEL;CHEMBL4420606;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells expressing wild type SAMHD1 assessed as reduction in cell viability in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160330;;HEL;CHEMBL4420607;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells expressing SAMHD1 D311A mutant assessed as reduction in cell viability in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160331;;THP-1;CHEMBL4420608;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxic activity against human THP1 cells assessed as reduction in cell viability in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160332;;THP-1;CHEMBL4420609;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxic activity against human THP1 cells with CRISP/CAS9 SAMHD1 knockout assessed as reduction in cell viability in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160333;;OCI-AML-3;CHEMBL4420610;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of control shRNA in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160334;;OCI-AML-3;CHEMBL4420611;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of shSAMHD1 in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160335;;HEL;CHEMBL4420612;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells expressing wild type SAMHD1 assessed as reduction in cell viability in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160336;;HEL;CHEMBL4420613;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells expressing SAMHD1 D311A mutant assessed as reduction in cell viability in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160337;;THP-1;CHEMBL4420614;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxic activity against human THP1 cells assessed as reduction in cell viability in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160338;;THP-1;CHEMBL4420615;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxic activity against human THP1 cells with CRISP/CAS9 SAMHD1 knockout assessed as reduction in cell viability in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160339;;OCI-AML-3;CHEMBL4420616;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of control shRNA in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160340;;OCI-AML-3;CHEMBL4420617;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295392;Target assigned is non-molecular;1;Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of shSAMHD1 in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL4296479;;
1160341;;HEL;CHEMBL4420618;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells expressing wild type SAMHD1 assessed as reduction in cell viability in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160342;;HEL;CHEMBL4420619;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308090;Target assigned is non-molecular;1;Cytotoxic activity against human HEL cells expressing SAMHD1 D311A mutant assessed as reduction in cell viability in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL613888;;
1160343;;BFTC-905;CHEMBL4420620;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308470;Target assigned is non-molecular;1;Cytotoxic activity against human BFTC905 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL1075396;;
1160344;;KU-19-19;CHEMBL4420621;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308111;Target assigned is non-molecular;1;Cytotoxic activity against human KU-19-19 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL1075483;;
1160345;;RT-112;CHEMBL4420622;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307307;Target assigned is non-molecular;1;Cytotoxic activity against human RT112 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614145;;
1160346;;TCC-SUP;CHEMBL4420623;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307466;Target assigned is non-molecular;1;Cytotoxic activity against human TCCSUP cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL615010;;
1160347;;T-24;CHEMBL4420624;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;Cytotoxic activity against human T24 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614774;;
1160348;;BFTC-905;CHEMBL4420625;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308470;Target assigned is non-molecular;1;Cytotoxic activity against human BFTC905 cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL1075396;;
1160349;;KU-19-19;CHEMBL4420626;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308111;Target assigned is non-molecular;1;Cytotoxic activity against human KU-19-19 cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL1075483;;
1160350;;RT-112;CHEMBL4420627;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307307;Target assigned is non-molecular;1;Cytotoxic activity against human RT112 cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614145;;
1160351;;TCC-SUP;CHEMBL4420628;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307466;Target assigned is non-molecular;1;Cytotoxic activity against human TCCSUP cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL615010;;
1160352;;T-24;CHEMBL4420629;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;Cytotoxic activity against human T24 cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614774;;
1160353;;BFTC-905;CHEMBL4420630;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308470;Target assigned is non-molecular;1;Cytotoxic activity against human BFTC905 cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL1075396;;
1160354;;KU-19-19;CHEMBL4420631;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308111;Target assigned is non-molecular;1;Cytotoxic activity against human KU-19-19 cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL1075483;;
1160355;;RT-112;CHEMBL4420632;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307307;Target assigned is non-molecular;1;Cytotoxic activity against human RT112 cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614145;;
1160356;;TCC-SUP;CHEMBL4420633;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307466;Target assigned is non-molecular;1;Cytotoxic activity against human TCCSUP cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL615010;;
1160357;;T-24;CHEMBL4420634;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;Cytotoxic activity against human T24 cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614774;;
853985;;HeLa;CHEMBL4432284;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay;CHEMBL4431333;Non-molecular target assigned;N;;1;CHEMBL399;;
853986;;KB ;CHEMBL4432285;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay;CHEMBL4431333;Non-molecular target assigned;N;;1;CHEMBL398;;
853987;;MCF7;CHEMBL4432286;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay;CHEMBL4431333;Non-molecular target assigned;N;;1;CHEMBL387;;
853988;;HepG2;CHEMBL4432287;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay;CHEMBL4431333;Non-molecular target assigned;N;;1;CHEMBL395;;
853989;;NHDF;CHEMBL4432288;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307481;Target assigned is non-molecular;1;Cytotoxicity against HDF assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay;CHEMBL4431333;Non-molecular target assigned;N;;1;CHEMBL614200;;
853991;;;CHEMBL4432290;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for HDF to IC50 for human HeLa cells;CHEMBL4431333;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
853992;;;CHEMBL4432291;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for HDF to IC50 for human KB cells;CHEMBL4431333;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
853993;;;CHEMBL4432292;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for HDF to IC50 for human MCF7 cells;CHEMBL4431333;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
853994;;;CHEMBL4432293;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for HDF to IC50 for human HepG2 cells;CHEMBL4431333;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1_KUZ;;;CHEMBL4495582;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate;CHEMBL4495564;Direct protein target assigned;D;;52;CHEMBL4523582;;
1_LEY;;Vero C1008;CHEMBL4513082;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4495565;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1282777;;MV4-11;CHEMBL4770560;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308063;Target assigned is non-molecular;1;Antitumor activity against human MV4-11 cells xenografted in Balb/c nude mouse assessed as reduction in tumor volume at 40 mg/kg, iv administered once daily for 21 days (Rvb = 1.00 g);CHEMBL4765336;Non-molecular target assigned;N;;1;CHEMBL613835;;
1282297;;SK-BR-3;CHEMBL4772196;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308062;Target assigned is non-molecular;1;Antiproliferative activity against human SK-BR-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay;CHEMBL4765380;Non-molecular target assigned;N;;1;CHEMBL613834;;
1282298;;SK-OV-3;CHEMBL4772197;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay;CHEMBL4765380;Non-molecular target assigned;N;;1;CHEMBL614925;;
1282299;;PC-3;CHEMBL4772198;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Antiproliferative activity against human PC-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay;CHEMBL4765380;Non-molecular target assigned;N;;1;CHEMBL390;;
1282300;;U-87MG ATCC;CHEMBL4772199;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307575;Target assigned is non-molecular;1;Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay;CHEMBL4765380;Non-molecular target assigned;N;;1;CHEMBL614247;;
1282301;;A549;CHEMBL4772200;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay;CHEMBL4765380;Non-molecular target assigned;N;;1;CHEMBL392;;
1282302;;HDFa;CHEMBL4772201;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human HDF cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay;CHEMBL4765380;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1282303;;;CHEMBL4772202;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human SK-BR-3 cells;CHEMBL4765380;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1282304;;;CHEMBL4772203;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human SK-OV-3 cells;CHEMBL4765380;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1282305;;;CHEMBL4772204;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human PC-3 cells;CHEMBL4765380;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1282306;;;CHEMBL4772205;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human U-87 MG cells;CHEMBL4765380;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1282307;;;CHEMBL4772206;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human A549 cells;CHEMBL4765380;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1342091;;MV4-11;CHEMBL4832206;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308063;Target assigned is non-molecular;1;Antitumor activity against human MV4-11 cells xenografted in female nude mouse assessed as tumor weight growth inhibition at 100 mg/kg, ip measured after 21 days;CHEMBL4831498;Non-molecular target assigned;N;;1;CHEMBL613835;;
1434875;;A549;CHEMBL5110566;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay;CHEMBL5108023;Non-molecular target assigned;N;;1;CHEMBL392;;
1434876;;WI-38;CHEMBL5110567;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307614;Target assigned is non-molecular;1;Antiproliferative activity against human WI-38 cells measured after 48 hrs by MTT assay;CHEMBL5108023;Non-molecular target assigned;N;;1;CHEMBL614391;;
1434877;;;CHEMBL5110568;[];;[];;;;;;T;Toxicity;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio IC50 for antiproliferative activity against human WI-38 cells over IC50 for antiproliferative activity against human A549 cells;CHEMBL5108023;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1397350;;;CHEMBL5134922;[];Hepatitis C virus;[];;;11103.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against HCV by replicon assay;CHEMBL5131483;Non-molecular target assigned;N;;1;CHEMBL379;;
1397355;;U-87MG ATCC;CHEMBL5134923;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307575;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human U-87 MG cells measured after 3 days by Celltiter-glo assay;CHEMBL5131483;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1437035;;MCF7;CHEMBL5216179;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 48 hrs by AlamarBlue assay;CHEMBL5214922;Non-molecular target assigned;N;;1;CHEMBL387;;
